id	sid	tid	token	lemma	pos
dpc-2259	1	1	dermatology	dermatology	NOUN
dpc-2259	1	2	:	:	PUNCT
dpc-2259	1	3	practical	practical	ADJ
dpc-2259	1	4	and	and	CCONJ
dpc-2259	1	5	conceptual	conceptual	ADJ
dpc-2259	1	6	original	original	ADJ
dpc-2259	1	7	article	article	NOUN
dpc-2259	1	8	|	|	ADV
dpc-2259	1	9	dermatol	dermatol	ADJ
dpc-2259	1	10	pract	pract	NOUN
dpc-2259	1	11	concept	concept	NOUN
dpc-2259	1	12	.	.	PUNCT
dpc-2259	2	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	2	2	1	1	NUM
dpc-2259	2	3	impact	impact	NOUN
dpc-2259	2	4	of	of	ADP
dpc-2259	2	5	covid-19	covid-19	PROPN
dpc-2259	2	6	pandemic	pandemic	NOUN
dpc-2259	2	7	on	on	ADP
dpc-2259	2	8	hidradenitis	hidradenitis	PROPN
dpc-2259	2	9	suppurativa	suppurativa	NOUN
dpc-2259	2	10	patients	patient	NOUN
dpc-2259	2	11	:	:	PUNCT
dpc-2259	2	12	a	a	DET
dpc-2259	2	13	cross	cross	ADJ
dpc-2259	2	14	-	-	ADJ
dpc-2259	2	15	sectional	sectional	ADJ
dpc-2259	2	16	study	study	NOUN
dpc-2259	2	17	from	from	ADP
dpc-2259	2	18	tertiary	tertiary	ADJ
dpc-2259	2	19	referral	referral	ADJ
dpc-2259	2	20	hospital	hospital	NOUN
dpc-2259	2	21	ecem	ecem	PROPN
dpc-2259	2	22	bostan1	bostan1	PROPN
dpc-2259	2	23	,	,	PUNCT
dpc-2259	2	24	adam	adam	PROPN
dpc-2259	2	25	jarbou1	jarbou1	PROPN
dpc-2259	2	26	,	,	PUNCT
dpc-2259	2	27	aysen	aysen	PROPN
dpc-2259	2	28	karaduman1	karaduman1	PROPN
dpc-2259	2	29	,	,	PUNCT
dpc-2259	2	30	duygu	duygu	PROPN
dpc-2259	2	31	gulseren1	gulseren1	PROPN
dpc-2259	2	32	,	,	PUNCT
dpc-2259	2	33	basak	basak	PROPN
dpc-2259	2	34	yalici	yalici	PROPN
dpc-2259	2	35	-	-	PUNCT
dpc-2259	2	36	armagan1	armagan1	PROPN
dpc-2259	2	37	,	,	PUNCT
dpc-2259	2	38	neslihan	neslihan	NOUN
dpc-2259	2	39	akdogan1	akdogan1	NOUN
dpc-2259	2	40	1	1	NUM
dpc-2259	2	41	department	department	NOUN
dpc-2259	2	42	of	of	ADP
dpc-2259	2	43	dermatology	dermatology	NOUN
dpc-2259	2	44	and	and	CCONJ
dpc-2259	2	45	venereology	venereology	NOUN
dpc-2259	2	46	,	,	PUNCT
dpc-2259	2	47	hacettepe	hacettepe	PROPN
dpc-2259	2	48	university	university	NOUN
dpc-2259	2	49	,	,	PUNCT
dpc-2259	2	50	faculty	faculty	NOUN
dpc-2259	2	51	of	of	ADP
dpc-2259	2	52	medicine	medicine	NOUN
dpc-2259	2	53	,	,	PUNCT
dpc-2259	2	54	ankara	ankara	PROPN
dpc-2259	2	55	,	,	PUNCT
dpc-2259	2	56	turkey	turkey	PROPN
dpc-2259	2	57	key	key	ADJ
dpc-2259	2	58	words	word	NOUN
dpc-2259	2	59	:	:	PUNCT
dpc-2259	2	60	covid-19	covid-19	PROPN
dpc-2259	2	61	,	,	PUNCT
dpc-2259	2	62	hidradenitis	hidradenitis	PROPN
dpc-2259	2	63	suppurativa	suppurativa	PROPN
dpc-2259	2	64	,	,	PUNCT
dpc-2259	2	65	impact	impact	NOUN
dpc-2259	2	66	,	,	PUNCT
dpc-2259	2	67	treatment	treatment	NOUN
dpc-2259	2	68	citation	citation	NOUN
dpc-2259	2	69	:	:	PUNCT
dpc-2259	2	70	bostan	bostan	PROPN
dpc-2259	2	71	e	e	PROPN
dpc-2259	2	72	,	,	PUNCT
dpc-2259	2	73	jarbou	jarbou	PROPN
dpc-2259	2	74	a	a	PROPN
dpc-2259	2	75	,	,	PUNCT
dpc-2259	2	76	karaduman	karaduman	PROPN
dpc-2259	2	77	a	a	NOUN
dpc-2259	2	78	,	,	PUNCT
dpc-2259	2	79	gulseren	gulseren	PROPN
dpc-2259	2	80	d	d	PROPN
dpc-2259	2	81	,	,	PUNCT
dpc-2259	2	82	yalici	yalici	PROPN
dpc-2259	2	83	-	-	PUNCT
dpc-2259	2	84	armagan	armagan	PROPN
dpc-2259	2	85	b	b	PROPN
dpc-2259	2	86	,	,	PUNCT
dpc-2259	2	87	akdogan	akdogan	VERB
dpc-2259	2	88	n.	n.	NOUN
dpc-2259	2	89	impact	impact	NOUN
dpc-2259	2	90	of	of	ADP
dpc-2259	2	91	covid-19	covid-19	PROPN
dpc-2259	2	92	pandemic	pandemic	NOUN
dpc-2259	2	93	on	on	ADP
dpc-2259	2	94	hidradenitis	hidradenitis	PROPN
dpc-2259	2	95	suppurativa	suppurativa	NOUN
dpc-2259	2	96	patients	patient	NOUN
dpc-2259	2	97	:	:	PUNCT
dpc-2259	2	98	a	a	DET
dpc-2259	2	99	cross	cross	ADJ
dpc-2259	2	100	-	-	ADJ
dpc-2259	2	101	sectional	sectional	ADJ
dpc-2259	2	102	study	study	NOUN
dpc-2259	2	103	from	from	ADP
dpc-2259	2	104	tertiary	tertiary	ADJ
dpc-2259	2	105	referral	referral	ADJ
dpc-2259	2	106	hospital	hospital	NOUN
dpc-2259	2	107	.	.	PUNCT
dpc-2259	3	1	dermatol	dermatol	NOUN
dpc-2259	3	2	pract	pract	PROPN
dpc-2259	3	3	concept	concept	NOUN
dpc-2259	3	4	.	.	PUNCT
dpc-2259	4	1	2022;12(4):e2022192	2022;12(4):e2022192	X
dpc-2259	4	2	.	.	PUNCT
dpc-2259	4	3	doi	doi	PROPN
dpc-2259	4	4	:	:	PUNCT
dpc-2259	4	5	https://doi.org/10.5826/dpc.1204a192	https://doi.org/10.5826/dpc.1204a192	NOUN
dpc-2259	4	6	accepted	accept	VERB
dpc-2259	4	7	:	:	PUNCT
dpc-2259	4	8	march	march	PROPN
dpc-2259	4	9	21	21	NUM
dpc-2259	4	10	,	,	PUNCT
dpc-2259	4	11	2022	2022	NUM
dpc-2259	4	12	;	;	PUNCT
dpc-2259	4	13	published	publish	VERB
dpc-2259	4	14	:	:	PUNCT
dpc-2259	4	15	october	october	PROPN
dpc-2259	4	16	2022	2022	NUM
dpc-2259	5	1	copyright	copyright	NOUN
dpc-2259	5	2	:	:	PUNCT
dpc-2259	5	3	©	©	PROPN
dpc-2259	5	4	2022	2022	NUM
dpc-2259	5	5	bostan	bostan	PROPN
dpc-2259	5	6	et	et	PROPN
dpc-2259	5	7	al	al	PROPN
dpc-2259	5	8	.	.	PUNCT
dpc-2259	6	1	this	this	PRON
dpc-2259	6	2	is	be	AUX
dpc-2259	6	3	an	an	DET
dpc-2259	6	4	open	open	ADJ
dpc-2259	6	5	-	-	PUNCT
dpc-2259	6	6	access	access	NOUN
dpc-2259	6	7	article	article	NOUN
dpc-2259	6	8	distributed	distribute	VERB
dpc-2259	6	9	under	under	ADP
dpc-2259	6	10	the	the	DET
dpc-2259	6	11	terms	term	NOUN
dpc-2259	6	12	of	of	ADP
dpc-2259	6	13	the	the	DET
dpc-2259	6	14	creative	creative	ADJ
dpc-2259	6	15	commons	common	NOUN
dpc-2259	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2259	6	17	license	license	NOUN
dpc-2259	6	18	(	(	PUNCT
dpc-2259	6	19	by	by	ADP
dpc-2259	6	20	-	-	PUNCT
dpc-2259	6	21	nc-4.0	nc-4.0	NOUN
dpc-2259	6	22	)	)	PUNCT
dpc-2259	6	23	,	,	PUNCT
dpc-2259	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2259	6	25	,	,	PUNCT
dpc-2259	6	26	which	which	PRON
dpc-2259	6	27	permits	permit	VERB
dpc-2259	6	28	unrestricted	unrestricted	ADJ
dpc-2259	6	29	noncommercial	noncommercial	ADJ
dpc-2259	6	30	use	use	NOUN
dpc-2259	6	31	,	,	PUNCT
dpc-2259	6	32	distribution	distribution	NOUN
dpc-2259	6	33	,	,	PUNCT
dpc-2259	6	34	and	and	CCONJ
dpc-2259	6	35	reproduction	reproduction	NOUN
dpc-2259	6	36	in	in	ADP
dpc-2259	6	37	any	any	DET
dpc-2259	6	38	medium	medium	NOUN
dpc-2259	6	39	,	,	PUNCT
dpc-2259	6	40	provided	provide	VERB
dpc-2259	6	41	the	the	DET
dpc-2259	6	42	original	original	ADJ
dpc-2259	6	43	authors	author	NOUN
dpc-2259	6	44	and	and	CCONJ
dpc-2259	6	45	source	source	NOUN
dpc-2259	6	46	are	be	AUX
dpc-2259	6	47	credited	credit	VERB
dpc-2259	6	48	.	.	PUNCT
dpc-2259	7	1	funding	funding	NOUN
dpc-2259	7	2	:	:	PUNCT
dpc-2259	7	3	none	none	NOUN
dpc-2259	7	4	.	.	PUNCT
dpc-2259	8	1	competing	compete	VERB
dpc-2259	8	2	interests	interest	NOUN
dpc-2259	8	3	:	:	PUNCT
dpc-2259	8	4	none	none	NOUN
dpc-2259	8	5	.	.	PUNCT
dpc-2259	9	1	authorship	authorship	NOUN
dpc-2259	9	2	:	:	PUNCT
dpc-2259	9	3	all	all	DET
dpc-2259	9	4	authors	author	NOUN
dpc-2259	9	5	have	have	AUX
dpc-2259	9	6	contributed	contribute	VERB
dpc-2259	9	7	significantly	significantly	ADV
dpc-2259	9	8	to	to	ADP
dpc-2259	9	9	this	this	DET
dpc-2259	9	10	publication	publication	NOUN
dpc-2259	9	11	.	.	PUNCT
dpc-2259	10	1	corresponding	correspond	VERB
dpc-2259	10	2	author	author	NOUN
dpc-2259	10	3	:	:	PUNCT
dpc-2259	10	4	ecem	ecem	PROPN
dpc-2259	10	5	bostan	bostan	PROPN
dpc-2259	10	6	,	,	PUNCT
dpc-2259	10	7	md	md	PROPN
dpc-2259	10	8	,	,	PUNCT
dpc-2259	10	9	hacettepe	hacettepe	PROPN
dpc-2259	10	10	university	university	NOUN
dpc-2259	10	11	,	,	PUNCT
dpc-2259	10	12	faculty	faculty	NOUN
dpc-2259	10	13	of	of	ADP
dpc-2259	10	14	medicine	medicine	NOUN
dpc-2259	10	15	,	,	PUNCT
dpc-2259	10	16	department	department	NOUN
dpc-2259	10	17	of	of	ADP
dpc-2259	10	18	dermatology	dermatology	NOUN
dpc-2259	10	19	and	and	CCONJ
dpc-2259	10	20	venereology	venereology	NOUN
dpc-2259	10	21	,	,	PUNCT
dpc-2259	10	22	ankara	ankara	PROPN
dpc-2259	10	23	,	,	PUNCT
dpc-2259	10	24	turkey	turkey	PROPN
dpc-2259	10	25	,	,	PUNCT
dpc-2259	10	26	phone	phone	NOUN
dpc-2259	10	27	:	:	PUNCT
dpc-2259	10	28	03123051704	03123051704	NUM
dpc-2259	10	29	,	,	PUNCT
dpc-2259	10	30	fax	fax	NOUN
dpc-2259	10	31	:	:	PUNCT
dpc-2259	10	32	0	0	NUM
dpc-2259	10	33	3123054127	3123054127	NUM
dpc-2259	10	34	,	,	PUNCT
dpc-2259	10	35	e	e	NOUN
dpc-2259	10	36	-	-	NOUN
dpc-2259	10	37	mail	mail	NOUN
dpc-2259	10	38	:	:	PUNCT
dpc-2259	10	39	bostanecem@gmail.com	bostanecem@gmail.com	X
dpc-2259	11	1	introduction	introduction	NOUN
dpc-2259	11	2	:	:	PUNCT
dpc-2259	11	3	hidradenitis	hidradenitis	PROPN
dpc-2259	11	4	suppurativa	suppurativa	PROPN
dpc-2259	11	5	(	(	PUNCT
dpc-2259	11	6	hs	hs	X
dpc-2259	11	7	)	)	PUNCT
dpc-2259	11	8	is	be	AUX
dpc-2259	11	9	a	a	DET
dpc-2259	11	10	chronic	chronic	NOUN
dpc-2259	11	11	,	,	PUNCT
dpc-2259	11	12	disabling	disable	VERB
dpc-2259	11	13	skin	skin	NOUN
dpc-2259	11	14	disorder	disorder	NOUN
dpc-2259	11	15	which	which	PRON
dpc-2259	11	16	is	be	AUX
dpc-2259	11	17	characterized	characterize	VERB
dpc-2259	11	18	by	by	ADP
dpc-2259	11	19	recurrent	recurrent	ADJ
dpc-2259	11	20	attacks	attack	NOUN
dpc-2259	11	21	of	of	ADP
dpc-2259	11	22	nodule	nodule	NOUN
dpc-2259	11	23	,	,	PUNCT
dpc-2259	11	24	abscess	abscess	NOUN
dpc-2259	11	25	,	,	PUNCT
dpc-2259	11	26	sinus	sinus	NOUN
dpc-2259	11	27	tract	tract	NOUN
dpc-2259	11	28	formation	formation	NOUN
dpc-2259	11	29	and	and	CCONJ
dpc-2259	11	30	scarring	scarring	NOUN
dpc-2259	11	31	.	.	PUNCT
dpc-2259	12	1	oral	oral	ADJ
dpc-2259	12	2	/	/	SYM
dpc-2259	12	3	topical	topical	ADJ
dpc-2259	12	4	antibiotics	antibiotic	NOUN
dpc-2259	12	5	,	,	PUNCT
dpc-2259	12	6	oral	oral	ADJ
dpc-2259	12	7	retinoids	retinoid	NOUN
dpc-2259	12	8	and	and	CCONJ
dpc-2259	12	9	tnf	tnf	PROPN
dpc-2259	12	10	-	-	PUNCT
dpc-2259	12	11	alpha	alpha	NOUN
dpc-2259	12	12	inhibitors	inhibitor	NOUN
dpc-2259	12	13	are	be	AUX
dpc-2259	12	14	used	use	VERB
dpc-2259	12	15	for	for	ADP
dpc-2259	12	16	the	the	DET
dpc-2259	12	17	treatment	treatment	NOUN
dpc-2259	12	18	of	of	ADP
dpc-2259	12	19	hs	hs	PROPN
dpc-2259	12	20	.	.	PROPN
dpc-2259	12	21	objectives	objective	NOUN
dpc-2259	12	22	:	:	PUNCT
dpc-2259	12	23	in	in	ADP
dpc-2259	12	24	the	the	DET
dpc-2259	12	25	present	present	ADJ
dpc-2259	12	26	study	study	NOUN
dpc-2259	12	27	,	,	PUNCT
dpc-2259	12	28	we	we	PRON
dpc-2259	12	29	aimed	aim	VERB
dpc-2259	12	30	to	to	PART
dpc-2259	12	31	determine	determine	VERB
dpc-2259	12	32	the	the	DET
dpc-2259	12	33	prevalence	prevalence	NOUN
dpc-2259	12	34	of	of	ADP
dpc-2259	12	35	coronavirus	coronavirus	NOUN
dpc-2259	12	36	 	 	SPACE
dpc-2259	12	37	disease	disease	NOUN
dpc-2259	12	38	2019	2019	NUM
dpc-2259	12	39	(	(	PUNCT
dpc-2259	12	40	covid-19	covid-19	PROPN
dpc-2259	12	41	)	)	PUNCT
dpc-2259	12	42	real	real	ADJ
dpc-2259	12	43	-	-	PUNCT
dpc-2259	12	44	time	time	NOUN
dpc-2259	12	45	polymerase	polymerase	NOUN
dpc-2259	12	46	chain	chain	NOUN
dpc-2259	12	47	reaction	reaction	NOUN
dpc-2259	12	48	(	(	PUNCT
dpc-2259	12	49	real	real	ADJ
dpc-2259	12	50	-	-	PUNCT
dpc-2259	12	51	time	time	NOUN
dpc-2259	12	52	pcr	pcr	NOUN
dpc-2259	12	53	)	)	PUNCT
dpc-2259	12	54	positivity	positivity	NOUN
dpc-2259	12	55	and	and	CCONJ
dpc-2259	12	56	the	the	DET
dpc-2259	12	57	presence	presence	NOUN
dpc-2259	12	58	of	of	ADP
dpc-2259	12	59	covid-19	covid-19	PROPN
dpc-2259	12	60	related	related	ADJ
dpc-2259	12	61	symptoms	symptom	NOUN
dpc-2259	12	62	in	in	ADP
dpc-2259	12	63	relation	relation	NOUN
dpc-2259	12	64	to	to	ADP
dpc-2259	12	65	the	the	DET
dpc-2259	12	66	age	age	NOUN
dpc-2259	12	67	,	,	PUNCT
dpc-2259	12	68	gender	gender	NOUN
dpc-2259	12	69	,	,	PUNCT
dpc-2259	12	70	body	body	NOUN
dpc-2259	12	71	mass	mass	PROPN
dpc-2259	12	72	index	index	NOUN
dpc-2259	12	73	,	,	PUNCT
dpc-2259	12	74	disease	disease	NOUN
dpc-2259	12	75	duration	duration	NOUN
dpc-2259	12	76	,	,	PUNCT
dpc-2259	12	77	treatment	treatment	NOUN
dpc-2259	12	78	used	use	VERB
dpc-2259	12	79	for	for	ADP
dpc-2259	12	80	hs	hs	PROPN
dpc-2259	12	81	,	,	PUNCT
dpc-2259	12	82	treatment	treatment	NOUN
dpc-2259	12	83	duration	duration	NOUN
dpc-2259	12	84	and	and	CCONJ
dpc-2259	12	85	smoking	smoking	NOUN
dpc-2259	12	86	.	.	PUNCT
dpc-2259	13	1	methods	method	NOUN
dpc-2259	13	2	:	:	PUNCT
dpc-2259	13	3	we	we	PRON
dpc-2259	13	4	conducted	conduct	VERB
dpc-2259	13	5	a	a	DET
dpc-2259	13	6	comparative	comparative	NOUN
dpc-2259	13	7	,	,	PUNCT
dpc-2259	13	8	cross	cross	ADJ
dpc-2259	13	9	-	-	ADJ
dpc-2259	13	10	sectional	sectional	ADJ
dpc-2259	13	11	study	study	NOUN
dpc-2259	13	12	of	of	ADP
dpc-2259	13	13	178	178	NUM
dpc-2259	13	14	patients	patient	NOUN
dpc-2259	13	15	diagnosed	diagnose	VERB
dpc-2259	13	16	with	with	ADP
dpc-2259	13	17	hs	hs	PRON
dpc-2259	13	18	in	in	ADP
dpc-2259	13	19	a	a	DET
dpc-2259	13	20	referral	referral	ADJ
dpc-2259	13	21	hospital	hospital	NOUN
dpc-2259	13	22	.	.	PUNCT
dpc-2259	14	1	age	age	NOUN
dpc-2259	14	2	,	,	PUNCT
dpc-2259	14	3	gender	gender	NOUN
dpc-2259	14	4	,	,	PUNCT
dpc-2259	14	5	smoking	smoking	NOUN
dpc-2259	14	6	status	status	NOUN
dpc-2259	14	7	,	,	PUNCT
dpc-2259	14	8	body	body	NOUN
dpc-2259	14	9	mass	mass	PROPN
dpc-2259	14	10	index	index	NOUN
dpc-2259	14	11	,	,	PUNCT
dpc-2259	14	12	treatment	treatment	NOUN
dpc-2259	14	13	modalities	modality	NOUN
dpc-2259	14	14	used	use	VERB
dpc-2259	14	15	for	for	ADP
dpc-2259	14	16	hs	hs	PROPN
dpc-2259	14	17	,	,	PUNCT
dpc-2259	14	18	the	the	DET
dpc-2259	14	19	presence	presence	NOUN
dpc-2259	14	20	of	of	ADP
dpc-2259	14	21	covid-19	covid-19	PROPN
dpc-2259	14	22	related	related	ADJ
dpc-2259	14	23	symptoms	symptom	NOUN
dpc-2259	14	24	,	,	PUNCT
dpc-2259	14	25	history	history	NOUN
dpc-2259	14	26	of	of	ADP
dpc-2259	14	27	close	close	ADJ
dpc-2259	14	28	contact	contact	NOUN
dpc-2259	14	29	to	to	ADP
dpc-2259	14	30	a	a	DET
dpc-2259	14	31	person	person	NOUN
dpc-2259	14	32	with	with	ADP
dpc-2259	14	33	covid-19	covid-19	PROPN
dpc-2259	14	34	and	and	CCONJ
dpc-2259	14	35	covid-19	covid-19	PROPN
dpc-2259	14	36	real	real	ADJ
dpc-2259	14	37	time	time	NOUN
dpc-2259	14	38	-	-	PUNCT
dpc-2259	14	39	pcr	pcr	ADJ
dpc-2259	14	40	results	result	NOUN
dpc-2259	14	41	were	be	AUX
dpc-2259	14	42	determined	determine	VERB
dpc-2259	14	43	by	by	ADP
dpc-2259	14	44	a	a	DET
dpc-2259	14	45	telephone	telephone	NOUN
dpc-2259	14	46	questionnaire	questionnaire	NOUN
dpc-2259	14	47	.	.	PUNCT
dpc-2259	15	1	results	result	NOUN
dpc-2259	15	2	:	:	PUNCT
dpc-2259	15	3	sixty	sixty	NUM
dpc-2259	15	4	-	-	PUNCT
dpc-2259	15	5	three	three	NUM
dpc-2259	15	6	patients	patient	NOUN
dpc-2259	15	7	were	be	AUX
dpc-2259	15	8	female	female	ADJ
dpc-2259	15	9	,	,	PUNCT
dpc-2259	15	10	whereas	whereas	SCONJ
dpc-2259	15	11	115	115	NUM
dpc-2259	15	12	patients	patient	NOUN
dpc-2259	15	13	were	be	AUX
dpc-2259	15	14	male	male	ADJ
dpc-2259	15	15	.	.	PUNCT
dpc-2259	16	1	during	during	ADP
dpc-2259	16	2	covid-19	covid-19	PROPN
dpc-2259	16	3	pandemic	pandemic	NOUN
dpc-2259	16	4	,	,	PUNCT
dpc-2259	16	5	94	94	NUM
dpc-2259	16	6	out	out	ADP
dpc-2259	16	7	of	of	ADP
dpc-2259	16	8	178	178	NUM
dpc-2259	16	9	patients	patient	NOUN
dpc-2259	16	10	had	have	VERB
dpc-2259	16	11	covid-19	covid-19	PROPN
dpc-2259	16	12	related	related	ADJ
dpc-2259	16	13	symptoms	symptom	NOUN
dpc-2259	16	14	;	;	PUNCT
dpc-2259	16	15	covid-19	covid-19	PROPN
dpc-2259	16	16	real	real	ADJ
dpc-2259	16	17	time	time	NOUN
dpc-2259	16	18	-	-	PUNCT
dpc-2259	16	19	pcr	pcr	ADJ
dpc-2259	16	20	test	test	NOUN
dpc-2259	16	21	was	be	AUX
dpc-2259	16	22	performed	perform	VERB
dpc-2259	16	23	in	in	ADP
dpc-2259	16	24	109	109	NUM
dpc-2259	16	25	(	(	PUNCT
dpc-2259	16	26	61.2	61.2	NUM
dpc-2259	16	27	%	%	NOUN
dpc-2259	16	28	)	)	PUNCT
dpc-2259	16	29	patients	patient	NOUN
dpc-2259	16	30	.	.	PUNCT
dpc-2259	17	1	thirty	thirty	NUM
dpc-2259	17	2	(	(	PUNCT
dpc-2259	17	3	27.5	27.5	NUM
dpc-2259	17	4	%	%	NOUN
dpc-2259	17	5	)	)	PUNCT
dpc-2259	17	6	cases	case	NOUN
dpc-2259	17	7	tested	test	VERB
dpc-2259	17	8	positive	positive	ADJ
dpc-2259	17	9	for	for	ADP
dpc-2259	17	10	covid-19	covid-19	PROPN
dpc-2259	17	11	whereas	whereas	SCONJ
dpc-2259	17	12	79	79	NUM
dpc-2259	17	13	(	(	PUNCT
dpc-2259	17	14	72.5	72.5	NUM
dpc-2259	17	15	%	%	NOUN
dpc-2259	17	16	)	)	PUNCT
dpc-2259	17	17	tested	test	VERB
dpc-2259	17	18	negative	negative	ADJ
dpc-2259	17	19	.	.	PUNCT
dpc-2259	18	1	abstract	abstract	ADJ
dpc-2259	18	2	2	2	NUM
dpc-2259	18	3	original	original	ADJ
dpc-2259	18	4	article	article	NOUN
dpc-2259	18	5	|	|	ADV
dpc-2259	18	6	dermatol	dermatol	ADJ
dpc-2259	18	7	pract	pract	NOUN
dpc-2259	18	8	concept	concept	NOUN
dpc-2259	18	9	.	.	PUNCT
dpc-2259	19	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	19	2	introduction	introduction	NOUN
dpc-2259	19	3	hidradenitis	hidradenitis	PROPN
dpc-2259	19	4	suppurativa	suppurativa	PROPN
dpc-2259	19	5	(	(	PUNCT
dpc-2259	19	6	hs	hs	X
dpc-2259	19	7	)	)	PUNCT
dpc-2259	19	8	is	be	AUX
dpc-2259	19	9	a	a	DET
dpc-2259	19	10	chronic	chronic	NOUN
dpc-2259	19	11	,	,	PUNCT
dpc-2259	19	12	inflammatory	inflammatory	ADJ
dpc-2259	19	13	,	,	PUNCT
dpc-2259	19	14	debilitating	debilitate	VERB
dpc-2259	19	15	skin	skin	NOUN
dpc-2259	19	16	disorder	disorder	NOUN
dpc-2259	19	17	characterized	characterize	VERB
dpc-2259	19	18	by	by	ADP
dpc-2259	19	19	painful	painful	ADJ
dpc-2259	19	20	,	,	PUNCT
dpc-2259	19	21	deep	deep	ADJ
dpc-2259	19	22	-	-	PUNCT
dpc-2259	19	23	seated	seat	VERB
dpc-2259	19	24	nodules	nodule	NOUN
dpc-2259	19	25	and	and	CCONJ
dpc-2259	19	26	abscesses	abscess	NOUN
dpc-2259	19	27	,	,	PUNCT
dpc-2259	19	28	draining	drain	VERB
dpc-2259	19	29	sinus	sinus	NOUN
dpc-2259	19	30	tracts	tract	NOUN
dpc-2259	19	31	and	and	CCONJ
dpc-2259	19	32	cicatrisation	cicatrisation	NOUN
dpc-2259	19	33	[	[	X
dpc-2259	19	34	1	1	NUM
dpc-2259	19	35	]	]	PUNCT
dpc-2259	19	36	.	.	PUNCT
dpc-2259	20	1	the	the	DET
dpc-2259	20	2	disease	disease	NOUN
dpc-2259	20	3	is	be	AUX
dpc-2259	20	4	more	more	ADV
dpc-2259	20	5	likely	likely	ADJ
dpc-2259	20	6	to	to	PART
dpc-2259	20	7	be	be	AUX
dpc-2259	20	8	seen	see	VERB
dpc-2259	20	9	in	in	ADP
dpc-2259	20	10	the	the	DET
dpc-2259	20	11	intertriginous	intertriginous	ADJ
dpc-2259	20	12	areas	area	NOUN
dpc-2259	20	13	of	of	ADP
dpc-2259	20	14	the	the	DET
dpc-2259	20	15	body	body	NOUN
dpc-2259	20	16	including	include	VERB
dpc-2259	20	17	groin	groin	NOUN
dpc-2259	20	18	,	,	PUNCT
dpc-2259	20	19	gluteal	gluteal	NOUN
dpc-2259	20	20	area	area	NOUN
dpc-2259	20	21	,	,	PUNCT
dpc-2259	20	22	axillae	axillae	NOUN
dpc-2259	20	23	and	and	CCONJ
dpc-2259	20	24	inframammary	inframammary	ADJ
dpc-2259	20	25	region	region	NOUN
dpc-2259	21	1	[	[	X
dpc-2259	21	2	1	1	NUM
dpc-2259	21	3	]	]	PUNCT
dpc-2259	21	4	.	.	PUNCT
dpc-2259	22	1	hs	hs	PROPN
dpc-2259	22	2	is	be	AUX
dpc-2259	22	3	staged	stage	VERB
dpc-2259	22	4	according	accord	VERB
dpc-2259	22	5	to	to	ADP
dpc-2259	22	6	the	the	DET
dpc-2259	22	7	type	type	NOUN
dpc-2259	22	8	,	,	PUNCT
dpc-2259	22	9	extent	extent	NOUN
dpc-2259	22	10	and	and	CCONJ
dpc-2259	22	11	severity	severity	NOUN
dpc-2259	22	12	of	of	ADP
dpc-2259	22	13	the	the	DET
dpc-2259	22	14	skin	skin	NOUN
dpc-2259	22	15	lesions	lesion	NOUN
dpc-2259	22	16	[	[	X
dpc-2259	22	17	2	2	NUM
dpc-2259	22	18	]	]	PUNCT
dpc-2259	22	19	.	.	PUNCT
dpc-2259	23	1	single	single	ADJ
dpc-2259	23	2	or	or	CCONJ
dpc-2259	23	3	multiple	multiple	ADJ
dpc-2259	23	4	nodules	nodule	NOUN
dpc-2259	23	5	or	or	CCONJ
dpc-2259	23	6	abscesses	abscess	NOUN
dpc-2259	23	7	without	without	ADP
dpc-2259	23	8	sinus	sinus	NOUN
dpc-2259	23	9	tracts	tract	NOUN
dpc-2259	23	10	and	and	CCONJ
dpc-2259	23	11	cicatrix	cicatrix	NOUN
dpc-2259	23	12	formation	formation	NOUN
dpc-2259	23	13	refer	refer	VERB
dpc-2259	23	14	to	to	ADP
dpc-2259	23	15	hurley	hurley	PROPN
dpc-2259	23	16	stage	stage	NOUN
dpc-2259	23	17	1	1	NUM
dpc-2259	23	18	;	;	PUNCT
dpc-2259	23	19	recurrent	recurrent	ADJ
dpc-2259	23	20	nodules	nodule	NOUN
dpc-2259	23	21	or	or	CCONJ
dpc-2259	23	22	abscesses	abscess	NOUN
dpc-2259	23	23	with	with	ADP
dpc-2259	23	24	limited	limited	ADJ
dpc-2259	23	25	sinus	sinus	NOUN
dpc-2259	23	26	tract	tract	NOUN
dpc-2259	23	27	formation	formation	NOUN
dpc-2259	23	28	and	and	CCONJ
dpc-2259	23	29	scarring	scarring	NOUN
dpc-2259	23	30	refers	refer	VERB
dpc-2259	23	31	to	to	ADP
dpc-2259	23	32	hurley	hurley	PROPN
dpc-2259	23	33	stage	stage	NOUN
dpc-2259	23	34	2	2	NUM
dpc-2259	23	35	;	;	PUNCT
dpc-2259	23	36	whereas	whereas	SCONJ
dpc-2259	23	37	stage	stage	NOUN
dpc-2259	23	38	3	3	NUM
dpc-2259	23	39	disease	disease	NOUN
dpc-2259	23	40	is	be	AUX
dpc-2259	23	41	characterized	characterize	VERB
dpc-2259	23	42	by	by	ADP
dpc-2259	23	43	diffuse	diffuse	NOUN
dpc-2259	23	44	involvement	involvement	NOUN
dpc-2259	23	45	of	of	ADP
dpc-2259	23	46	the	the	DET
dpc-2259	23	47	affected	affected	ADJ
dpc-2259	23	48	area	area	NOUN
dpc-2259	23	49	by	by	ADP
dpc-2259	23	50	nodules	nodule	NOUN
dpc-2259	23	51	/	/	SYM
dpc-2259	23	52	abscesses	abscess	NOUN
dpc-2259	23	53	,	,	PUNCT
dpc-2259	23	54	multiple	multiple	ADJ
dpc-2259	23	55	interconnected	interconnected	ADJ
dpc-2259	23	56	sinus	sinus	NOUN
dpc-2259	23	57	tracts	tract	NOUN
dpc-2259	23	58	and	and	CCONJ
dpc-2259	23	59	cicatrisation	cicatrisation	NOUN
dpc-2259	24	1	[	[	X
dpc-2259	24	2	2	2	NUM
dpc-2259	24	3	]	]	PUNCT
dpc-2259	24	4	.	.	PUNCT
dpc-2259	25	1	genetic	genetic	ADJ
dpc-2259	25	2	,	,	PUNCT
dpc-2259	25	3	environmental	environmental	ADJ
dpc-2259	25	4	,	,	PUNCT
dpc-2259	25	5	endocrinologic	endocrinologic	NOUN
dpc-2259	25	6	,	,	PUNCT
dpc-2259	25	7	bacterial	bacterial	ADJ
dpc-2259	25	8	and	and	CCONJ
dpc-2259	25	9	host	host	NOUN
dpc-2259	25	10	defense	defense	NOUN
dpc-2259	25	11	related	relate	VERB
dpc-2259	25	12	immunologic	immunologic	ADJ
dpc-2259	25	13	factors	factor	NOUN
dpc-2259	25	14	as	as	ADV
dpc-2259	25	15	well	well	ADV
dpc-2259	25	16	as	as	ADP
dpc-2259	25	17	obesity	obesity	NOUN
dpc-2259	25	18	,	,	PUNCT
dpc-2259	25	19	smoking	smoking	NOUN
dpc-2259	25	20	have	have	AUX
dpc-2259	25	21	all	all	PRON
dpc-2259	25	22	been	be	AUX
dpc-2259	25	23	implicated	implicate	VERB
dpc-2259	25	24	in	in	ADP
dpc-2259	25	25	the	the	DET
dpc-2259	25	26	etiology	etiology	NOUN
dpc-2259	25	27	of	of	ADP
dpc-2259	25	28	hs	hs	PROPN
dpc-2259	26	1	[	[	X
dpc-2259	26	2	3	3	NUM
dpc-2259	26	3	]	]	PUNCT
dpc-2259	26	4	.	.	PUNCT
dpc-2259	27	1	depression	depression	NOUN
dpc-2259	27	2	,	,	PUNCT
dpc-2259	27	3	inflammatory	inflammatory	ADJ
dpc-2259	27	4	bowel	bowel	NOUN
dpc-2259	27	5	disease	disease	NOUN
dpc-2259	27	6	,	,	PUNCT
dpc-2259	27	7	spondyloarthropathy	spondyloarthropathy	ADJ
dpc-2259	27	8	,	,	PUNCT
dpc-2259	27	9	diabetes	diabetes	NOUN
dpc-2259	27	10	mellitus	mellitus	NOUN
dpc-2259	27	11	,	,	PUNCT
dpc-2259	27	12	hyperlipidemia	hyperlipidemia	NOUN
dpc-2259	27	13	and	and	CCONJ
dpc-2259	27	14	metabolic	metabolic	NOUN
dpc-2259	27	15	syndrome	syndrome	NOUN
dpc-2259	27	16	are	be	AUX
dpc-2259	27	17	among	among	ADP
dpc-2259	27	18	the	the	DET
dpc-2259	27	19	common	common	ADJ
dpc-2259	27	20	associated	associate	VERB
dpc-2259	27	21	comorbidities	comorbiditie	NOUN
dpc-2259	27	22	in	in	ADP
dpc-2259	27	23	hs	hs	PROPN
dpc-2259	27	24	patients	patient	NOUN
dpc-2259	27	25	[	[	X
dpc-2259	27	26	4	4	NUM
dpc-2259	27	27	]	]	PUNCT
dpc-2259	27	28	.	.	PUNCT
dpc-2259	28	1	low	low	ADJ
dpc-2259	28	2	self	self	NOUN
dpc-2259	28	3	-	-	PUNCT
dpc-2259	28	4	confidence	confidence	NOUN
dpc-2259	28	5	,	,	PUNCT
dpc-2259	28	6	sexual	sexual	ADJ
dpc-2259	28	7	dysfunction	dysfunction	NOUN
dpc-2259	28	8	,	,	PUNCT
dpc-2259	28	9	impairment	impairment	NOUN
dpc-2259	28	10	of	of	ADP
dpc-2259	28	11	daily	daily	ADJ
dpc-2259	28	12	functioning	functioning	NOUN
dpc-2259	28	13	,	,	PUNCT
dpc-2259	28	14	chronic	chronic	ADJ
dpc-2259	28	15	anxiety	anxiety	NOUN
dpc-2259	28	16	and	and	CCONJ
dpc-2259	28	17	depression	depression	NOUN
dpc-2259	28	18	all	all	PRON
dpc-2259	28	19	lead	lead	VERB
dpc-2259	28	20	to	to	ADP
dpc-2259	28	21	poor	poor	ADJ
dpc-2259	28	22	life	life	NOUN
dpc-2259	28	23	quality	quality	NOUN
dpc-2259	28	24	for	for	ADP
dpc-2259	28	25	hs	hs	PROPN
dpc-2259	28	26	patients	patient	NOUN
dpc-2259	28	27	[	[	X
dpc-2259	28	28	5,6	5,6	NUM
dpc-2259	28	29	]	]	PUNCT
dpc-2259	28	30	.	.	PUNCT
dpc-2259	29	1	in	in	ADP
dpc-2259	29	2	the	the	DET
dpc-2259	29	3	early	early	ADJ
dpc-2259	29	4	stages	stage	NOUN
dpc-2259	29	5	of	of	ADP
dpc-2259	29	6	the	the	DET
dpc-2259	29	7	disease	disease	NOUN
dpc-2259	29	8	characterized	characterize	VERB
dpc-2259	29	9	by	by	ADP
dpc-2259	29	10	only	only	ADV
dpc-2259	29	11	a	a	DET
dpc-2259	29	12	few	few	ADJ
dpc-2259	29	13	nodules	nodule	NOUN
dpc-2259	29	14	or	or	CCONJ
dpc-2259	29	15	abscess	abscess	NOUN
dpc-2259	29	16	,	,	PUNCT
dpc-2259	29	17	only	only	ADV
dpc-2259	29	18	systemic	systemic	ADJ
dpc-2259	29	19	antibiotics	antibiotic	NOUN
dpc-2259	29	20	in	in	ADP
dpc-2259	29	21	combination	combination	NOUN
dpc-2259	29	22	with	with	ADP
dpc-2259	29	23	topical	topical	ADJ
dpc-2259	29	24	antibiotics	antibiotic	NOUN
dpc-2259	29	25	or	or	CCONJ
dpc-2259	29	26	intralesional	intralesional	ADJ
dpc-2259	29	27	corticosteroids	corticosteroid	NOUN
dpc-2259	29	28	,	,	PUNCT
dpc-2259	29	29	are	be	AUX
dpc-2259	29	30	usually	usually	ADV
dpc-2259	29	31	enough	enough	ADJ
dpc-2259	29	32	to	to	PART
dpc-2259	29	33	control	control	VERB
dpc-2259	29	34	disease	disease	NOUN
dpc-2259	29	35	activity	activity	NOUN
dpc-2259	29	36	[	[	X
dpc-2259	29	37	7,8	7,8	NUM
dpc-2259	29	38	]	]	PUNCT
dpc-2259	29	39	.	.	PUNCT
dpc-2259	30	1	however	however	ADV
dpc-2259	30	2	,	,	PUNCT
dpc-2259	30	3	advanced	advanced	ADJ
dpc-2259	30	4	stages	stage	NOUN
dpc-2259	30	5	require	require	VERB
dpc-2259	30	6	both	both	PRON
dpc-2259	30	7	surgical	surgical	ADJ
dpc-2259	30	8	intervention	intervention	NOUN
dpc-2259	30	9	and	and	CCONJ
dpc-2259	30	10	systemic	systemic	ADJ
dpc-2259	30	11	treatment	treatment	NOUN
dpc-2259	30	12	modalities	modality	NOUN
dpc-2259	30	13	.	.	PUNCT
dpc-2259	31	1	tumor	tumor	NOUN
dpc-2259	31	2	necrosis	necrosis	NOUN
dpc-2259	31	3	factor	factor	NOUN
dpc-2259	31	4	-	-	PUNCT
dpc-2259	31	5	alpha	alpha	NOUN
dpc-2259	31	6	(	(	PUNCT
dpc-2259	31	7	tnf	tnf	PROPN
dpc-2259	31	8	-	-	PUNCT
dpc-2259	31	9	α	α	NOUN
dpc-2259	31	10	)	)	PUNCT
dpc-2259	31	11	inhibitors	inhibitor	NOUN
dpc-2259	31	12	(	(	PUNCT
dpc-2259	31	13	especially	especially	ADV
dpc-2259	31	14	adalimumab	adalimumab	NOUN
dpc-2259	31	15	and	and	CCONJ
dpc-2259	31	16	infliximab	infliximab	NOUN
dpc-2259	31	17	)	)	PUNCT
dpc-2259	31	18	are	be	AUX
dpc-2259	31	19	the	the	DET
dpc-2259	31	20	much	much	ADV
dpc-2259	31	21	-	-	PUNCT
dpc-2259	31	22	preferred	prefer	VERB
dpc-2259	31	23	agents	agent	NOUN
dpc-2259	31	24	used	use	VERB
dpc-2259	31	25	in	in	ADP
dpc-2259	31	26	the	the	DET
dpc-2259	31	27	treatment	treatment	NOUN
dpc-2259	31	28	of	of	ADP
dpc-2259	31	29	advanced	advanced	ADJ
dpc-2259	31	30	stage	stage	NOUN
dpc-2259	31	31	hs	hs	PROPN
dpc-2259	31	32	,	,	PUNCT
dpc-2259	31	33	in	in	ADP
dpc-2259	31	34	combination	combination	NOUN
dpc-2259	31	35	with	with	ADP
dpc-2259	31	36	topical	topical	ADJ
dpc-2259	31	37	and	and	CCONJ
dpc-2259	31	38	systemic	systemic	ADJ
dpc-2259	31	39	antibiotics	antibiotic	NOUN
dpc-2259	31	40	[	[	X
dpc-2259	31	41	9	9	NUM
dpc-2259	31	42	]	]	PUNCT
dpc-2259	31	43	.	.	PUNCT
dpc-2259	32	1	during	during	ADP
dpc-2259	32	2	coronavirus	coronavirus	NOUN
dpc-2259	32	3	 	 	SPACE
dpc-2259	32	4	disease	disease	NOUN
dpc-2259	32	5	2019	2019	NUM
dpc-2259	32	6	(	(	PUNCT
dpc-2259	32	7	covid-19	covid-19	PROPN
dpc-2259	32	8	)	)	PUNCT
dpc-2259	32	9	pandemic	pandemic	NOUN
dpc-2259	32	10	,	,	PUNCT
dpc-2259	32	11	the	the	DET
dpc-2259	32	12	safety	safety	NOUN
dpc-2259	32	13	of	of	ADP
dpc-2259	32	14	biologic	biologic	ADJ
dpc-2259	32	15	agents	agent	NOUN
dpc-2259	32	16	is	be	AUX
dpc-2259	32	17	one	one	NUM
dpc-2259	32	18	of	of	ADP
dpc-2259	32	19	the	the	DET
dpc-2259	32	20	most	most	ADV
dpc-2259	32	21	frequently	frequently	ADV
dpc-2259	32	22	investigated	investigate	VERB
dpc-2259	32	23	issues	issue	NOUN
dpc-2259	32	24	in	in	ADP
dpc-2259	32	25	dermatology	dermatology	NOUN
dpc-2259	32	26	practice	practice	NOUN
dpc-2259	32	27	.	.	PUNCT
dpc-2259	33	1	the	the	DET
dpc-2259	33	2	use	use	NOUN
dpc-2259	33	3	of	of	ADP
dpc-2259	33	4	antibiotics	antibiotic	NOUN
dpc-2259	33	5	and	and	CCONJ
dpc-2259	33	6	tnf	tnf	PROPN
dpc-2259	33	7	-	-	PUNCT
dpc-2259	33	8	α	α	PROPN
dpc-2259	33	9	inhibitors	inhibitor	NOUN
dpc-2259	33	10	in	in	ADP
dpc-2259	33	11	the	the	DET
dpc-2259	33	12	patients	patient	NOUN
dpc-2259	33	13	with	with	ADP
dpc-2259	33	14	hs	hs	PROPN
dpc-2259	33	15	does	do	AUX
dpc-2259	33	16	not	not	PART
dpc-2259	33	17	seem	seem	VERB
dpc-2259	33	18	to	to	PART
dpc-2259	33	19	increase	increase	VERB
dpc-2259	33	20	the	the	DET
dpc-2259	33	21	risk	risk	NOUN
dpc-2259	33	22	for	for	ADP
dpc-2259	33	23	covid-19	covid-19	PROPN
dpc-2259	34	1	[	[	X
dpc-2259	34	2	10	10	NUM
dpc-2259	34	3	]	]	PUNCT
dpc-2259	34	4	.	.	PUNCT
dpc-2259	35	1	objectives	objective	NOUN
dpc-2259	35	2	in	in	ADP
dpc-2259	35	3	our	our	PRON
dpc-2259	35	4	study	study	NOUN
dpc-2259	35	5	,	,	PUNCT
dpc-2259	35	6	we	we	PRON
dpc-2259	35	7	aimed	aim	VERB
dpc-2259	35	8	to	to	PART
dpc-2259	35	9	investigate	investigate	VERB
dpc-2259	35	10	the	the	DET
dpc-2259	35	11	prevalence	prevalence	NOUN
dpc-2259	35	12	of	of	ADP
dpc-2259	35	13	covid-19	covid-19	PROPN
dpc-2259	35	14	real	real	ADJ
dpc-2259	35	15	-	-	PUNCT
dpc-2259	35	16	time	time	NOUN
dpc-2259	35	17	polymerase	polymerase	NOUN
dpc-2259	35	18	chain	chain	NOUN
dpc-2259	35	19	reaction	reaction	NOUN
dpc-2259	35	20	(	(	PUNCT
dpc-2259	35	21	real	real	ADJ
dpc-2259	35	22	time	time	NOUN
dpc-2259	35	23	-	-	PUNCT
dpc-2259	35	24	pcr	pcr	ADJ
dpc-2259	35	25	)	)	PUNCT
dpc-2259	35	26	positivity	positivity	NOUN
dpc-2259	35	27	and	and	CCONJ
dpc-2259	35	28	the	the	DET
dpc-2259	35	29	presence	presence	NOUN
dpc-2259	35	30	of	of	ADP
dpc-2259	35	31	covid-19	covid-19	PROPN
dpc-2259	35	32	related	related	ADJ
dpc-2259	35	33	symptoms	symptom	NOUN
dpc-2259	35	34	in	in	ADP
dpc-2259	35	35	relation	relation	NOUN
dpc-2259	35	36	to	to	ADP
dpc-2259	35	37	the	the	DET
dpc-2259	35	38	age	age	NOUN
dpc-2259	35	39	,	,	PUNCT
dpc-2259	35	40	gender	gender	NOUN
dpc-2259	35	41	,	,	PUNCT
dpc-2259	35	42	body	body	NOUN
dpc-2259	35	43	mass	mass	NOUN
dpc-2259	35	44	index	index	NOUN
dpc-2259	35	45	(	(	PUNCT
dpc-2259	35	46	bmi	bmi	PROPN
dpc-2259	35	47	)	)	PUNCT
dpc-2259	35	48	,	,	PUNCT
dpc-2259	35	49	smoking	smoking	NOUN
dpc-2259	35	50	status	status	NOUN
dpc-2259	35	51	,	,	PUNCT
dpc-2259	35	52	accompanying	accompany	VERB
dpc-2259	35	53	systemic	systemic	ADJ
dpc-2259	35	54	diseases	disease	NOUN
dpc-2259	35	55	,	,	PUNCT
dpc-2259	35	56	disease	disease	NOUN
dpc-2259	35	57	duration	duration	NOUN
dpc-2259	35	58	and	and	CCONJ
dpc-2259	35	59	different	different	ADJ
dpc-2259	35	60	treatment	treatment	NOUN
dpc-2259	35	61	modalities	modality	NOUN
dpc-2259	35	62	used	use	VERB
dpc-2259	35	63	for	for	ADP
dpc-2259	35	64	hs	hs	PROPN
dpc-2259	35	65	.	.	PROPN
dpc-2259	35	66	methods	method	NOUN
dpc-2259	35	67	we	we	PRON
dpc-2259	35	68	conducted	conduct	VERB
dpc-2259	35	69	a	a	DET
dpc-2259	35	70	cross	cross	ADJ
dpc-2259	35	71	-	-	ADJ
dpc-2259	35	72	sectional	sectional	ADJ
dpc-2259	35	73	,	,	PUNCT
dpc-2259	35	74	descriptive	descriptive	ADJ
dpc-2259	35	75	study	study	NOUN
dpc-2259	35	76	of	of	ADP
dpc-2259	35	77	178	178	NUM
dpc-2259	35	78	hs	hs	PROPN
dpc-2259	35	79	patients	patient	NOUN
dpc-2259	35	80	who	who	PRON
dpc-2259	35	81	were	be	AUX
dpc-2259	35	82	followed	follow	VERB
dpc-2259	35	83	up	up	ADP
dpc-2259	35	84	in	in	ADP
dpc-2259	35	85	our	our	PRON
dpc-2259	35	86	dermatology	dermatology	NOUN
dpc-2259	35	87	outpatient	outpatient	NOUN
dpc-2259	35	88	clinic	clinic	NOUN
dpc-2259	35	89	.	.	PUNCT
dpc-2259	36	1	all	all	DET
dpc-2259	36	2	178	178	NUM
dpc-2259	36	3	participants	participant	NOUN
dpc-2259	36	4	were	be	AUX
dpc-2259	36	5	clinically	clinically	ADV
dpc-2259	36	6	diagnosed	diagnose	VERB
dpc-2259	36	7	with	with	ADP
dpc-2259	36	8	hs	hs	PROPN
dpc-2259	36	9	and	and	CCONJ
dpc-2259	36	10	further	far	ADV
dpc-2259	36	11	receiving	receive	VERB
dpc-2259	36	12	various	various	ADJ
dpc-2259	36	13	treatment	treatment	NOUN
dpc-2259	36	14	modalities	modality	NOUN
dpc-2259	36	15	according	accord	VERB
dpc-2259	36	16	to	to	ADP
dpc-2259	36	17	disease	disease	NOUN
dpc-2259	36	18	stage	stage	NOUN
dpc-2259	36	19	in	in	ADP
dpc-2259	36	20	our	our	PRON
dpc-2259	36	21	center	center	NOUN
dpc-2259	36	22	’s	’s	PART
dpc-2259	36	23	chronic	chronic	ADJ
dpc-2259	36	24	dermatologic	dermatologic	ADJ
dpc-2259	36	25	illnesses	illness	NOUN
dpc-2259	36	26	outpatient	outpatient	NOUN
dpc-2259	36	27	clinic	clinic	NOUN
dpc-2259	36	28	between	between	ADP
dpc-2259	36	29	january	january	PROPN
dpc-2259	36	30	2018	2018	NUM
dpc-2259	36	31	and	and	CCONJ
dpc-2259	36	32	september	september	PROPN
dpc-2259	36	33	2021	2021	NUM
dpc-2259	36	34	.	.	PUNCT
dpc-2259	37	1	only	only	ADV
dpc-2259	37	2	patients	patient	NOUN
dpc-2259	37	3	who	who	PRON
dpc-2259	37	4	were	be	AUX
dpc-2259	37	5	under	under	ADP
dpc-2259	37	6	active	active	ADJ
dpc-2259	37	7	-	-	PUNCT
dpc-2259	37	8	continuous	continuous	ADJ
dpc-2259	37	9	treatment	treatment	NOUN
dpc-2259	37	10	for	for	ADP
dpc-2259	37	11	hs	hs	PROPN
dpc-2259	37	12	during	during	ADP
dpc-2259	37	13	covid-19	covid-19	PROPN
dpc-2259	37	14	pandemic	pandemic	NOUN
dpc-2259	37	15	,	,	PUNCT
dpc-2259	37	16	were	be	AUX
dpc-2259	37	17	included	include	VERB
dpc-2259	37	18	.	.	PUNCT
dpc-2259	38	1	local	local	ADJ
dpc-2259	38	2	ethics	ethic	NOUN
dpc-2259	38	3	committee	committee	PROPN
dpc-2259	38	4	approval	approval	NOUN
dpc-2259	38	5	was	be	AUX
dpc-2259	38	6	obtained	obtain	VERB
dpc-2259	38	7	for	for	ADP
dpc-2259	38	8	the	the	DET
dpc-2259	38	9	present	present	ADJ
dpc-2259	38	10	study	study	NOUN
dpc-2259	38	11	(	(	PUNCT
dpc-2259	38	12	the	the	DET
dpc-2259	38	13	date	date	NOUN
dpc-2259	38	14	,	,	PUNCT
dpc-2259	38	15	project	project	NOUN
dpc-2259	38	16	number	number	NOUN
dpc-2259	38	17	,	,	PUNCT
dpc-2259	38	18	decision	decision	NOUN
dpc-2259	38	19	number	number	NOUN
dpc-2259	38	20	:	:	PUNCT
dpc-2259	38	21	september	september	PROPN
dpc-2259	38	22	7	7	NUM
dpc-2259	38	23	,	,	PUNCT
dpc-2259	38	24	2021	2021	NUM
dpc-2259	38	25	,	,	PUNCT
dpc-2259	38	26	go	go	VERB
dpc-2259	38	27	21/934	21/934	NUM
dpc-2259	38	28	,	,	PUNCT
dpc-2259	38	29	2021/14	2021/14	NUM
dpc-2259	38	30	-	-	SYM
dpc-2259	38	31	66	66	NUM
dpc-2259	38	32	)	)	PUNCT
dpc-2259	38	33	.	.	PUNCT
dpc-2259	39	1	an	an	DET
dpc-2259	39	2	oral	oral	ADJ
dpc-2259	39	3	questionnaire	questionnaire	NOUN
dpc-2259	39	4	composed	compose	VERB
dpc-2259	39	5	of	of	ADP
dpc-2259	39	6	15	15	NUM
dpc-2259	39	7	questions	question	NOUN
dpc-2259	39	8	related	relate	VERB
dpc-2259	39	9	to	to	ADP
dpc-2259	39	10	the	the	DET
dpc-2259	39	11	demographical	demographical	ADJ
dpc-2259	39	12	data	datum	NOUN
dpc-2259	39	13	,	,	PUNCT
dpc-2259	39	14	hs	hs	PROPN
dpc-2259	39	15	disease	disease	NOUN
dpc-2259	39	16	and	and	CCONJ
dpc-2259	39	17	covid-19	covid-19	PROPN
dpc-2259	39	18	,	,	PUNCT
dpc-2259	39	19	was	be	AUX
dpc-2259	39	20	formed	form	VERB
dpc-2259	39	21	(	(	PUNCT
dpc-2259	39	22	supplementary	supplementary	ADJ
dpc-2259	39	23	file	file	NOUN
dpc-2259	39	24	 	 	SPACE
dpc-2259	39	25	1	1	NUM
dpc-2259	39	26	)	)	PUNCT
dpc-2259	39	27	.	.	PUNCT
dpc-2259	40	1	the	the	DET
dpc-2259	40	2	answers	answer	NOUN
dpc-2259	40	3	were	be	AUX
dpc-2259	40	4	obtained	obtain	VERB
dpc-2259	40	5	via	via	ADP
dpc-2259	40	6	a	a	DET
dpc-2259	40	7	telephone	telephone	NOUN
dpc-2259	40	8	survey	survey	NOUN
dpc-2259	40	9	and	and	CCONJ
dpc-2259	40	10	an	an	DET
dpc-2259	40	11	oral	oral	ADJ
dpc-2259	40	12	informed	informed	ADJ
dpc-2259	40	13	consent	consent	NOUN
dpc-2259	40	14	was	be	AUX
dpc-2259	40	15	taken	take	VERB
dpc-2259	40	16	from	from	ADP
dpc-2259	40	17	all	all	DET
dpc-2259	40	18	the	the	DET
dpc-2259	40	19	patients	patient	NOUN
dpc-2259	40	20	before	before	ADP
dpc-2259	40	21	the	the	DET
dpc-2259	40	22	start	start	NOUN
dpc-2259	40	23	of	of	ADP
dpc-2259	40	24	the	the	DET
dpc-2259	40	25	survey	survey	NOUN
dpc-2259	40	26	.	.	PUNCT
dpc-2259	41	1	the	the	DET
dpc-2259	41	2	accuracy	accuracy	NOUN
dpc-2259	41	3	of	of	ADP
dpc-2259	41	4	questions	question	NOUN
dpc-2259	41	5	related	relate	VERB
dpc-2259	41	6	to	to	ADP
dpc-2259	41	7	covid-19	covid-19	PROPN
dpc-2259	41	8	status	status	NOUN
dpc-2259	41	9	of	of	ADP
dpc-2259	41	10	the	the	DET
dpc-2259	41	11	participants	participant	NOUN
dpc-2259	41	12	,	,	PUNCT
dpc-2259	41	13	characteristics	characteristic	NOUN
dpc-2259	41	14	of	of	ADP
dpc-2259	41	15	treatment	treatment	NOUN
dpc-2259	41	16	given	give	VERB
dpc-2259	41	17	for	for	ADP
dpc-2259	41	18	hs	hs	PROPN
dpc-2259	41	19	and	and	CCONJ
dpc-2259	41	20	treatment	treatment	NOUN
dpc-2259	41	21	duration	duration	NOUN
dpc-2259	41	22	,	,	PUNCT
dpc-2259	41	23	was	be	AUX
dpc-2259	41	24	also	also	ADV
dpc-2259	41	25	verified	verify	VERB
dpc-2259	41	26	from	from	ADP
dpc-2259	41	27	the	the	DET
dpc-2259	41	28	medical	medical	ADJ
dpc-2259	41	29	data	data	NOUN
dpc-2259	41	30	records	record	NOUN
dpc-2259	41	31	.	.	PUNCT
dpc-2259	42	1	ibm	ibm	PROPN
dpc-2259	42	2	spss	spss	PROPN
dpc-2259	42	3	for	for	ADP
dpc-2259	42	4	windows	window	NOUN
dpc-2259	42	5	version	version	PROPN
dpc-2259	42	6	20.0	20.0	NUM
dpc-2259	42	7	was	be	AUX
dpc-2259	42	8	used	use	VERB
dpc-2259	42	9	for	for	ADP
dpc-2259	42	10	the	the	DET
dpc-2259	42	11	statistical	statistical	ADJ
dpc-2259	42	12	analysis	analysis	NOUN
dpc-2259	42	13	.	.	PUNCT
dpc-2259	43	1	numerical	numerical	ADJ
dpc-2259	43	2	variables	variable	NOUN
dpc-2259	43	3	were	be	AUX
dpc-2259	43	4	shown	show	VERB
dpc-2259	43	5	as	as	ADP
dpc-2259	43	6	mean	mean	VERB
dpc-2259	43	7	 	 	SPACE
dpc-2259	43	8	±	±	NOUN
dpc-2259	43	9	standard	standard	ADJ
dpc-2259	43	10	deviation	deviation	NOUN
dpc-2259	43	11	(	(	PUNCT
dpc-2259	43	12	range	range	NOUN
dpc-2259	43	13	:	:	PUNCT
dpc-2259	43	14	minimum	minimum	ADJ
dpc-2259	43	15	-	-	PUNCT
dpc-2259	43	16	maximum	maximum	NOUN
dpc-2259	43	17	)	)	PUNCT
dpc-2259	43	18	,	,	PUNCT
dpc-2259	43	19	whereas	whereas	SCONJ
dpc-2259	43	20	categorical	categorical	ADJ
dpc-2259	43	21	variables	variable	NOUN
dpc-2259	43	22	were	be	AUX
dpc-2259	43	23	given	give	VERB
dpc-2259	43	24	as	as	ADP
dpc-2259	43	25	percentages	percentage	NOUN
dpc-2259	43	26	and	and	CCONJ
dpc-2259	43	27	frequencies	frequency	NOUN
dpc-2259	43	28	.	.	PUNCT
dpc-2259	44	1	shapiro	shapiro	PROPN
dpc-2259	44	2	-	-	PUNCT
dpc-2259	44	3	wilk	wilk	PROPN
dpc-2259	44	4	test	test	NOUN
dpc-2259	44	5	was	be	AUX
dpc-2259	44	6	used	use	VERB
dpc-2259	44	7	to	to	PART
dpc-2259	44	8	determine	determine	VERB
dpc-2259	44	9	if	if	SCONJ
dpc-2259	44	10	the	the	DET
dpc-2259	44	11	numerical	numerical	ADJ
dpc-2259	44	12	variables	variable	NOUN
dpc-2259	44	13	are	be	AUX
dpc-2259	44	14	distributed	distribute	VERB
dpc-2259	44	15	normally	normally	ADV
dpc-2259	44	16	.	.	PUNCT
dpc-2259	45	1	fisher	fisher	PROPN
dpc-2259	45	2	’s	’s	PART
dpc-2259	45	3	exact	exact	ADJ
dpc-2259	45	4	test	test	NOUN
dpc-2259	45	5	or	or	CCONJ
dpc-2259	45	6	chi	chi	ADJ
dpc-2259	45	7	-	-	PUNCT
dpc-2259	45	8	square	square	NOUN
dpc-2259	45	9	test	test	NOUN
dpc-2259	45	10	was	be	AUX
dpc-2259	45	11	used	use	VERB
dpc-2259	45	12	to	to	PART
dpc-2259	45	13	compare	compare	VERB
dpc-2259	45	14	the	the	DET
dpc-2259	45	15	differences	difference	NOUN
dpc-2259	45	16	between	between	ADP
dpc-2259	45	17	patients	patient	NOUN
dpc-2259	45	18	receiving	receive	VERB
dpc-2259	45	19	various	various	ADJ
dpc-2259	45	20	different	different	ADJ
dpc-2259	45	21	modalities	modality	NOUN
dpc-2259	45	22	for	for	ADP
dpc-2259	45	23	hs	hs	PROPN
dpc-2259	45	24	(	(	PUNCT
dpc-2259	45	25	divided	divide	VERB
dpc-2259	45	26	into	into	ADP
dpc-2259	45	27	4	4	NUM
dpc-2259	45	28	groups	group	NOUN
dpc-2259	45	29	as	as	ADP
dpc-2259	45	30	oral	oral	ADJ
dpc-2259	45	31	antibiotics±	antibiotics±	NOUN
dpc-2259	45	32	topical	topical	ADJ
dpc-2259	45	33	antibiotics	antibiotic	NOUN
dpc-2259	45	34	,	,	PUNCT
dpc-2259	45	35	oral	oral	ADJ
dpc-2259	45	36	retinoids±	retinoids±	NOUN
dpc-2259	45	37	topical	topical	ADJ
dpc-2259	45	38	antibiotics	antibiotic	NOUN
dpc-2259	45	39	,	,	PUNCT
dpc-2259	45	40	tnf	tnf	PROPN
dpc-2259	45	41	-	-	PUNCT
dpc-2259	45	42	α	α	PROPN
dpc-2259	45	43	inhibitors	inhibitor	NOUN
dpc-2259	45	44	±	±	NOUN
dpc-2259	45	45	oral	oral	ADJ
dpc-2259	45	46	/	/	SYM
dpc-2259	45	47	topical	topical	ADJ
dpc-2259	45	48	antibiotics	antibiotic	NOUN
dpc-2259	45	49	and	and	CCONJ
dpc-2259	45	50	only	only	ADV
dpc-2259	45	51	topical	topical	ADJ
dpc-2259	45	52	antibiotics).logistic	antibiotics).logistic	ADJ
dpc-2259	45	53	regression	regression	NOUN
dpc-2259	45	54	analyses	analysis	NOUN
dpc-2259	45	55	(	(	PUNCT
dpc-2259	45	56	in	in	ADP
dpc-2259	45	57	which	which	PRON
dpc-2259	45	58	age	age	NOUN
dpc-2259	45	59	,	,	PUNCT
dpc-2259	45	60	gender	gender	NOUN
dpc-2259	45	61	,	,	PUNCT
dpc-2259	45	62	bmi	bmi	PROPN
dpc-2259	45	63	,	,	PUNCT
dpc-2259	45	64	the	the	DET
dpc-2259	45	65	presence	presence	NOUN
dpc-2259	45	66	of	of	ADP
dpc-2259	45	67	any	any	DET
dpc-2259	45	68	other	other	ADJ
dpc-2259	45	69	systemic	systemic	ADJ
dpc-2259	45	70	disease	disease	NOUN
dpc-2259	45	71	and	and	CCONJ
dpc-2259	45	72	smoking	smoking	NOUN
dpc-2259	45	73	were	be	AUX
dpc-2259	45	74	included	include	VERB
dpc-2259	45	75	as	as	ADP
dpc-2259	45	76	independent	independent	ADJ
dpc-2259	45	77	variables	variable	NOUN
dpc-2259	45	78	)	)	PUNCT
dpc-2259	45	79	were	be	AUX
dpc-2259	45	80	also	also	ADV
dpc-2259	45	81	performed	perform	VERB
dpc-2259	45	82	taking	take	VERB
dpc-2259	45	83	the	the	DET
dpc-2259	45	84	presence	presence	NOUN
dpc-2259	45	85	of	of	ADP
dpc-2259	45	86	covid-19	covid-19	PROPN
dpc-2259	45	87	symptoms	symptom	NOUN
dpc-2259	45	88	and	and	CCONJ
dpc-2259	45	89	covid-19	covid-19	PROPN
dpc-2259	45	90	real	real	ADJ
dpc-2259	45	91	time	time	NOUN
dpc-2259	45	92	-	-	PUNCT
dpc-2259	45	93	pcr	pcr	ADJ
dpc-2259	45	94	results	result	NOUN
dpc-2259	45	95	(	(	PUNCT
dpc-2259	45	96	positive	positive	ADJ
dpc-2259	45	97	or	or	CCONJ
dpc-2259	45	98	negative	negative	ADJ
dpc-2259	45	99	)	)	PUNCT
dpc-2259	45	100	as	as	ADP
dpc-2259	45	101	the	the	DET
dpc-2259	45	102	dependent	dependent	ADJ
dpc-2259	45	103	variables	variable	NOUN
dpc-2259	45	104	.	.	PUNCT
dpc-2259	46	1	p	p	X
dpc-2259	46	2	  	  	SPACE
dpc-2259	46	3	values	value	NOUN
dpc-2259	46	4	less	less	ADJ
dpc-2259	46	5	than	than	ADP
dpc-2259	46	6	0.05	0.05	NUM
dpc-2259	46	7	were	be	AUX
dpc-2259	46	8	considered	consider	VERB
dpc-2259	46	9	statistically	statistically	ADV
dpc-2259	46	10	significant	significant	ADJ
dpc-2259	46	11	.	.	PUNCT
dpc-2259	47	1	conclusions	conclusion	NOUN
dpc-2259	47	2	:	:	PUNCT
dpc-2259	47	3	patients	patient	NOUN
dpc-2259	47	4	having	have	VERB
dpc-2259	47	5	covid-19	covid-19	PROPN
dpc-2259	47	6	related	related	ADJ
dpc-2259	47	7	symptoms	symptom	NOUN
dpc-2259	47	8	were	be	AUX
dpc-2259	47	9	shown	show	VERB
dpc-2259	47	10	to	to	PART
dpc-2259	47	11	have	have	VERB
dpc-2259	47	12	statistically	statistically	ADV
dpc-2259	47	13	significantly	significantly	ADV
dpc-2259	47	14	higher	high	ADJ
dpc-2259	47	15	mean	mean	ADJ
dpc-2259	47	16	age	age	NOUN
dpc-2259	47	17	compared	compare	VERB
dpc-2259	47	18	to	to	ADP
dpc-2259	47	19	the	the	DET
dpc-2259	47	20	ones	one	NOUN
dpc-2259	47	21	who	who	PRON
dpc-2259	47	22	did	do	AUX
dpc-2259	47	23	not	not	PART
dpc-2259	47	24	have	have	VERB
dpc-2259	47	25	any	any	DET
dpc-2259	47	26	symptoms	symptom	NOUN
dpc-2259	47	27	(	(	PUNCT
dpc-2259	47	28	p	p	X
dpc-2259	47	29	=	=	NOUN
dpc-2259	47	30	0.031	0.031	NUM
dpc-2259	47	31	)	)	PUNCT
dpc-2259	47	32	.	.	PUNCT
dpc-2259	48	1	no	no	DET
dpc-2259	48	2	statistically	statistically	ADV
dpc-2259	48	3	significant	significant	ADJ
dpc-2259	48	4	relationship	relationship	NOUN
dpc-2259	48	5	was	be	AUX
dpc-2259	48	6	found	find	VERB
dpc-2259	48	7	covid-19	covid-19	PROPN
dpc-2259	48	8	real	real	ADJ
dpc-2259	48	9	time	time	NOUN
dpc-2259	48	10	-	-	PUNCT
dpc-2259	48	11	pcr	pcr	NOUN
dpc-2259	48	12	positivity	positivity	NOUN
dpc-2259	48	13	and	and	CCONJ
dpc-2259	48	14	the	the	DET
dpc-2259	48	15	type	type	NOUN
dpc-2259	48	16	of	of	ADP
dpc-2259	48	17	treatment	treatment	NOUN
dpc-2259	48	18	administered	administer	VERB
dpc-2259	48	19	for	for	ADP
dpc-2259	48	20	hs	hs	PRON
dpc-2259	48	21	when	when	SCONJ
dpc-2259	48	22	categorized	categorize	VERB
dpc-2259	48	23	as	as	ADP
dpc-2259	48	24	tumor	tumor	NOUN
dpc-2259	48	25	necrosis	necrosis	NOUN
dpc-2259	48	26	factor	factor	NOUN
dpc-2259	48	27	-	-	PUNCT
dpc-2259	48	28	alpha	alpha	NOUN
dpc-2259	48	29	inhibitor	inhibitor	NOUN
dpc-2259	48	30	,	,	PUNCT
dpc-2259	48	31	oral	oral	ADJ
dpc-2259	48	32	retinoid	retinoid	NOUN
dpc-2259	48	33	,	,	PUNCT
dpc-2259	48	34	topical	topical	ADJ
dpc-2259	48	35	antibiotic	antibiotic	ADJ
dpc-2259	48	36	and	and	CCONJ
dpc-2259	48	37	oral	oral	ADJ
dpc-2259	48	38	antibiotic	antibiotic	ADJ
dpc-2259	48	39	group	group	NOUN
dpc-2259	48	40	(	(	PUNCT
dpc-2259	48	41	p	p	X
dpc-2259	48	42	>	>	X
dpc-2259	48	43	0.05	0.05	NUM
dpc-2259	48	44	)	)	PUNCT
dpc-2259	48	45	.	.	PUNCT
dpc-2259	49	1	original	original	ADJ
dpc-2259	49	2	article	article	NOUN
dpc-2259	49	3	|	|	ADV
dpc-2259	49	4	dermatol	dermatol	ADJ
dpc-2259	49	5	pract	pract	NOUN
dpc-2259	49	6	concept	concept	NOUN
dpc-2259	49	7	.	.	PUNCT
dpc-2259	50	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	50	2	3	3	NUM
dpc-2259	50	3	results	result	VERB
dpc-2259	50	4	a	a	DET
dpc-2259	50	5	total	total	ADJ
dpc-2259	50	6	number	number	NOUN
dpc-2259	50	7	of	of	ADP
dpc-2259	50	8	178	178	NUM
dpc-2259	50	9	patients	patient	NOUN
dpc-2259	50	10	were	be	AUX
dpc-2259	50	11	included	include	VERB
dpc-2259	50	12	in	in	ADP
dpc-2259	50	13	the	the	DET
dpc-2259	50	14	study	study	NOUN
dpc-2259	50	15	.	.	PUNCT
dpc-2259	51	1	the	the	DET
dpc-2259	51	2	mean	mean	ADJ
dpc-2259	51	3	age	age	NOUN
dpc-2259	51	4	was	be	AUX
dpc-2259	51	5	35.69	35.69	NUM
dpc-2259	51	6	±	±	NUM
dpc-2259	51	7	11.21	11.21	NUM
dpc-2259	51	8	years	year	NOUN
dpc-2259	51	9	(	(	PUNCT
dpc-2259	51	10	range:16	range:16	NOUN
dpc-2259	51	11	-	-	PUNCT
dpc-2259	51	12	61	61	NUM
dpc-2259	51	13	)	)	PUNCT
dpc-2259	51	14	.	.	PUNCT
dpc-2259	52	1	sixty	sixty	NUM
dpc-2259	52	2	-	-	PUNCT
dpc-2259	52	3	three	three	NUM
dpc-2259	52	4	(	(	PUNCT
dpc-2259	52	5	35.4	35.4	NUM
dpc-2259	52	6	%	%	NOUN
dpc-2259	52	7	)	)	PUNCT
dpc-2259	52	8	patients	patient	NOUN
dpc-2259	52	9	were	be	AUX
dpc-2259	52	10	female	female	ADJ
dpc-2259	52	11	,	,	PUNCT
dpc-2259	52	12	whereas	whereas	SCONJ
dpc-2259	52	13	115	115	NUM
dpc-2259	52	14	(	(	PUNCT
dpc-2259	52	15	64.6	64.6	NUM
dpc-2259	52	16	%	%	NOUN
dpc-2259	52	17	)	)	PUNCT
dpc-2259	52	18	patients	patient	NOUN
dpc-2259	52	19	were	be	AUX
dpc-2259	52	20	male	male	ADJ
dpc-2259	52	21	.	.	PUNCT
dpc-2259	53	1	fifty	fifty	NUM
dpc-2259	53	2	-	-	PUNCT
dpc-2259	53	3	two	two	NUM
dpc-2259	53	4	(	(	PUNCT
dpc-2259	53	5	29.2	29.2	NUM
dpc-2259	53	6	%	%	NOUN
dpc-2259	53	7	)	)	PUNCT
dpc-2259	54	1	patients	patient	NOUN
dpc-2259	54	2	had	have	VERB
dpc-2259	54	3	hurley	hurley	NOUN
dpc-2259	54	4	stage	stage	NOUN
dpc-2259	54	5	1	1	NUM
dpc-2259	54	6	disease	disease	NOUN
dpc-2259	54	7	,	,	PUNCT
dpc-2259	54	8	52	52	NUM
dpc-2259	54	9	(	(	PUNCT
dpc-2259	54	10	29.2	29.2	NUM
dpc-2259	54	11	%	%	NOUN
dpc-2259	54	12	)	)	PUNCT
dpc-2259	54	13	patients	patient	NOUN
dpc-2259	54	14	had	have	VERB
dpc-2259	54	15	hurley	hurley	NOUN
dpc-2259	54	16	stage	stage	NOUN
dpc-2259	54	17	2	2	NUM
dpc-2259	54	18	disease	disease	NOUN
dpc-2259	54	19	whereas	whereas	SCONJ
dpc-2259	54	20	74	74	NUM
dpc-2259	54	21	(	(	PUNCT
dpc-2259	54	22	41.6	41.6	NUM
dpc-2259	54	23	%	%	NOUN
dpc-2259	54	24	)	)	PUNCT
dpc-2259	54	25	had	have	VERB
dpc-2259	54	26	stage	stage	NOUN
dpc-2259	54	27	3	3	NUM
dpc-2259	54	28	disease	disease	NOUN
dpc-2259	54	29	.	.	PUNCT
dpc-2259	55	1	the	the	DET
dpc-2259	55	2	mean	mean	ADJ
dpc-2259	55	3	bmi	bmi	NOUN
dpc-2259	55	4	was	be	AUX
dpc-2259	55	5	27.55	27.55	NUM
dpc-2259	55	6	±3	±3	ADJ
dpc-2259	55	7	.30	.30	NUM
dpc-2259	55	8	kg/	kg/	NOUN
dpc-2259	55	9	m2	m2	PROPN
dpc-2259	55	10	(	(	PUNCT
dpc-2259	55	11	range:17.09	range:17.09	PROPN
dpc-2259	55	12	-	-	PUNCT
dpc-2259	55	13	43.25	43.25	NUM
dpc-2259	55	14	)	)	PUNCT
dpc-2259	55	15	;	;	PUNCT
dpc-2259	55	16	one	one	NUM
dpc-2259	55	17	(	(	PUNCT
dpc-2259	55	18	0.6	0.6	NUM
dpc-2259	55	19	%	%	NOUN
dpc-2259	55	20	)	)	PUNCT
dpc-2259	55	21	patient	patient	NOUN
dpc-2259	55	22	had	have	VERB
dpc-2259	55	23	a	a	DET
dpc-2259	55	24	bmi	bmi	NOUN
dpc-2259	55	25	of	of	ADP
dpc-2259	55	26	<	<	PROPN
dpc-2259	55	27	18.5	18.5	NUM
dpc-2259	55	28	kg	kg	NOUN
dpc-2259	55	29	/	/	SYM
dpc-2259	55	30	m2	m2	PROPN
dpc-2259	55	31	(	(	PUNCT
dpc-2259	55	32	underweight	underweight	PROPN
dpc-2259	55	33	)	)	PUNCT
dpc-2259	55	34	;	;	PUNCT
dpc-2259	55	35	31	31	NUM
dpc-2259	55	36	(	(	PUNCT
dpc-2259	55	37	17.4	17.4	NUM
dpc-2259	55	38	%	%	NOUN
dpc-2259	55	39	)	)	PUNCT
dpc-2259	55	40	patients	patient	NOUN
dpc-2259	55	41	had	have	VERB
dpc-2259	55	42	a	a	DET
dpc-2259	55	43	bmi	bmi	NOUN
dpc-2259	55	44	in	in	ADP
dpc-2259	55	45	18.5	18.5	NUM
dpc-2259	55	46	to	to	ADP
dpc-2259	55	47	24.9	24.9	NUM
dpc-2259	55	48	kg	kg	NOUN
dpc-2259	55	49	/	/	SYM
dpc-2259	55	50	m2	m2	PROPN
dpc-2259	55	51	range	range	NOUN
dpc-2259	55	52	(	(	PUNCT
dpc-2259	55	53	optimal	optimal	ADJ
dpc-2259	55	54	)	)	PUNCT
dpc-2259	55	55	.	.	PUNCT
dpc-2259	56	1	one	one	NUM
dpc-2259	56	2	hundred	hundred	NUM
dpc-2259	56	3	ten	ten	NUM
dpc-2259	56	4	(	(	PUNCT
dpc-2259	56	5	61.8	61.8	NUM
dpc-2259	56	6	%	%	NOUN
dpc-2259	56	7	)	)	PUNCT
dpc-2259	56	8	out	out	ADP
dpc-2259	56	9	of	of	ADP
dpc-2259	56	10	178	178	NUM
dpc-2259	56	11	cases	case	NOUN
dpc-2259	56	12	were	be	AUX
dpc-2259	56	13	determined	determine	VERB
dpc-2259	56	14	to	to	PART
dpc-2259	56	15	fall	fall	VERB
dpc-2259	56	16	within	within	ADP
dpc-2259	56	17	the	the	DET
dpc-2259	56	18	overweight	overweight	ADJ
dpc-2259	56	19	category	category	NOUN
dpc-2259	56	20	(	(	PUNCT
dpc-2259	56	21	a	a	DET
dpc-2259	56	22	bmi	bmi	NOUN
dpc-2259	56	23	of	of	ADP
dpc-2259	56	24	25	25	NUM
dpc-2259	56	25	-	-	SYM
dpc-2259	56	26	29.9	29.9	NUM
dpc-2259	56	27	kg	kg	NOUN
dpc-2259	56	28	/	/	SYM
dpc-2259	56	29	m2	m2	PROPN
dpc-2259	56	30	)	)	PUNCT
dpc-2259	56	31	whereas	whereas	SCONJ
dpc-2259	56	32	36	36	NUM
dpc-2259	56	33	(	(	PUNCT
dpc-2259	56	34	20.2	20.2	NUM
dpc-2259	56	35	%	%	NOUN
dpc-2259	56	36	)	)	PUNCT
dpc-2259	56	37	patients	patient	NOUN
dpc-2259	56	38	were	be	AUX
dpc-2259	56	39	within	within	ADP
dpc-2259	56	40	the	the	DET
dpc-2259	56	41	obese	obese	ADJ
dpc-2259	56	42	category	category	NOUN
dpc-2259	56	43	(	(	PUNCT
dpc-2259	56	44	a	a	DET
dpc-2259	56	45	bmi	bmi	NOUN
dpc-2259	56	46	of	of	ADP
dpc-2259	56	47	>	>	PROPN
dpc-2259	56	48	30	30	NUM
dpc-2259	56	49	kg	kg	NOUN
dpc-2259	56	50	/	/	SYM
dpc-2259	56	51	m2	m2	PROPN
dpc-2259	56	52	)	)	PUNCT
dpc-2259	56	53	.	.	PUNCT
dpc-2259	57	1	one	one	NUM
dpc-2259	57	2	hundred	hundred	NUM
dpc-2259	57	3	nine	nine	NUM
dpc-2259	57	4	out	out	ADP
dpc-2259	57	5	of	of	ADP
dpc-2259	57	6	178	178	NUM
dpc-2259	57	7	patients	patient	NOUN
dpc-2259	57	8	were	be	AUX
dpc-2259	57	9	current	current	ADJ
dpc-2259	57	10	smokers	smoker	NOUN
dpc-2259	57	11	,	,	PUNCT
dpc-2259	57	12	the	the	DET
dpc-2259	57	13	mean	mean	ADJ
dpc-2259	57	14	pack	pack	NOUN
dpc-2259	57	15	-	-	PUNCT
dpc-2259	57	16	years	year	NOUN
dpc-2259	57	17	of	of	ADP
dpc-2259	57	18	smoking	smoking	NOUN
dpc-2259	57	19	was	be	AUX
dpc-2259	57	20	21.06	21.06	NUM
dpc-2259	57	21	±	±	NUM
dpc-2259	57	22	14.12	14.12	NUM
dpc-2259	57	23	pack	pack	NOUN
dpc-2259	57	24	-	-	PUNCT
dpc-2259	57	25	years	year	NOUN
dpc-2259	57	26	(	(	PUNCT
dpc-2259	57	27	range	range	NOUN
dpc-2259	57	28	:	:	PUNCT
dpc-2259	57	29	3	3	NUM
dpc-2259	57	30	-	-	SYM
dpc-2259	57	31	80	80	NUM
dpc-2259	57	32	)	)	PUNCT
dpc-2259	57	33	.	.	PUNCT
dpc-2259	58	1	the	the	DET
dpc-2259	58	2	mean	mean	ADJ
dpc-2259	58	3	duration	duration	NOUN
dpc-2259	58	4	of	of	ADP
dpc-2259	58	5	treatment	treatment	NOUN
dpc-2259	58	6	for	for	ADP
dpc-2259	58	7	hs	hs	PROPN
dpc-2259	58	8	was	be	AUX
dpc-2259	58	9	18.37	18.37	NUM
dpc-2259	58	10	±	±	NUM
dpc-2259	58	11	18.90	18.90	NUM
dpc-2259	58	12	months	month	NOUN
dpc-2259	58	13	(	(	PUNCT
dpc-2259	58	14	1	1	NUM
dpc-2259	58	15	-	-	NUM
dpc-2259	58	16	108	108	NUM
dpc-2259	58	17	)	)	PUNCT
dpc-2259	58	18	whereas	whereas	SCONJ
dpc-2259	58	19	the	the	DET
dpc-2259	58	20	average	average	ADJ
dpc-2259	58	21	duration	duration	NOUN
dpc-2259	58	22	of	of	ADP
dpc-2259	58	23	the	the	DET
dpc-2259	58	24	disease	disease	NOUN
dpc-2259	58	25	was	be	AUX
dpc-2259	58	26	119.38	119.38	NUM
dpc-2259	58	27	±	±	NUM
dpc-2259	58	28	91.97	91.97	NUM
dpc-2259	58	29	months	month	NOUN
dpc-2259	58	30	(	(	PUNCT
dpc-2259	58	31	2	2	NUM
dpc-2259	58	32	-	-	SYM
dpc-2259	58	33	552	552	NUM
dpc-2259	58	34	)	)	PUNCT
dpc-2259	58	35	.	.	PUNCT
dpc-2259	59	1	forty	forty	NUM
dpc-2259	59	2	-	-	PUNCT
dpc-2259	59	3	eight	eight	NUM
dpc-2259	59	4	(	(	PUNCT
dpc-2259	59	5	27	27	NUM
dpc-2259	59	6	%	%	NOUN
dpc-2259	59	7	)	)	PUNCT
dpc-2259	59	8	cases	case	NOUN
dpc-2259	59	9	were	be	AUX
dpc-2259	59	10	on	on	ADP
dpc-2259	59	11	oral	oral	ADJ
dpc-2259	59	12	antibiotics	antibiotic	NOUN
dpc-2259	59	13	(	(	PUNCT
dpc-2259	59	14	doxycycline	doxycycline	NOUN
dpc-2259	59	15	,	,	PUNCT
dpc-2259	59	16	clindamycin	clindamycin	NOUN
dpc-2259	59	17	and	and	CCONJ
dpc-2259	59	18	rifampicin	rifampicin	VERB
dpc-2259	59	19	,	,	PUNCT
dpc-2259	59	20	only	only	ADV
dpc-2259	59	21	clindamycin	clindamycin	NOUN
dpc-2259	59	22	,	,	PUNCT
dpc-2259	59	23	tetracycline	tetracycline	NOUN
dpc-2259	59	24	)	)	PUNCT
dpc-2259	59	25	treatment	treatment	NOUN
dpc-2259	59	26	either	either	CCONJ
dpc-2259	59	27	alone	alone	ADV
dpc-2259	59	28	or	or	CCONJ
dpc-2259	59	29	combination	combination	NOUN
dpc-2259	59	30	with	with	ADP
dpc-2259	59	31	topical	topical	ADJ
dpc-2259	59	32	treatment	treatment	NOUN
dpc-2259	59	33	modalities	modality	NOUN
dpc-2259	59	34	.	.	PUNCT
dpc-2259	60	1	thirty	thirty	NUM
dpc-2259	60	2	(	(	PUNCT
dpc-2259	60	3	16.9	16.9	NUM
dpc-2259	60	4	%	%	NOUN
dpc-2259	60	5	)	)	PUNCT
dpc-2259	60	6	patients	patient	NOUN
dpc-2259	60	7	were	be	AUX
dpc-2259	60	8	on	on	ADP
dpc-2259	60	9	oral	oral	ADJ
dpc-2259	60	10	retinoid	retinoid	NOUN
dpc-2259	60	11	(	(	PUNCT
dpc-2259	60	12	isotretinoin	isotretinoin	PROPN
dpc-2259	60	13	or	or	CCONJ
dpc-2259	60	14	acitretin	acitretin	ADJ
dpc-2259	60	15	)	)	PUNCT
dpc-2259	60	16	treatment	treatment	NOUN
dpc-2259	60	17	whereas	whereas	SCONJ
dpc-2259	60	18	85	85	NUM
dpc-2259	60	19	(	(	PUNCT
dpc-2259	60	20	47.8	47.8	NUM
dpc-2259	60	21	%	%	NOUN
dpc-2259	60	22	)	)	PUNCT
dpc-2259	60	23	were	be	AUX
dpc-2259	60	24	using	use	VERB
dpc-2259	60	25	tnf	tnf	PROPN
dpc-2259	60	26	-	-	PUNCT
dpc-2259	60	27	α	α	NOUN
dpc-2259	60	28	inhibitors	inhibitor	NOUN
dpc-2259	60	29	either	either	CCONJ
dpc-2259	60	30	alone	alone	ADJ
dpc-2259	60	31	or	or	CCONJ
dpc-2259	60	32	with	with	ADP
dpc-2259	60	33	oral	oral	ADJ
dpc-2259	60	34	/	/	SYM
dpc-2259	60	35	topical	topical	ADJ
dpc-2259	60	36	antibiotics	antibiotic	NOUN
dpc-2259	60	37	.	.	PUNCT
dpc-2259	61	1	out	out	ADP
dpc-2259	61	2	of	of	ADP
dpc-2259	61	3	85	85	NUM
dpc-2259	61	4	patients	patient	NOUN
dpc-2259	61	5	from	from	ADP
dpc-2259	61	6	anti	anti	ADJ
dpc-2259	61	7	-	-	ADJ
dpc-2259	61	8	tnf	tnf	ADJ
dpc-2259	61	9	-	-	PUNCT
dpc-2259	61	10	α	α	PROPN
dpc-2259	61	11	group	group	NOUN
dpc-2259	61	12	,	,	PUNCT
dpc-2259	61	13	9	9	NUM
dpc-2259	61	14	(	(	PUNCT
dpc-2259	61	15	10.58	10.58	NUM
dpc-2259	61	16	%	%	NOUN
dpc-2259	61	17	)	)	PUNCT
dpc-2259	61	18	patients	patient	NOUN
dpc-2259	61	19	were	be	AUX
dpc-2259	61	20	under	under	ADP
dpc-2259	61	21	infliximab	infliximab	NOUN
dpc-2259	61	22	treatment	treatment	NOUN
dpc-2259	61	23	,	,	PUNCT
dpc-2259	61	24	whereas	whereas	SCONJ
dpc-2259	61	25	76	76	NUM
dpc-2259	61	26	(	(	PUNCT
dpc-2259	61	27	89.41	89.41	NUM
dpc-2259	61	28	%	%	NOUN
dpc-2259	61	29	)	)	PUNCT
dpc-2259	61	30	were	be	AUX
dpc-2259	61	31	under	under	ADP
dpc-2259	61	32	adalimumab	adalimumab	NOUN
dpc-2259	61	33	treatment	treatment	NOUN
dpc-2259	61	34	.	.	PUNCT
dpc-2259	62	1	patients	patient	NOUN
dpc-2259	62	2	with	with	ADP
dpc-2259	62	3	stage	stage	NOUN
dpc-2259	62	4	2	2	NUM
dpc-2259	62	5	and	and	CCONJ
dpc-2259	62	6	3	3	NUM
dpc-2259	62	7	hs	hs	PRON
dpc-2259	62	8	were	be	AUX
dpc-2259	62	9	additionally	additionally	ADV
dpc-2259	62	10	using	use	VERB
dpc-2259	62	11	colchicine	colchicine	NOUN
dpc-2259	62	12	.	.	PUNCT
dpc-2259	63	1	out	out	ADP
dpc-2259	63	2	of	of	ADP
dpc-2259	63	3	178	178	NUM
dpc-2259	63	4	cases	case	NOUN
dpc-2259	63	5	,	,	PUNCT
dpc-2259	63	6	75	75	NUM
dpc-2259	63	7	(	(	PUNCT
dpc-2259	63	8	42.1	42.1	NUM
dpc-2259	63	9	%	%	NOUN
dpc-2259	63	10	)	)	PUNCT
dpc-2259	63	11	patients	patient	NOUN
dpc-2259	63	12	had	have	VERB
dpc-2259	63	13	at	at	ADV
dpc-2259	63	14	least	least	ADV
dpc-2259	63	15	one	one	NUM
dpc-2259	63	16	systemic	systemic	ADJ
dpc-2259	63	17	disease	disease	NOUN
dpc-2259	63	18	.	.	PUNCT
dpc-2259	64	1	nineteen	nineteen	NUM
dpc-2259	64	2	(	(	PUNCT
dpc-2259	64	3	10.7	10.7	NUM
dpc-2259	64	4	%	%	NOUN
dpc-2259	64	5	)	)	PUNCT
dpc-2259	64	6	patients	patient	NOUN
dpc-2259	64	7	had	have	VERB
dpc-2259	64	8	rheumatologic	rheumatologic	NOUN
dpc-2259	64	9	illnesses	illness	NOUN
dpc-2259	64	10	(	(	PUNCT
dpc-2259	64	11	most	most	ADV
dpc-2259	64	12	common	common	ADJ
dpc-2259	64	13	ones	one	NOUN
dpc-2259	64	14	being	be	AUX
dpc-2259	64	15	familial	familial	ADJ
dpc-2259	64	16	mediterranean	mediterranean	ADJ
dpc-2259	64	17	fever	fever	NOUN
dpc-2259	64	18	,	,	PUNCT
dpc-2259	64	19	behçet	behçet	ADJ
dpc-2259	64	20	disease	disease	NOUN
dpc-2259	64	21	and	and	CCONJ
dpc-2259	64	22	ankylosing	ankylose	VERB
dpc-2259	64	23	spondylitis	spondylitis	NOUN
dpc-2259	64	24	)	)	PUNCT
dpc-2259	64	25	;	;	PUNCT
dpc-2259	64	26	22	22	NUM
dpc-2259	64	27	(	(	PUNCT
dpc-2259	64	28	12.4	12.4	NUM
dpc-2259	64	29	%	%	NOUN
dpc-2259	64	30	)	)	PUNCT
dpc-2259	64	31	patients	patient	NOUN
dpc-2259	64	32	had	have	VERB
dpc-2259	64	33	cardiovascular	cardiovascular	ADJ
dpc-2259	64	34	diseases	disease	NOUN
dpc-2259	64	35	most	most	ADV
dpc-2259	64	36	frequently	frequently	ADV
dpc-2259	64	37	being	be	AUX
dpc-2259	64	38	hypertension	hypertension	NOUN
dpc-2259	64	39	,	,	PUNCT
dpc-2259	64	40	coronary	coronary	ADJ
dpc-2259	64	41	artery	artery	NOUN
dpc-2259	64	42	disease	disease	NOUN
dpc-2259	64	43	and	and	CCONJ
dpc-2259	64	44	heart	heart	NOUN
dpc-2259	64	45	failure	failure	NOUN
dpc-2259	64	46	.	.	PUNCT
dpc-2259	65	1	five	five	NUM
dpc-2259	65	2	(	(	PUNCT
dpc-2259	65	3	2.8	2.8	NUM
dpc-2259	65	4	%	%	NOUN
dpc-2259	65	5	)	)	PUNCT
dpc-2259	65	6	case	case	NOUN
dpc-2259	65	7	presented	present	VERB
dpc-2259	65	8	with	with	ADP
dpc-2259	65	9	nephrologic	nephrologic	ADJ
dpc-2259	65	10	diseases	disease	NOUN
dpc-2259	65	11	whereas	whereas	SCONJ
dpc-2259	65	12	five	five	NUM
dpc-2259	65	13	other	other	ADJ
dpc-2259	65	14	(	(	PUNCT
dpc-2259	65	15	2.8	2.8	NUM
dpc-2259	65	16	%	%	NOUN
dpc-2259	65	17	)	)	PUNCT
dpc-2259	65	18	patients	patient	NOUN
dpc-2259	65	19	had	have	VERB
dpc-2259	65	20	prior	prior	ADJ
dpc-2259	65	21	history	history	NOUN
dpc-2259	65	22	of	of	ADP
dpc-2259	65	23	malignancy	malignancy	NOUN
dpc-2259	65	24	.	.	PUNCT
dpc-2259	66	1	endocrinologic	endocrinologic	ADJ
dpc-2259	66	2	disorders	disorder	NOUN
dpc-2259	66	3	such	such	ADJ
dpc-2259	66	4	as	as	ADP
dpc-2259	66	5	diabetes	diabetes	NOUN
dpc-2259	66	6	mellitus	mellitus	NOUN
dpc-2259	66	7	,	,	PUNCT
dpc-2259	66	8	hypothyroidism	hypothyroidism	NOUN
dpc-2259	66	9	and	and	CCONJ
dpc-2259	66	10	hyperlipidemia	hyperlipidemia	NOUN
dpc-2259	66	11	were	be	AUX
dpc-2259	66	12	seen	see	VERB
dpc-2259	66	13	in	in	ADP
dpc-2259	66	14	33	33	NUM
dpc-2259	66	15	(	(	PUNCT
dpc-2259	66	16	18.5	18.5	NUM
dpc-2259	66	17	%	%	NOUN
dpc-2259	66	18	)	)	PUNCT
dpc-2259	66	19	cases	case	NOUN
dpc-2259	66	20	,	,	PUNCT
dpc-2259	66	21	whereas	whereas	SCONJ
dpc-2259	66	22	respiratory	respiratory	ADJ
dpc-2259	66	23	diseases	disease	NOUN
dpc-2259	66	24	(	(	PUNCT
dpc-2259	66	25	most	most	ADV
dpc-2259	66	26	commonly	commonly	ADV
dpc-2259	66	27	asthma	asthma	NOUN
dpc-2259	66	28	,	,	PUNCT
dpc-2259	66	29	allergic	allergic	ADJ
dpc-2259	66	30	rhinitis	rhinitis	NOUN
dpc-2259	66	31	)	)	PUNCT
dpc-2259	66	32	were	be	AUX
dpc-2259	66	33	present	present	ADJ
dpc-2259	66	34	in	in	ADP
dpc-2259	66	35	11	11	NUM
dpc-2259	66	36	(	(	PUNCT
dpc-2259	66	37	6.2	6.2	NUM
dpc-2259	66	38	%	%	NOUN
dpc-2259	66	39	)	)	PUNCT
dpc-2259	66	40	patients	patient	NOUN
dpc-2259	66	41	.	.	PUNCT
dpc-2259	67	1	during	during	ADP
dpc-2259	67	2	covid-19	covid-19	PROPN
dpc-2259	67	3	pandemic	pandemic	NOUN
dpc-2259	67	4	,	,	PUNCT
dpc-2259	67	5	94	94	NUM
dpc-2259	67	6	(	(	PUNCT
dpc-2259	67	7	52.8	52.8	NUM
dpc-2259	67	8	%	%	NOUN
dpc-2259	67	9	)	)	PUNCT
dpc-2259	67	10	out	out	ADP
dpc-2259	67	11	of	of	ADP
dpc-2259	67	12	178	178	NUM
dpc-2259	67	13	patients	patient	NOUN
dpc-2259	67	14	had	have	VERB
dpc-2259	67	15	covid-19	covid-19	PROPN
dpc-2259	67	16	related	related	ADJ
dpc-2259	67	17	symptoms	symptom	NOUN
dpc-2259	67	18	such	such	ADJ
dpc-2259	67	19	as	as	ADP
dpc-2259	67	20	fever	fever	NOUN
dpc-2259	67	21	,	,	PUNCT
dpc-2259	67	22	anosmia	anosmia	NOUN
dpc-2259	67	23	,	,	PUNCT
dpc-2259	67	24	ageusia	ageusia	NOUN
dpc-2259	67	25	,	,	PUNCT
dpc-2259	67	26	malaise	malaise	NOUN
dpc-2259	67	27	,	,	PUNCT
dpc-2259	67	28	sore	sore	ADJ
dpc-2259	67	29	throat	throat	NOUN
dpc-2259	67	30	,	,	PUNCT
dpc-2259	67	31	dry	dry	ADJ
dpc-2259	67	32	cough	cough	NOUN
dpc-2259	67	33	,	,	PUNCT
dpc-2259	67	34	diarrhea	diarrhea	NOUN
dpc-2259	67	35	and	and	CCONJ
dpc-2259	67	36	myalgia	myalgia	NOUN
dpc-2259	67	37	.	.	PUNCT
dpc-2259	68	1	covid-19	covid-19	PROPN
dpc-2259	68	2	real	real	ADJ
dpc-2259	68	3	time	time	NOUN
dpc-2259	68	4	-	-	PUNCT
dpc-2259	68	5	pcr	pcr	ADJ
dpc-2259	68	6	test	test	NOUN
dpc-2259	68	7	was	be	AUX
dpc-2259	68	8	performed	perform	VERB
dpc-2259	68	9	in	in	ADP
dpc-2259	68	10	one	one	NUM
dpc-2259	68	11	hundred	hundred	NUM
dpc-2259	68	12	nine	nine	NUM
dpc-2259	68	13	(	(	PUNCT
dpc-2259	68	14	61.2	61.2	NUM
dpc-2259	68	15	%	%	NOUN
dpc-2259	68	16	)	)	PUNCT
dpc-2259	68	17	out	out	ADP
dpc-2259	68	18	of	of	ADP
dpc-2259	68	19	178	178	NUM
dpc-2259	68	20	patients	patient	NOUN
dpc-2259	68	21	.	.	PUNCT
dpc-2259	69	1	thirty	thirty	NUM
dpc-2259	69	2	(	(	PUNCT
dpc-2259	69	3	27.5	27.5	NUM
dpc-2259	69	4	%	%	NOUN
dpc-2259	69	5	)	)	PUNCT
dpc-2259	69	6	cases	case	NOUN
dpc-2259	69	7	tested	test	VERB
dpc-2259	69	8	positive	positive	ADJ
dpc-2259	69	9	for	for	ADP
dpc-2259	69	10	covid-19	covid-19	PROPN
dpc-2259	69	11	whereas	whereas	SCONJ
dpc-2259	69	12	79	79	NUM
dpc-2259	69	13	(	(	PUNCT
dpc-2259	69	14	72.5	72.5	NUM
dpc-2259	69	15	%	%	NOUN
dpc-2259	69	16	)	)	PUNCT
dpc-2259	69	17	tested	test	VERB
dpc-2259	69	18	negative	negative	ADJ
dpc-2259	69	19	.	.	PUNCT
dpc-2259	70	1	forty	forty	NUM
dpc-2259	70	2	-	-	PUNCT
dpc-2259	70	3	seven	seven	NUM
dpc-2259	70	4	(	(	PUNCT
dpc-2259	70	5	26.4	26.4	NUM
dpc-2259	70	6	%	%	NOUN
dpc-2259	70	7	)	)	PUNCT
dpc-2259	70	8	cases	case	NOUN
dpc-2259	70	9	had	have	VERB
dpc-2259	70	10	a	a	DET
dpc-2259	70	11	history	history	NOUN
dpc-2259	70	12	of	of	ADP
dpc-2259	70	13	close	close	ADJ
dpc-2259	70	14	contact	contact	NOUN
dpc-2259	70	15	to	to	ADP
dpc-2259	70	16	someone	someone	PRON
dpc-2259	70	17	with	with	ADP
dpc-2259	70	18	a	a	DET
dpc-2259	70	19	confirmed	confirm	VERB
dpc-2259	70	20	diagnosis	diagnosis	NOUN
dpc-2259	70	21	of	of	ADP
dpc-2259	70	22	covid-19	covid-19	PROPN
dpc-2259	70	23	.	.	PUNCT
dpc-2259	71	1	of	of	ADP
dpc-2259	71	2	109	109	NUM
dpc-2259	71	3	patients	patient	NOUN
dpc-2259	71	4	with	with	ADP
dpc-2259	71	5	covid-19	covid-19	PROPN
dpc-2259	71	6	real	real	ADJ
dpc-2259	71	7	-	-	PUNCT
dpc-2259	71	8	time	time	NOUN
dpc-2259	71	9	pcr	pcr	PROPN
dpc-2259	71	10	test	test	NOUN
dpc-2259	71	11	,	,	PUNCT
dpc-2259	71	12	30	30	NUM
dpc-2259	71	13	(	(	PUNCT
dpc-2259	71	14	27.5	27.5	NUM
dpc-2259	71	15	%	%	NOUN
dpc-2259	71	16	)	)	PUNCT
dpc-2259	71	17	had	have	VERB
dpc-2259	71	18	positive	positive	ADJ
dpc-2259	71	19	test	test	NOUN
dpc-2259	71	20	result	result	NOUN
dpc-2259	71	21	whereas	whereas	SCONJ
dpc-2259	71	22	79	79	NUM
dpc-2259	71	23	(	(	PUNCT
dpc-2259	71	24	72.5	72.5	NUM
dpc-2259	71	25	%	%	NOUN
dpc-2259	71	26	)	)	PUNCT
dpc-2259	71	27	were	be	AUX
dpc-2259	71	28	tested	test	VERB
dpc-2259	71	29	negative	negative	ADJ
dpc-2259	71	30	.	.	PUNCT
dpc-2259	72	1	the	the	DET
dpc-2259	72	2	average	average	ADJ
dpc-2259	72	3	age	age	NOUN
dpc-2259	72	4	of	of	ADP
dpc-2259	72	5	patients	patient	NOUN
dpc-2259	72	6	with	with	ADP
dpc-2259	72	7	positive	positive	ADJ
dpc-2259	72	8	real	real	ADJ
dpc-2259	72	9	-	-	PUNCT
dpc-2259	72	10	time	time	NOUN
dpc-2259	72	11	pcr	pcr	NOUN
dpc-2259	72	12	was	be	AUX
dpc-2259	72	13	statistically	statistically	ADV
dpc-2259	72	14	significantly	significantly	ADV
dpc-2259	72	15	higher	high	ADJ
dpc-2259	72	16	compared	compare	VERB
dpc-2259	72	17	to	to	ADP
dpc-2259	72	18	the	the	DET
dpc-2259	72	19	patients	patient	NOUN
dpc-2259	72	20	with	with	ADP
dpc-2259	72	21	negative	negative	ADJ
dpc-2259	72	22	result	result	NOUN
dpc-2259	72	23	(	(	PUNCT
dpc-2259	72	24	p=0.007	p=0.007	X
dpc-2259	72	25	)	)	PUNCT
dpc-2259	72	26	(	(	PUNCT
dpc-2259	72	27	table	table	NOUN
dpc-2259	72	28	  	  	SPACE
dpc-2259	72	29	1	1	NUM
dpc-2259	72	30	)	)	PUNCT
dpc-2259	72	31	.	.	PUNCT
dpc-2259	73	1	there	there	PRON
dpc-2259	73	2	was	be	VERB
dpc-2259	73	3	no	no	DET
dpc-2259	73	4	statistically	statistically	ADV
dpc-2259	73	5	significant	significant	ADJ
dpc-2259	73	6	relationship	relationship	NOUN
dpc-2259	73	7	between	between	ADP
dpc-2259	73	8	gender	gender	NOUN
dpc-2259	73	9	versus	versus	ADP
dpc-2259	73	10	covid-19	covid-19	PROPN
dpc-2259	73	11	real	real	ADJ
dpc-2259	73	12	-	-	PUNCT
dpc-2259	73	13	time	time	NOUN
dpc-2259	73	14	pcr	pcr	NOUN
dpc-2259	73	15	positivity	positivity	NOUN
dpc-2259	73	16	(	(	PUNCT
dpc-2259	73	17	p	p	X
dpc-2259	73	18	=	=	NOUN
dpc-2259	73	19	0.275	0.275	NUM
dpc-2259	73	20	)	)	PUNCT
dpc-2259	73	21	and	and	CCONJ
dpc-2259	73	22	bmi	bmi	NOUN
dpc-2259	73	23	vs	vs	ADP
dpc-2259	73	24	covid-19	covid-19	PROPN
dpc-2259	73	25	real	real	ADJ
dpc-2259	73	26	-	-	PUNCT
dpc-2259	73	27	time	time	NOUN
dpc-2259	73	28	pcr	pcr	NOUN
dpc-2259	73	29	positivity	positivity	NOUN
dpc-2259	73	30	(	(	PUNCT
dpc-2259	73	31	p	p	X
dpc-2259	73	32	=	=	NOUN
dpc-2259	73	33	0.873	0.873	NUM
dpc-2259	73	34	)	)	PUNCT
dpc-2259	73	35	(	(	PUNCT
dpc-2259	73	36	table	table	NOUN
dpc-2259	73	37	 	 	SPACE
dpc-2259	73	38	1	1	NUM
dpc-2259	73	39	)	)	PUNCT
dpc-2259	73	40	.	.	PUNCT
dpc-2259	74	1	there	there	PRON
dpc-2259	74	2	was	be	VERB
dpc-2259	74	3	no	no	DET
dpc-2259	74	4	statistically	statistically	ADV
dpc-2259	74	5	significant	significant	ADJ
dpc-2259	74	6	difference	difference	NOUN
dpc-2259	74	7	in	in	ADP
dpc-2259	74	8	covid-19	covid-19	PROPN
dpc-2259	74	9	real	real	ADJ
dpc-2259	74	10	-	-	PUNCT
dpc-2259	74	11	time	time	NOUN
dpc-2259	74	12	pcr	pcr	NOUN
dpc-2259	74	13	positivity	positivity	NOUN
dpc-2259	74	14	between	between	ADP
dpc-2259	74	15	smokers	smoker	NOUN
dpc-2259	74	16	and	and	CCONJ
dpc-2259	74	17	non	non	NOUN
dpc-2259	74	18	-	-	NOUN
dpc-2259	74	19	smokers	smoker	NOUN
dpc-2259	74	20	(	(	PUNCT
dpc-2259	74	21	p	p	X
dpc-2259	74	22	=	=	NOUN
dpc-2259	74	23	0.111	0.111	NUM
dpc-2259	74	24	)	)	PUNCT
dpc-2259	74	25	(	(	PUNCT
dpc-2259	74	26	table	table	NOUN
dpc-2259	74	27	2	2	NUM
dpc-2259	74	28	)	)	PUNCT
dpc-2259	74	29	.	.	PUNCT
dpc-2259	75	1	there	there	PRON
dpc-2259	75	2	was	be	VERB
dpc-2259	75	3	no	no	DET
dpc-2259	75	4	statistically	statistically	ADV
dpc-2259	75	5	significant	significant	ADJ
dpc-2259	75	6	relationship	relationship	NOUN
dpc-2259	75	7	between	between	ADP
dpc-2259	75	8	the	the	DET
dpc-2259	75	9	mean	mean	ADJ
dpc-2259	75	10	pack	pack	NOUN
dpc-2259	75	11	-	-	PUNCT
dpc-2259	75	12	years	year	NOUN
dpc-2259	75	13	of	of	ADP
dpc-2259	75	14	smoking	smoking	NOUN
dpc-2259	75	15	of	of	ADP
dpc-2259	75	16	patients	patient	NOUN
dpc-2259	75	17	who	who	PRON
dpc-2259	75	18	tested	test	VERB
dpc-2259	75	19	positive	positive	ADJ
dpc-2259	75	20	and	and	CCONJ
dpc-2259	75	21	negative	negative	ADJ
dpc-2259	75	22	for	for	ADP
dpc-2259	75	23	covid-19	covid-19	PROPN
dpc-2259	75	24	(	(	PUNCT
dpc-2259	75	25	p	p	NOUN
dpc-2259	75	26	=	=	NOUN
dpc-2259	75	27	0.222	0.222	NUM
dpc-2259	75	28	)	)	PUNCT
dpc-2259	75	29	(	(	PUNCT
dpc-2259	75	30	table	table	NOUN
dpc-2259	75	31	2	2	NUM
dpc-2259	75	32	)	)	PUNCT
dpc-2259	75	33	.	.	PUNCT
dpc-2259	76	1	we	we	PRON
dpc-2259	76	2	found	find	VERB
dpc-2259	76	3	a	a	DET
dpc-2259	76	4	statistically	statistically	ADV
dpc-2259	76	5	significant	significant	ADJ
dpc-2259	76	6	relationship	relationship	NOUN
dpc-2259	76	7	between	between	ADP
dpc-2259	76	8	covid-19	covid-19	PROPN
dpc-2259	76	9	real	real	ADJ
dpc-2259	76	10	-	-	PUNCT
dpc-2259	76	11	time	time	NOUN
dpc-2259	76	12	pcr	pcr	NOUN
dpc-2259	76	13	results	result	NOUN
dpc-2259	76	14	and	and	CCONJ
dpc-2259	76	15	the	the	DET
dpc-2259	76	16	mean	mean	ADJ
dpc-2259	76	17	disease	disease	NOUN
dpc-2259	76	18	duration	duration	NOUN
dpc-2259	76	19	for	for	ADP
dpc-2259	76	20	hs	hs	PROPN
dpc-2259	76	21	(	(	PUNCT
dpc-2259	76	22	p	p	NOUN
dpc-2259	76	23	=	=	NOUN
dpc-2259	76	24	0.031	0.031	NUM
dpc-2259	76	25	)	)	PUNCT
dpc-2259	76	26	(	(	PUNCT
dpc-2259	76	27	table	table	NOUN
dpc-2259	76	28	3	3	NUM
dpc-2259	76	29	)	)	PUNCT
dpc-2259	76	30	.	.	PUNCT
dpc-2259	77	1	the	the	DET
dpc-2259	77	2	patients	patient	NOUN
dpc-2259	77	3	with	with	ADP
dpc-2259	77	4	positive	positive	ADJ
dpc-2259	77	5	real	real	ADJ
dpc-2259	77	6	-	-	PUNCT
dpc-2259	77	7	time	time	NOUN
dpc-2259	77	8	pcr	pcr	NOUN
dpc-2259	77	9	results	result	NOUN
dpc-2259	77	10	have	have	VERB
dpc-2259	77	11	a	a	DET
dpc-2259	77	12	higher	high	ADJ
dpc-2259	77	13	mean	mean	NOUN
dpc-2259	77	14	disease	disease	NOUN
dpc-2259	77	15	duration	duration	NOUN
dpc-2259	77	16	compared	compare	VERB
dpc-2259	77	17	to	to	ADP
dpc-2259	77	18	the	the	DET
dpc-2259	77	19	ones	one	NOUN
dpc-2259	77	20	with	with	ADP
dpc-2259	77	21	negative	negative	ADJ
dpc-2259	77	22	covid-19	covid-19	PROPN
dpc-2259	77	23	real	real	ADJ
dpc-2259	77	24	-	-	PUNCT
dpc-2259	77	25	time	time	NOUN
dpc-2259	77	26	pcr	pcr	NOUN
dpc-2259	77	27	results	result	NOUN
dpc-2259	77	28	.	.	PUNCT
dpc-2259	78	1	however	however	ADV
dpc-2259	78	2	,	,	PUNCT
dpc-2259	78	3	no	no	DET
dpc-2259	78	4	statistically	statistically	ADV
dpc-2259	78	5	significant	significant	ADJ
dpc-2259	78	6	relationship	relationship	NOUN
dpc-2259	78	7	was	be	AUX
dpc-2259	78	8	found	find	VERB
dpc-2259	78	9	between	between	ADP
dpc-2259	78	10	the	the	DET
dpc-2259	78	11	positive	positive	ADJ
dpc-2259	78	12	results	result	NOUN
dpc-2259	78	13	of	of	ADP
dpc-2259	78	14	covid-19	covid-19	PROPN
dpc-2259	78	15	real	real	ADJ
dpc-2259	78	16	-	-	PUNCT
dpc-2259	78	17	time	time	NOUN
dpc-2259	78	18	pcr	pcr	NOUN
dpc-2259	78	19	and	and	CCONJ
dpc-2259	78	20	the	the	DET
dpc-2259	78	21	mean	mean	ADJ
dpc-2259	78	22	duration	duration	NOUN
dpc-2259	78	23	of	of	ADP
dpc-2259	78	24	treatment	treatment	NOUN
dpc-2259	78	25	for	for	ADP
dpc-2259	78	26	hs	hs	PROPN
dpc-2259	78	27	(	(	PUNCT
dpc-2259	78	28	p	p	NOUN
dpc-2259	78	29	=	=	NOUN
dpc-2259	78	30	0.716	0.716	NUM
dpc-2259	78	31	)	)	PUNCT
dpc-2259	78	32	(	(	PUNCT
dpc-2259	78	33	table	table	NOUN
dpc-2259	78	34	3	3	NUM
dpc-2259	78	35	)	)	PUNCT
dpc-2259	78	36	.	.	PUNCT
dpc-2259	79	1	table	table	NOUN
dpc-2259	79	2	1	1	NUM
dpc-2259	79	3	:	:	PUNCT
dpc-2259	79	4	covid-19	covid-19	PROPN
dpc-2259	79	5	real	real	ADJ
dpc-2259	79	6	time	time	NOUN
dpc-2259	79	7	-	-	PUNCT
dpc-2259	79	8	pcr	pcr	ADJ
dpc-2259	79	9	results	result	NOUN
dpc-2259	79	10	in	in	ADP
dpc-2259	79	11	relation	relation	NOUN
dpc-2259	79	12	to	to	ADP
dpc-2259	79	13	the	the	DET
dpc-2259	79	14	age	age	NOUN
dpc-2259	79	15	,	,	PUNCT
dpc-2259	79	16	gender	gender	NOUN
dpc-2259	79	17	and	and	CCONJ
dpc-2259	79	18	body	body	NOUN
dpc-2259	79	19	-	-	PUNCT
dpc-2259	79	20	mass	mass	NOUN
dpc-2259	79	21	index	index	NOUN
dpc-2259	79	22	.	.	PUNCT
dpc-2259	80	1	covid-19	covid-19	PROPN
dpc-2259	80	2	real	real	ADJ
dpc-2259	80	3	time	time	NOUN
dpc-2259	80	4	-	-	PUNCT
dpc-2259	80	5	pcr	pcr	ADJ
dpc-2259	80	6	results	result	NOUN
dpc-2259	80	7	number	number	NOUN
dpc-2259	80	8	of	of	ADP
dpc-2259	80	9	patients	patient	NOUN
dpc-2259	80	10	(	(	PUNCT
dpc-2259	80	11	n	n	CCONJ
dpc-2259	80	12	)	)	PUNCT
dpc-2259	80	13	age	age	NOUN
dpc-2259	80	14	(	(	PUNCT
dpc-2259	80	15	years	year	NOUN
dpc-2259	80	16	)	)	PUNCT
dpc-2259	80	17	gender	gender	NOUN
dpc-2259	80	18	body	body	NOUN
dpc-2259	80	19	-	-	PUNCT
dpc-2259	80	20	mass	mass	NOUN
dpc-2259	80	21	index	index	NOUN
dpc-2259	80	22	mean	mean	VERB
dpc-2259	80	23	sd	sd	ADP
dpc-2259	80	24	minimum	minimum	ADJ
dpc-2259	80	25	maximum	maximum	ADJ
dpc-2259	80	26	female	female	ADJ
dpc-2259	80	27	n	n	NOUN
dpc-2259	80	28	(	(	PUNCT
dpc-2259	80	29	%	%	INTJ
dpc-2259	80	30	)	)	PUNCT
dpc-2259	80	31	male	male	NOUN
dpc-2259	80	32	n	n	CCONJ
dpc-2259	80	33	(	(	PUNCT
dpc-2259	80	34	%	%	INTJ
dpc-2259	80	35	)	)	PUNCT
dpc-2259	80	36	mean	mean	VERB
dpc-2259	80	37	sd	sd	ADP
dpc-2259	80	38	minimum	minimum	NOUN
dpc-2259	81	1	maximum	maximum	ADJ
dpc-2259	81	2	negative	negative	ADJ
dpc-2259	81	3	79	79	NUM
dpc-2259	81	4	35.65	35.65	NUM
dpc-2259	81	5	9.94	9.94	NUM
dpc-2259	81	6	17	17	NUM
dpc-2259	81	7	60	60	NUM
dpc-2259	81	8	27	27	NUM
dpc-2259	81	9	(	(	PUNCT
dpc-2259	81	10	79.4	79.4	NUM
dpc-2259	81	11	)	)	PUNCT
dpc-2259	81	12	52	52	NUM
dpc-2259	81	13	(	(	PUNCT
dpc-2259	81	14	69.3	69.3	NUM
dpc-2259	81	15	)	)	PUNCT
dpc-2259	81	16	27.38	27.38	NUM
dpc-2259	81	17	3.17	3.17	NUM
dpc-2259	81	18	17.09	17.09	NUM
dpc-2259	81	19	38.74	38.74	NUM
dpc-2259	81	20	positive	positive	ADJ
dpc-2259	81	21	30	30	NUM
dpc-2259	81	22	42.07	42.07	NUM
dpc-2259	81	23	11.75	11.75	NUM
dpc-2259	81	24	20	20	NUM
dpc-2259	81	25	61	61	NUM
dpc-2259	81	26	7	7	NUM
dpc-2259	81	27	(	(	PUNCT
dpc-2259	81	28	20.6	20.6	NUM
dpc-2259	81	29	)	)	PUNCT
dpc-2259	81	30	23	23	NUM
dpc-2259	81	31	(	(	PUNCT
dpc-2259	81	32	30.7	30.7	NUM
dpc-2259	81	33	)	)	PUNCT
dpc-2259	81	34	27.72	27.72	NUM
dpc-2259	81	35	3.62	3.62	NUM
dpc-2259	81	36	20.2	20.2	NUM
dpc-2259	81	37	37.72	37.72	NUM
dpc-2259	81	38	total	total	NOUN
dpc-2259	81	39	109	109	NUM
dpc-2259	81	40	37.41	37.41	NUM
dpc-2259	81	41	10.80	10.80	NUM
dpc-2259	81	42	17	17	NUM
dpc-2259	81	43	61	61	NUM
dpc-2259	81	44	34	34	NUM
dpc-2259	81	45	(	(	PUNCT
dpc-2259	81	46	100	100	NUM
dpc-2259	81	47	)	)	PUNCT
dpc-2259	81	48	75	75	NUM
dpc-2259	81	49	(	(	PUNCT
dpc-2259	81	50	100	100	NUM
dpc-2259	81	51	)	)	PUNCT
dpc-2259	81	52	27.48	27.48	NUM
dpc-2259	81	53	3.29	3.29	NUM
dpc-2259	81	54	17.09	17.09	NUM
dpc-2259	81	55	38.74	38.74	NUM
dpc-2259	81	56	sd	sd	NOUN
dpc-2259	81	57	=	=	PUNCT
dpc-2259	81	58	standard	standard	ADJ
dpc-2259	81	59	deviation	deviation	NOUN
dpc-2259	81	60	.	.	PUNCT
dpc-2259	82	1	the	the	DET
dpc-2259	82	2	average	average	ADJ
dpc-2259	82	3	age	age	NOUN
dpc-2259	82	4	of	of	ADP
dpc-2259	82	5	patients	patient	NOUN
dpc-2259	82	6	with	with	ADP
dpc-2259	82	7	positive	positive	ADJ
dpc-2259	82	8	covid	covid	NOUN
dpc-2259	82	9	real	real	ADJ
dpc-2259	82	10	time	time	NOUN
dpc-2259	82	11	-	-	PUNCT
dpc-2259	82	12	pcr	pcr	NOUN
dpc-2259	82	13	was	be	AUX
dpc-2259	82	14	statistically	statistically	ADV
dpc-2259	82	15	significantly	significantly	ADV
dpc-2259	82	16	higher	high	ADJ
dpc-2259	82	17	compared	compare	VERB
dpc-2259	82	18	to	to	ADP
dpc-2259	82	19	the	the	DET
dpc-2259	82	20	patients	patient	NOUN
dpc-2259	82	21	with	with	ADP
dpc-2259	82	22	negative	negative	ADJ
dpc-2259	82	23	result	result	NOUN
dpc-2259	82	24	(	(	PUNCT
dpc-2259	82	25	p	p	X
dpc-2259	82	26	<	<	X
dpc-2259	82	27	0.007	0.007	NUM
dpc-2259	82	28	)	)	PUNCT
dpc-2259	82	29	.	.	PUNCT
dpc-2259	83	1	there	there	PRON
dpc-2259	83	2	was	be	VERB
dpc-2259	83	3	no	no	DET
dpc-2259	83	4	statistically	statistically	ADV
dpc-2259	83	5	significant	significant	ADJ
dpc-2259	83	6	relationship	relationship	NOUN
dpc-2259	83	7	between	between	ADP
dpc-2259	83	8	the	the	DET
dpc-2259	83	9	gender	gender	NOUN
dpc-2259	83	10	vs	vs	ADP
dpc-2259	83	11	covid-19	covid-19	PROPN
dpc-2259	83	12	real	real	ADJ
dpc-2259	83	13	time	time	NOUN
dpc-2259	83	14	-	-	PUNCT
dpc-2259	83	15	pcr	pcr	ADJ
dpc-2259	83	16	results	result	NOUN
dpc-2259	83	17	(	(	PUNCT
dpc-2259	83	18	p	p	X
dpc-2259	83	19	=	=	NOUN
dpc-2259	83	20	0.275	0.275	NUM
dpc-2259	83	21	)	)	PUNCT
dpc-2259	83	22	.	.	PUNCT
dpc-2259	84	1	additionally	additionally	ADV
dpc-2259	84	2	,	,	PUNCT
dpc-2259	84	3	there	there	PRON
dpc-2259	84	4	was	be	VERB
dpc-2259	84	5	also	also	ADV
dpc-2259	84	6	no	no	DET
dpc-2259	84	7	statistically	statistically	ADV
dpc-2259	84	8	significant	significant	ADJ
dpc-2259	84	9	relationship	relationship	NOUN
dpc-2259	84	10	between	between	ADP
dpc-2259	84	11	the	the	DET
dpc-2259	84	12	body	body	NOUN
dpc-2259	84	13	-	-	PUNCT
dpc-2259	84	14	mass	mass	NOUN
dpc-2259	84	15	index	index	NOUN
dpc-2259	84	16	versus	versus	ADP
dpc-2259	84	17	covid-19	covid-19	PROPN
dpc-2259	84	18	real	real	ADJ
dpc-2259	84	19	time	time	NOUN
dpc-2259	84	20	-	-	PUNCT
dpc-2259	84	21	pcr	pcr	ADJ
dpc-2259	84	22	results	result	NOUN
dpc-2259	84	23	(	(	PUNCT
dpc-2259	84	24	p	p	X
dpc-2259	84	25	 	 	SPACE
dpc-2259	84	26	=	=	SYM
dpc-2259	84	27	0.873	0.873	NUM
dpc-2259	84	28	)	)	PUNCT
dpc-2259	84	29	.	.	PUNCT
dpc-2259	85	1	4	4	NUM
dpc-2259	85	2	original	original	ADJ
dpc-2259	85	3	article	article	NOUN
dpc-2259	85	4	|	|	ADV
dpc-2259	85	5	dermatol	dermatol	ADJ
dpc-2259	85	6	pract	pract	NOUN
dpc-2259	85	7	concept	concept	NOUN
dpc-2259	85	8	.	.	PUNCT
dpc-2259	86	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	86	2	categories	category	NOUN
dpc-2259	86	3	as	as	SCONJ
dpc-2259	86	4	tnfα	tnfα	NOUN
dpc-2259	86	5	inhibitors	inhibitor	VERB
dpc-2259	86	6	±	±	NUM
dpc-2259	86	7	oral	oral	ADJ
dpc-2259	86	8	/	/	SYM
dpc-2259	86	9	topical	topical	ADJ
dpc-2259	86	10	antibiotics	antibiotic	NOUN
dpc-2259	86	11	and	and	CCONJ
dpc-2259	86	12	others	other	NOUN
dpc-2259	86	13	(	(	PUNCT
dpc-2259	86	14	p	p	X
dpc-2259	86	15	=	=	NOUN
dpc-2259	86	16	0.248	0.248	NUM
dpc-2259	86	17	)	)	PUNCT
dpc-2259	86	18	.	.	PUNCT
dpc-2259	87	1	in	in	ADP
dpc-2259	87	2	all	all	DET
dpc-2259	87	3	patients	patient	NOUN
dpc-2259	87	4	,	,	PUNCT
dpc-2259	87	5	with	with	ADP
dpc-2259	87	6	a	a	DET
dpc-2259	87	7	confirmed	confirm	VERB
dpc-2259	87	8	diagnosis	diagnosis	NOUN
dpc-2259	87	9	of	of	ADP
dpc-2259	87	10	covid-19	covid-19	PROPN
dpc-2259	87	11	;	;	PUNCT
dpc-2259	87	12	anti	anti	ADJ
dpc-2259	87	13	-	-	ADJ
dpc-2259	87	14	tnf	tnf	ADJ
dpc-2259	87	15	-	-	PUNCT
dpc-2259	87	16	α	α	NOUN
dpc-2259	87	17	treatment	treatment	NOUN
dpc-2259	87	18	was	be	AUX
dpc-2259	87	19	immediately	immediately	ADV
dpc-2259	87	20	suspended	suspend	VERB
dpc-2259	87	21	until	until	ADP
dpc-2259	87	22	full	full	ADJ
dpc-2259	87	23	recovery	recovery	NOUN
dpc-2259	87	24	from	from	ADP
dpc-2259	87	25	the	the	DET
dpc-2259	87	26	disease	disease	NOUN
dpc-2259	87	27	.	.	PUNCT
dpc-2259	88	1	lastly	lastly	ADV
dpc-2259	88	2	,	,	PUNCT
dpc-2259	88	3	there	there	PRON
dpc-2259	88	4	was	be	VERB
dpc-2259	88	5	no	no	DET
dpc-2259	88	6	statistically	statistically	ADV
dpc-2259	88	7	significant	significant	ADJ
dpc-2259	88	8	relationship	relationship	NOUN
dpc-2259	88	9	between	between	ADP
dpc-2259	88	10	covid-19	covid-19	PROPN
dpc-2259	88	11	real	real	ADJ
dpc-2259	88	12	time	time	NOUN
dpc-2259	88	13	-	-	PUNCT
dpc-2259	88	14	pcr	pcr	ADJ
dpc-2259	88	15	results	result	NOUN
dpc-2259	88	16	and	and	CCONJ
dpc-2259	88	17	the	the	DET
dpc-2259	88	18	presence	presence	NOUN
dpc-2259	88	19	of	of	ADP
dpc-2259	88	20	previous	previous	ADJ
dpc-2259	88	21	malignancy	malignancy	NOUN
dpc-2259	88	22	history	history	NOUN
dpc-2259	88	23	;	;	PUNCT
dpc-2259	88	24	respiratory	respiratory	ADJ
dpc-2259	88	25	,	,	PUNCT
dpc-2259	88	26	cardiovascular	cardiovascular	ADJ
dpc-2259	88	27	,	,	PUNCT
dpc-2259	88	28	no	no	DET
dpc-2259	88	29	statistically	statistically	ADV
dpc-2259	88	30	significant	significant	ADJ
dpc-2259	88	31	relationship	relationship	NOUN
dpc-2259	88	32	was	be	AUX
dpc-2259	88	33	found	find	VERB
dpc-2259	88	34	between	between	ADP
dpc-2259	88	35	covid-19	covid-19	PROPN
dpc-2259	88	36	real	real	ADJ
dpc-2259	88	37	-	-	PUNCT
dpc-2259	88	38	time	time	NOUN
dpc-2259	88	39	pcr	pcr	NOUN
dpc-2259	88	40	positivity	positivity	NOUN
dpc-2259	88	41	and	and	CCONJ
dpc-2259	88	42	the	the	DET
dpc-2259	88	43	type	type	NOUN
dpc-2259	88	44	of	of	ADP
dpc-2259	88	45	treatment	treatment	NOUN
dpc-2259	88	46	administered	administer	VERB
dpc-2259	88	47	for	for	ADP
dpc-2259	88	48	hs	hs	PRON
dpc-2259	88	49	when	when	SCONJ
dpc-2259	88	50	the	the	DET
dpc-2259	88	51	treatment	treatment	NOUN
dpc-2259	88	52	modalities	modality	NOUN
dpc-2259	88	53	are	be	AUX
dpc-2259	88	54	divided	divide	VERB
dpc-2259	88	55	into	into	ADP
dpc-2259	88	56	four	four	NUM
dpc-2259	88	57	categories	category	NOUN
dpc-2259	88	58	as	as	ADP
dpc-2259	88	59	oral	oral	ADJ
dpc-2259	88	60	antibiotics±	antibiotics±	NOUN
dpc-2259	88	61	topical	topical	ADJ
dpc-2259	88	62	antibiotics	antibiotic	NOUN
dpc-2259	88	63	,	,	PUNCT
dpc-2259	88	64	oral	oral	ADJ
dpc-2259	88	65	retinoids	retinoid	NOUN
dpc-2259	88	66	±	±	NOUN
dpc-2259	88	67	topical	topical	ADJ
dpc-2259	88	68	antibiotics	antibiotic	NOUN
dpc-2259	88	69	,	,	PUNCT
dpc-2259	88	70	tnf	tnf	PROPN
dpc-2259	88	71	-	-	PUNCT
dpc-2259	88	72	α	α	PROPN
dpc-2259	88	73	inhibitors	inhibitor	NOUN
dpc-2259	88	74	±	±	NOUN
dpc-2259	88	75	oral	oral	ADJ
dpc-2259	88	76	/	/	SYM
dpc-2259	88	77	topical	topical	ADJ
dpc-2259	88	78	antibiotics	antibiotic	NOUN
dpc-2259	88	79	and	and	CCONJ
dpc-2259	88	80	only	only	ADV
dpc-2259	88	81	topical	topical	ADJ
dpc-2259	88	82	antibiotics	antibiotic	NOUN
dpc-2259	88	83	(	(	PUNCT
dpc-2259	88	84	p	p	X
dpc-2259	88	85	=	=	NOUN
dpc-2259	88	86	0.657	0.657	NUM
dpc-2259	88	87	)	)	PUNCT
dpc-2259	88	88	(	(	PUNCT
dpc-2259	88	89	table	table	NOUN
dpc-2259	88	90	4	4	NUM
dpc-2259	88	91	and	and	CCONJ
dpc-2259	88	92	figure	figure	VERB
dpc-2259	88	93	1	1	NUM
dpc-2259	88	94	)	)	PUNCT
dpc-2259	88	95	or	or	CCONJ
dpc-2259	88	96	divided	divide	VERB
dpc-2259	88	97	into	into	ADP
dpc-2259	88	98	two	two	NUM
dpc-2259	88	99	table	table	NOUN
dpc-2259	88	100	2	2	NUM
dpc-2259	88	101	.	.	PUNCT
dpc-2259	89	1	covid-19	covid-19	PROPN
dpc-2259	89	2	real	real	ADJ
dpc-2259	89	3	time	time	NOUN
dpc-2259	89	4	-	-	PUNCT
dpc-2259	89	5	pcr	pcr	ADJ
dpc-2259	89	6	results	result	NOUN
dpc-2259	89	7	in	in	ADP
dpc-2259	89	8	relation	relation	NOUN
dpc-2259	89	9	to	to	ADP
dpc-2259	89	10	smoking	smoking	NOUN
dpc-2259	89	11	status	status	NOUN
dpc-2259	89	12	and	and	CCONJ
dpc-2259	89	13	pack	pack	NOUN
dpc-2259	89	14	-	-	PUNCT
dpc-2259	89	15	years	year	NOUN
dpc-2259	89	16	of	of	ADP
dpc-2259	89	17	smoking	smoking	NOUN
dpc-2259	89	18	.	.	PUNCT
dpc-2259	90	1	covid-19	covid-19	PROPN
dpc-2259	90	2	real	real	ADJ
dpc-2259	90	3	time	time	NOUN
dpc-2259	90	4	-	-	PUNCT
dpc-2259	90	5	pcr	pcr	ADJ
dpc-2259	90	6	results	result	NOUN
dpc-2259	90	7	number	number	NOUN
dpc-2259	90	8	of	of	ADP
dpc-2259	90	9	patients	patient	NOUN
dpc-2259	90	10	smoking	smoke	VERB
dpc-2259	90	11	status	status	NOUN
dpc-2259	90	12	pack	pack	NOUN
dpc-2259	90	13	-	-	PUNCT
dpc-2259	90	14	years	year	NOUN
dpc-2259	90	15	of	of	ADP
dpc-2259	90	16	smoking	smoking	NOUN
dpc-2259	90	17	(	(	PUNCT
dpc-2259	90	18	among	among	ADP
dpc-2259	90	19	smokers	smoker	NOUN
dpc-2259	90	20	)	)	PUNCT
dpc-2259	90	21	non	non	ADJ
dpc-2259	90	22	-	-	ADJ
dpc-2259	90	23	smoker	smoker	ADJ
dpc-2259	90	24	n	n	CCONJ
dpc-2259	90	25	(	(	PUNCT
dpc-2259	90	26	%	%	INTJ
dpc-2259	90	27	)	)	PUNCT
dpc-2259	90	28	smoker	smoker	NOUN
dpc-2259	90	29	n	n	PRON
dpc-2259	90	30	(	(	PUNCT
dpc-2259	90	31	%	%	INTJ
dpc-2259	90	32	)	)	PUNCT
dpc-2259	90	33	number	number	NOUN
dpc-2259	90	34	of	of	ADP
dpc-2259	90	35	patients	patient	NOUN
dpc-2259	90	36	mean	mean	VERB
dpc-2259	90	37	sd	sd	ADP
dpc-2259	90	38	minimum	minimum	NOUN
dpc-2259	90	39	maximum	maximum	ADJ
dpc-2259	90	40	negative	negative	ADJ
dpc-2259	90	41	79	79	NUM
dpc-2259	90	42	24	24	NUM
dpc-2259	90	43	(	(	PUNCT
dpc-2259	90	44	63.2	63.2	NUM
dpc-2259	90	45	)	)	PUNCT
dpc-2259	90	46	55	55	NUM
dpc-2259	90	47	(	(	PUNCT
dpc-2259	90	48	77.5	77.5	NUM
dpc-2259	90	49	)	)	PUNCT
dpc-2259	90	50	55	55	NUM
dpc-2259	90	51	21.73	21.73	NUM
dpc-2259	90	52	15.11	15.11	NUM
dpc-2259	90	53	4	4	NUM
dpc-2259	90	54	80	80	NUM
dpc-2259	90	55	positive	positive	ADJ
dpc-2259	90	56	30	30	NUM
dpc-2259	90	57	14	14	NUM
dpc-2259	90	58	(	(	PUNCT
dpc-2259	90	59	36.8	36.8	NUM
dpc-2259	90	60	)	)	PUNCT
dpc-2259	90	61	16	16	NUM
dpc-2259	90	62	(	(	PUNCT
dpc-2259	90	63	22.5	22.5	NUM
dpc-2259	90	64	)	)	PUNCT
dpc-2259	90	65	16	16	NUM
dpc-2259	90	66	25.75	25.75	NUM
dpc-2259	90	67	14.85	14.85	NUM
dpc-2259	90	68	10	10	NUM
dpc-2259	90	69	54	54	NUM
dpc-2259	90	70	total	total	NOUN
dpc-2259	90	71	109	109	NUM
dpc-2259	90	72	38	38	NUM
dpc-2259	90	73	(	(	PUNCT
dpc-2259	90	74	100	100	NUM
dpc-2259	90	75	)	)	PUNCT
dpc-2259	90	76	71	71	NUM
dpc-2259	90	77	(	(	PUNCT
dpc-2259	90	78	100	100	NUM
dpc-2259	90	79	)	)	PUNCT
dpc-2259	90	80	71	71	NUM
dpc-2259	90	81	22.63	22.63	NUM
dpc-2259	90	82	15.04	15.04	NUM
dpc-2259	90	83	4	4	NUM
dpc-2259	90	84	80	80	NUM
dpc-2259	90	85	there	there	PRON
dpc-2259	90	86	was	be	VERB
dpc-2259	90	87	no	no	DET
dpc-2259	90	88	statistically	statistically	ADV
dpc-2259	90	89	significant	significant	ADJ
dpc-2259	90	90	difference	difference	NOUN
dpc-2259	90	91	in	in	ADP
dpc-2259	90	92	covid-19	covid-19	PROPN
dpc-2259	90	93	real	real	ADJ
dpc-2259	90	94	time	time	NOUN
dpc-2259	90	95	-	-	PUNCT
dpc-2259	90	96	pcr	pcr	ADJ
dpc-2259	90	97	positivity	positivity	NOUN
dpc-2259	90	98	between	between	ADP
dpc-2259	90	99	smokers	smoker	NOUN
dpc-2259	90	100	and	and	CCONJ
dpc-2259	90	101	non	non	NOUN
dpc-2259	90	102	-	-	NOUN
dpc-2259	90	103	smokers	smoker	NOUN
dpc-2259	90	104	(	(	PUNCT
dpc-2259	90	105	p	p	X
dpc-2259	90	106	=	=	NOUN
dpc-2259	90	107	0.111	0.111	NUM
dpc-2259	90	108	)	)	PUNCT
dpc-2259	90	109	.	.	PUNCT
dpc-2259	91	1	among	among	ADP
dpc-2259	91	2	smokers	smoker	NOUN
dpc-2259	91	3	,	,	PUNCT
dpc-2259	91	4	no	no	DET
dpc-2259	91	5	statistically	statistically	ADV
dpc-2259	91	6	significant	significant	ADJ
dpc-2259	91	7	relationship	relationship	NOUN
dpc-2259	91	8	was	be	AUX
dpc-2259	91	9	found	find	VERB
dpc-2259	91	10	between	between	ADP
dpc-2259	91	11	the	the	DET
dpc-2259	91	12	mean	mean	ADJ
dpc-2259	91	13	pack	pack	NOUN
dpc-2259	91	14	-	-	PUNCT
dpc-2259	91	15	years	year	NOUN
dpc-2259	91	16	of	of	ADP
dpc-2259	91	17	smoking	smoking	NOUN
dpc-2259	91	18	of	of	ADP
dpc-2259	91	19	patients	patient	NOUN
dpc-2259	91	20	who	who	PRON
dpc-2259	91	21	tested	test	VERB
dpc-2259	91	22	positive	positive	ADJ
dpc-2259	91	23	and	and	CCONJ
dpc-2259	91	24	negative	negative	ADJ
dpc-2259	91	25	for	for	ADP
dpc-2259	91	26	covid-19	covid-19	PROPN
dpc-2259	91	27	(	(	PUNCT
dpc-2259	91	28	p	p	NOUN
dpc-2259	91	29	=	=	NOUN
dpc-2259	91	30	0.222	0.222	NUM
dpc-2259	91	31	)	)	PUNCT
dpc-2259	91	32	.	.	PUNCT
dpc-2259	92	1	table	table	NOUN
dpc-2259	92	2	3	3	NUM
dpc-2259	92	3	.	.	PUNCT
dpc-2259	93	1	covid-19	covid-19	PROPN
dpc-2259	93	2	real	real	ADJ
dpc-2259	93	3	time	time	NOUN
dpc-2259	93	4	-	-	PUNCT
dpc-2259	93	5	pcr	pcr	ADJ
dpc-2259	93	6	results	result	NOUN
dpc-2259	93	7	in	in	ADP
dpc-2259	93	8	relation	relation	NOUN
dpc-2259	93	9	to	to	PART
dpc-2259	93	10	disease	disease	NOUN
dpc-2259	93	11	duration	duration	NOUN
dpc-2259	93	12	and	and	CCONJ
dpc-2259	93	13	treatment	treatment	NOUN
dpc-2259	93	14	duration	duration	NOUN
dpc-2259	93	15	.	.	PUNCT
dpc-2259	94	1	covid-19	covid-19	PROPN
dpc-2259	94	2	real	real	ADJ
dpc-2259	94	3	time	time	NOUN
dpc-2259	94	4	-	-	PUNCT
dpc-2259	94	5	pcr	pcr	ADJ
dpc-2259	94	6	results	result	NOUN
dpc-2259	94	7	negative	negative	ADJ
dpc-2259	94	8	positive	positive	ADJ
dpc-2259	94	9	total	total	ADJ
dpc-2259	94	10	disease	disease	NOUN
dpc-2259	94	11	duration	duration	NOUN
dpc-2259	94	12	(	(	PUNCT
dpc-2259	94	13	months	month	NOUN
dpc-2259	94	14	)	)	PUNCT
dpc-2259	94	15	number	number	NOUN
dpc-2259	94	16	of	of	ADP
dpc-2259	94	17	patients	patient	NOUN
dpc-2259	94	18	79	79	NUM
dpc-2259	94	19	30	30	NUM
dpc-2259	94	20	109	109	NUM
dpc-2259	94	21	mean	mean	NOUN
dpc-2259	94	22	109.29	109.29	NUM
dpc-2259	94	23	155.40	155.40	NUM
dpc-2259	94	24	121.98	121.98	NUM
dpc-2259	94	25	standard	standard	ADJ
dpc-2259	94	26	deviation	deviation	NOUN
dpc-2259	94	27	82.15	82.15	NUM
dpc-2259	94	28	112.99	112.99	NUM
dpc-2259	94	29	93.43	93.43	NUM
dpc-2259	94	30	minimum	minimum	NOUN
dpc-2259	94	31	2	2	NUM
dpc-2259	94	32	4	4	NUM
dpc-2259	94	33	2	2	NUM
dpc-2259	94	34	maximum	maximum	NOUN
dpc-2259	94	35	432	432	NUM
dpc-2259	94	36	552	552	NUM
dpc-2259	94	37	552	552	NUM
dpc-2259	94	38	treatment	treatment	NOUN
dpc-2259	94	39	duration	duration	NOUN
dpc-2259	94	40	(	(	PUNCT
dpc-2259	94	41	months	month	NOUN
dpc-2259	94	42	)	)	PUNCT
dpc-2259	94	43	mean	mean	VERB
dpc-2259	94	44	19.37	19.37	NUM
dpc-2259	94	45	16.77	16.77	NUM
dpc-2259	94	46	18.65	18.65	NUM
dpc-2259	94	47	standard	standard	ADJ
dpc-2259	94	48	deviation	deviation	NOUN
dpc-2259	94	49	19.15	19.15	NUM
dpc-2259	94	50	13.80	13.80	NUM
dpc-2259	94	51	17.81	17.81	NUM
dpc-2259	94	52	minimum	minimum	NOUN
dpc-2259	94	53	1	1	NUM
dpc-2259	94	54	1	1	NUM
dpc-2259	94	55	1	1	NUM
dpc-2259	94	56	maximum	maximum	NOUN
dpc-2259	94	57	84	84	NUM
dpc-2259	94	58	48	48	NUM
dpc-2259	94	59	84	84	NUM
dpc-2259	94	60	statistically	statistically	ADV
dpc-2259	94	61	significant	significant	ADJ
dpc-2259	94	62	relationship	relationship	NOUN
dpc-2259	94	63	was	be	AUX
dpc-2259	94	64	present	present	ADJ
dpc-2259	94	65	between	between	ADP
dpc-2259	94	66	covid-19	covid-19	PROPN
dpc-2259	94	67	real	real	ADJ
dpc-2259	94	68	time	time	NOUN
dpc-2259	94	69	-	-	PUNCT
dpc-2259	94	70	pcr	pcr	ADJ
dpc-2259	94	71	results	result	NOUN
dpc-2259	94	72	and	and	CCONJ
dpc-2259	94	73	the	the	DET
dpc-2259	94	74	mean	mean	ADJ
dpc-2259	94	75	disease	disease	NOUN
dpc-2259	94	76	duration	duration	NOUN
dpc-2259	94	77	for	for	ADP
dpc-2259	94	78	hs	hs	PROPN
dpc-2259	94	79	(	(	PUNCT
dpc-2259	94	80	p	p	NOUN
dpc-2259	94	81	=	=	NOUN
dpc-2259	94	82	0.031	0.031	NUM
dpc-2259	94	83	)	)	PUNCT
dpc-2259	94	84	.	.	PUNCT
dpc-2259	95	1	the	the	DET
dpc-2259	95	2	patients	patient	NOUN
dpc-2259	95	3	with	with	ADP
dpc-2259	95	4	positive	positive	ADJ
dpc-2259	95	5	real	real	ADJ
dpc-2259	95	6	time	time	NOUN
dpc-2259	95	7	-	-	PUNCT
dpc-2259	95	8	pcr	pcr	ADJ
dpc-2259	95	9	results	result	NOUN
dpc-2259	95	10	have	have	VERB
dpc-2259	95	11	a	a	DET
dpc-2259	95	12	higher	high	ADJ
dpc-2259	95	13	mean	mean	NOUN
dpc-2259	95	14	disease	disease	NOUN
dpc-2259	95	15	duration	duration	NOUN
dpc-2259	95	16	compared	compare	VERB
dpc-2259	95	17	to	to	ADP
dpc-2259	95	18	the	the	DET
dpc-2259	95	19	ones	one	NOUN
dpc-2259	95	20	with	with	ADP
dpc-2259	95	21	negative	negative	ADJ
dpc-2259	95	22	covid	covid	ADJ
dpc-2259	95	23	-	-	ADJ
dpc-2259	95	24	pcr	pcr	ADJ
dpc-2259	95	25	results	result	NOUN
dpc-2259	95	26	.	.	PUNCT
dpc-2259	96	1	however	however	ADV
dpc-2259	96	2	,	,	PUNCT
dpc-2259	96	3	no	no	DET
dpc-2259	96	4	statistically	statistically	ADV
dpc-2259	96	5	significant	significant	ADJ
dpc-2259	96	6	relationship	relationship	NOUN
dpc-2259	96	7	was	be	AUX
dpc-2259	96	8	found	find	VERB
dpc-2259	96	9	between	between	ADP
dpc-2259	96	10	the	the	DET
dpc-2259	96	11	positive	positive	ADJ
dpc-2259	96	12	results	result	NOUN
dpc-2259	96	13	of	of	ADP
dpc-2259	96	14	covid-19	covid-19	PROPN
dpc-2259	96	15	real	real	ADJ
dpc-2259	96	16	time	time	NOUN
dpc-2259	96	17	-	-	PUNCT
dpc-2259	96	18	pcr	pcr	NOUN
dpc-2259	96	19	and	and	CCONJ
dpc-2259	96	20	the	the	DET
dpc-2259	96	21	mean	mean	ADJ
dpc-2259	96	22	duration	duration	NOUN
dpc-2259	96	23	of	of	ADP
dpc-2259	96	24	treatment	treatment	NOUN
dpc-2259	96	25	for	for	ADP
dpc-2259	96	26	hs	hs	PROPN
dpc-2259	96	27	(	(	PUNCT
dpc-2259	96	28	p	p	NOUN
dpc-2259	96	29	=	=	NOUN
dpc-2259	96	30	0.716	0.716	NUM
dpc-2259	96	31	)	)	PUNCT
dpc-2259	96	32	.	.	PUNCT
dpc-2259	97	1	table	table	NOUN
dpc-2259	97	2	4	4	NUM
dpc-2259	97	3	.	.	PUNCT
dpc-2259	98	1	covid-19	covid-19	PROPN
dpc-2259	98	2	real	real	ADJ
dpc-2259	98	3	time	time	NOUN
dpc-2259	98	4	-	-	PUNCT
dpc-2259	98	5	pcr	pcr	ADJ
dpc-2259	98	6	results	result	NOUN
dpc-2259	98	7	with	with	ADP
dpc-2259	98	8	respect	respect	NOUN
dpc-2259	98	9	to	to	ADP
dpc-2259	98	10	the	the	DET
dpc-2259	98	11	treatment	treatment	NOUN
dpc-2259	98	12	groups	group	NOUN
dpc-2259	98	13	.	.	PUNCT
dpc-2259	99	1	covid-19	covid-19	PROPN
dpc-2259	99	2	real	real	ADJ
dpc-2259	99	3	time	time	NOUN
dpc-2259	99	4	-	-	PUNCT
dpc-2259	99	5	pcr	pcr	ADJ
dpc-2259	99	6	results	result	NOUN
dpc-2259	99	7	treatment	treatment	NOUN
dpc-2259	99	8	groups	group	NOUN
dpc-2259	99	9	oral	oral	ADJ
dpc-2259	99	10	antibiotics	antibiotic	NOUN
dpc-2259	99	11	±	±	NOUN
dpc-2259	99	12	topical	topical	ADJ
dpc-2259	99	13	antibiotics	antibiotic	NOUN
dpc-2259	99	14	n	n	CCONJ
dpc-2259	99	15	(	(	PUNCT
dpc-2259	99	16	%	%	INTJ
dpc-2259	99	17	)	)	PUNCT
dpc-2259	99	18	oral	oral	ADJ
dpc-2259	99	19	retinoids	retinoid	NOUN
dpc-2259	99	20	±	±	NOUN
dpc-2259	99	21	topical	topical	ADJ
dpc-2259	99	22	antibiotics	antibiotic	NOUN
dpc-2259	99	23	n	n	CCONJ
dpc-2259	99	24	(	(	PUNCT
dpc-2259	99	25	%	%	INTJ
dpc-2259	99	26	)	)	PUNCT
dpc-2259	99	27	tnf	tnf	PROPN
dpc-2259	99	28	-	-	PUNCT
dpc-2259	99	29	alpha	alpha	NOUN
dpc-2259	99	30	inhibitors	inhibitor	NOUN
dpc-2259	99	31	±	±	NOUN
dpc-2259	99	32	oral	oral	ADJ
dpc-2259	99	33	/	/	SYM
dpc-2259	99	34	topical	topical	ADJ
dpc-2259	99	35	antibiotics	antibiotic	NOUN
dpc-2259	99	36	n	n	CCONJ
dpc-2259	99	37	(	(	PUNCT
dpc-2259	99	38	%	%	INTJ
dpc-2259	99	39	)	)	PUNCT
dpc-2259	99	40	only	only	ADV
dpc-2259	99	41	topical	topical	ADJ
dpc-2259	99	42	antibiotics	antibiotic	NOUN
dpc-2259	99	43	n	n	CCONJ
dpc-2259	99	44	(	(	PUNCT
dpc-2259	99	45	%	%	INTJ
dpc-2259	99	46	)	)	PUNCT
dpc-2259	99	47	negative	negative	ADJ
dpc-2259	99	48	20	20	NUM
dpc-2259	99	49	(	(	PUNCT
dpc-2259	99	50	74.1	74.1	NUM
dpc-2259	99	51	)	)	PUNCT
dpc-2259	99	52	15	15	NUM
dpc-2259	99	53	(	(	PUNCT
dpc-2259	99	54	78.9	78.9	NUM
dpc-2259	99	55	)	)	SYM
dpc-2259	99	56	35	35	NUM
dpc-2259	99	57	(	(	PUNCT
dpc-2259	99	58	67	67	NUM
dpc-2259	99	59	)	)	PUNCT
dpc-2259	99	60	9	9	NUM
dpc-2259	99	61	(	(	PUNCT
dpc-2259	99	62	81.8	81.8	NUM
dpc-2259	99	63	%	%	NOUN
dpc-2259	99	64	)	)	PUNCT
dpc-2259	99	65	positive	positive	ADJ
dpc-2259	99	66	7	7	NUM
dpc-2259	99	67	(	(	PUNCT
dpc-2259	99	68	25.9	25.9	NUM
dpc-2259	99	69	)	)	PUNCT
dpc-2259	99	70	4	4	NUM
dpc-2259	99	71	(	(	PUNCT
dpc-2259	99	72	21.1	21.1	NUM
dpc-2259	99	73	)	)	SYM
dpc-2259	99	74	17	17	NUM
dpc-2259	99	75	(	(	PUNCT
dpc-2259	99	76	33	33	NUM
dpc-2259	99	77	)	)	SYM
dpc-2259	99	78	2	2	NUM
dpc-2259	99	79	(	(	PUNCT
dpc-2259	99	80	18.2	18.2	NUM
dpc-2259	99	81	)	)	PUNCT
dpc-2259	99	82	total	total	NOUN
dpc-2259	99	83	27	27	NUM
dpc-2259	99	84	(	(	PUNCT
dpc-2259	99	85	100	100	NUM
dpc-2259	99	86	)	)	PUNCT
dpc-2259	99	87	19	19	NUM
dpc-2259	99	88	(	(	PUNCT
dpc-2259	99	89	100	100	NUM
dpc-2259	99	90	)	)	PUNCT
dpc-2259	99	91	52	52	NUM
dpc-2259	99	92	(	(	PUNCT
dpc-2259	99	93	100	100	NUM
dpc-2259	99	94	)	)	PUNCT
dpc-2259	99	95	11	11	NUM
dpc-2259	99	96	(	(	PUNCT
dpc-2259	99	97	100	100	NUM
dpc-2259	99	98	)	)	PUNCT
dpc-2259	99	99	no	no	DET
dpc-2259	99	100	statistically	statistically	ADV
dpc-2259	99	101	significant	significant	ADJ
dpc-2259	99	102	relationship	relationship	NOUN
dpc-2259	99	103	was	be	AUX
dpc-2259	99	104	found	find	VERB
dpc-2259	99	105	between	between	ADP
dpc-2259	99	106	covid-19	covid-19	PROPN
dpc-2259	99	107	real	real	ADJ
dpc-2259	99	108	time	time	NOUN
dpc-2259	99	109	-	-	PUNCT
dpc-2259	99	110	pcr	pcr	NOUN
dpc-2259	99	111	positivity	positivity	NOUN
dpc-2259	99	112	and	and	CCONJ
dpc-2259	99	113	the	the	DET
dpc-2259	99	114	type	type	NOUN
dpc-2259	99	115	of	of	ADP
dpc-2259	99	116	treatment	treatment	NOUN
dpc-2259	99	117	administered	administer	VERB
dpc-2259	99	118	for	for	ADP
dpc-2259	99	119	hs	hs	PRON
dpc-2259	99	120	when	when	SCONJ
dpc-2259	99	121	the	the	DET
dpc-2259	99	122	treatment	treatment	NOUN
dpc-2259	99	123	modalities	modality	NOUN
dpc-2259	99	124	are	be	AUX
dpc-2259	99	125	divided	divide	VERB
dpc-2259	99	126	into	into	ADP
dpc-2259	99	127	four	four	NUM
dpc-2259	99	128	categories	category	NOUN
dpc-2259	99	129	as	as	ADP
dpc-2259	99	130	oral	oral	ADJ
dpc-2259	99	131	antibiotics±	antibiotics±	NOUN
dpc-2259	99	132	topical	topical	ADJ
dpc-2259	99	133	antibiotics	antibiotic	NOUN
dpc-2259	99	134	,	,	PUNCT
dpc-2259	99	135	oral	oral	ADJ
dpc-2259	99	136	retinoids±	retinoids±	NOUN
dpc-2259	99	137	topical	topical	ADJ
dpc-2259	99	138	antibiotics	antibiotic	NOUN
dpc-2259	99	139	,	,	PUNCT
dpc-2259	99	140	tnf	tnf	PROPN
dpc-2259	99	141	-	-	PUNCT
dpc-2259	99	142	alpha	alpha	NOUN
dpc-2259	99	143	inhibitors	inhibitor	NOUN
dpc-2259	99	144	±	±	NOUN
dpc-2259	99	145	oral	oral	ADJ
dpc-2259	99	146	/	/	SYM
dpc-2259	99	147	topical	topical	ADJ
dpc-2259	99	148	antibiotics	antibiotic	NOUN
dpc-2259	99	149	and	and	CCONJ
dpc-2259	99	150	only	only	ADV
dpc-2259	99	151	topical	topical	ADJ
dpc-2259	99	152	antibiotics	antibiotic	NOUN
dpc-2259	99	153	(	(	PUNCT
dpc-2259	99	154	p	p	X
dpc-2259	99	155	=	=	NOUN
dpc-2259	99	156	0.657	0.657	NUM
dpc-2259	99	157	)	)	PUNCT
dpc-2259	99	158	original	original	ADJ
dpc-2259	99	159	article	article	NOUN
dpc-2259	99	160	|	|	ADV
dpc-2259	99	161	dermatol	dermatol	ADJ
dpc-2259	99	162	pract	pract	NOUN
dpc-2259	99	163	concept	concept	NOUN
dpc-2259	99	164	.	.	PUNCT
dpc-2259	100	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	100	2	5	5	NUM
dpc-2259	100	3	significantly	significantly	ADV
dpc-2259	100	4	higher	high	ADJ
dpc-2259	100	5	pack	pack	NOUN
dpc-2259	100	6	-	-	PUNCT
dpc-2259	100	7	years	year	NOUN
dpc-2259	100	8	of	of	ADP
dpc-2259	100	9	smoking	smoking	NOUN
dpc-2259	100	10	compared	compare	VERB
dpc-2259	100	11	to	to	ADP
dpc-2259	100	12	the	the	DET
dpc-2259	100	13	ones	one	NOUN
dpc-2259	100	14	with	with	ADP
dpc-2259	100	15	no	no	DET
dpc-2259	100	16	symptoms	symptom	NOUN
dpc-2259	100	17	(	(	PUNCT
dpc-2259	100	18	p	p	NOUN
dpc-2259	100	19	=	=	NOUN
dpc-2259	100	20	0.024	0.024	NUM
dpc-2259	100	21	)	)	PUNCT
dpc-2259	100	22	(	(	PUNCT
dpc-2259	100	23	figure	figure	NOUN
dpc-2259	100	24	4	4	NUM
dpc-2259	100	25	)	)	PUNCT
dpc-2259	100	26	.	.	PUNCT
dpc-2259	101	1	as	as	SCONJ
dpc-2259	101	2	expected	expect	VERB
dpc-2259	101	3	,	,	PUNCT
dpc-2259	101	4	there	there	PRON
dpc-2259	101	5	seems	seem	VERB
dpc-2259	101	6	to	to	PART
dpc-2259	101	7	be	be	AUX
dpc-2259	101	8	a	a	DET
dpc-2259	101	9	statistically	statistically	ADV
dpc-2259	101	10	significant	significant	ADJ
dpc-2259	101	11	relationship	relationship	NOUN
dpc-2259	101	12	between	between	ADP
dpc-2259	101	13	the	the	DET
dpc-2259	101	14	presence	presence	NOUN
dpc-2259	101	15	of	of	ADP
dpc-2259	101	16	covid-19	covid-19	PROPN
dpc-2259	101	17	symptoms	symptom	NOUN
dpc-2259	101	18	and	and	CCONJ
dpc-2259	101	19	covid-19	covid-19	PROPN
dpc-2259	101	20	rt	rt	PROPN
dpc-2259	101	21	-	-	PUNCT
dpc-2259	101	22	pcr	pcr	PROPN
dpc-2259	101	23	positivity	positivity	NOUN
dpc-2259	101	24	(	(	PUNCT
dpc-2259	101	25	p	p	X
dpc-2259	101	26	<	<	X
dpc-2259	101	27	0.001	0.001	NUM
dpc-2259	101	28	)	)	PUNCT
dpc-2259	101	29	(	(	PUNCT
dpc-2259	101	30	table	table	NOUN
dpc-2259	101	31	5	5	NUM
dpc-2259	101	32	)	)	PUNCT
dpc-2259	101	33	.	.	PUNCT
dpc-2259	102	1	of	of	ADP
dpc-2259	102	2	109	109	NUM
dpc-2259	102	3	patients	patient	NOUN
dpc-2259	102	4	who	who	PRON
dpc-2259	102	5	were	be	AUX
dpc-2259	102	6	tested	test	VERB
dpc-2259	102	7	for	for	ADP
dpc-2259	102	8	covid-19	covid-19	PROPN
dpc-2259	102	9	,	,	PUNCT
dpc-2259	102	10	75	75	NUM
dpc-2259	102	11	(	(	PUNCT
dpc-2259	102	12	68.8	68.8	NUM
dpc-2259	102	13	%	%	NOUN
dpc-2259	102	14	)	)	PUNCT
dpc-2259	102	15	had	have	VERB
dpc-2259	102	16	covid-19	covid-19	PROPN
dpc-2259	102	17	related	related	ADJ
dpc-2259	102	18	symptoms	symptom	NOUN
dpc-2259	102	19	;	;	PUNCT
dpc-2259	102	20	30	30	NUM
dpc-2259	102	21	(	(	PUNCT
dpc-2259	102	22	40	40	NUM
dpc-2259	102	23	%	%	NOUN
dpc-2259	102	24	)	)	PUNCT
dpc-2259	102	25	cases	case	NOUN
dpc-2259	102	26	out	out	ADP
dpc-2259	102	27	of	of	ADP
dpc-2259	102	28	75	75	NUM
dpc-2259	102	29	cases	case	NOUN
dpc-2259	102	30	with	with	ADP
dpc-2259	102	31	covid-19	covid-19	PROPN
dpc-2259	102	32	related	related	ADJ
dpc-2259	102	33	symptoms	symptom	NOUN
dpc-2259	102	34	,	,	PUNCT
dpc-2259	102	35	were	be	AUX
dpc-2259	102	36	tested	test	VERB
dpc-2259	102	37	positive	positive	ADJ
dpc-2259	102	38	for	for	ADP
dpc-2259	102	39	covid	covid	PROPN
dpc-2259	102	40	.	.	PUNCT
dpc-2259	103	1	thirty	thirty	NUM
dpc-2259	103	2	-	-	PUNCT
dpc-2259	103	3	four	four	NUM
dpc-2259	103	4	patients	patient	NOUN
dpc-2259	103	5	who	who	PRON
dpc-2259	103	6	did	do	AUX
dpc-2259	103	7	not	not	PART
dpc-2259	103	8	demonstrate	demonstrate	VERB
dpc-2259	103	9	any	any	DET
dpc-2259	103	10	symptoms	symptom	NOUN
dpc-2259	103	11	still	still	ADV
dpc-2259	103	12	gave	give	VERB
dpc-2259	103	13	covid-19	covid-19	PROPN
dpc-2259	103	14	pcr	pcr	ADJ
dpc-2259	103	15	test	test	NOUN
dpc-2259	103	16	,	,	PUNCT
dpc-2259	103	17	were	be	AUX
dpc-2259	103	18	all	all	PRON
dpc-2259	103	19	tested	test	VERB
dpc-2259	103	20	negative	negative	ADJ
dpc-2259	103	21	.	.	PUNCT
dpc-2259	104	1	of	of	ADP
dpc-2259	104	2	109	109	NUM
dpc-2259	104	3	patients	patient	NOUN
dpc-2259	104	4	who	who	PRON
dpc-2259	104	5	were	be	AUX
dpc-2259	104	6	tested	test	VERB
dpc-2259	104	7	for	for	ADP
dpc-2259	104	8	covid-19	covid-19	PROPN
dpc-2259	104	9	,	,	PUNCT
dpc-2259	104	10	43	43	NUM
dpc-2259	104	11	(	(	PUNCT
dpc-2259	104	12	39.45	39.45	NUM
dpc-2259	104	13	%	%	NOUN
dpc-2259	104	14	)	)	PUNCT
dpc-2259	104	15	had	have	VERB
dpc-2259	104	16	close	close	ADJ
dpc-2259	104	17	contact	contact	NOUN
dpc-2259	104	18	to	to	ADP
dpc-2259	104	19	someone	someone	PRON
dpc-2259	104	20	with	with	ADP
dpc-2259	104	21	a	a	DET
dpc-2259	104	22	confirmed	confirm	VERB
dpc-2259	104	23	diagnosis	diagnosis	NOUN
dpc-2259	104	24	of	of	ADP
dpc-2259	104	25	covid-19	covid-19	PROPN
dpc-2259	104	26	;	;	PUNCT
dpc-2259	104	27	whereas	whereas	SCONJ
dpc-2259	104	28	66	66	NUM
dpc-2259	104	29	(	(	PUNCT
dpc-2259	104	30	60.55	60.55	NUM
dpc-2259	104	31	%	%	NOUN
dpc-2259	104	32	)	)	PUNCT
dpc-2259	104	33	did	do	AUX
dpc-2259	104	34	not	not	PART
dpc-2259	104	35	have	have	VERB
dpc-2259	104	36	any	any	DET
dpc-2259	104	37	close	close	ADJ
dpc-2259	104	38	contact	contact	NOUN
dpc-2259	104	39	.	.	PUNCT
dpc-2259	105	1	twenty	twenty	NUM
dpc-2259	105	2	-	-	PUNCT
dpc-2259	105	3	seven	seven	NUM
dpc-2259	105	4	(	(	PUNCT
dpc-2259	105	5	62.8	62.8	NUM
dpc-2259	105	6	%	%	NOUN
dpc-2259	105	7	)	)	PUNCT
dpc-2259	105	8	cases	case	NOUN
dpc-2259	105	9	out	out	ADP
dpc-2259	105	10	of	of	ADP
dpc-2259	105	11	43	43	NUM
dpc-2259	105	12	with	with	ADP
dpc-2259	105	13	close	close	ADJ
dpc-2259	105	14	contact	contact	NOUN
dpc-2259	105	15	to	to	ADP
dpc-2259	105	16	a	a	DET
dpc-2259	105	17	person	person	NOUN
dpc-2259	105	18	diagnosed	diagnose	VERB
dpc-2259	105	19	with	with	ADP
dpc-2259	105	20	covid-19	covid-19	PROPN
dpc-2259	105	21	had	have	VERB
dpc-2259	105	22	positive	positive	ADJ
dpc-2259	105	23	rt	rt	ADJ
dpc-2259	105	24	-	-	PUNCT
dpc-2259	105	25	pcr	pcr	ADJ
dpc-2259	105	26	result	result	NOUN
dpc-2259	105	27	.	.	PUNCT
dpc-2259	106	1	we	we	PRON
dpc-2259	106	2	found	find	VERB
dpc-2259	106	3	a	a	DET
dpc-2259	106	4	statistically	statistically	ADV
dpc-2259	106	5	significant	significant	ADJ
dpc-2259	106	6	relationship	relationship	NOUN
dpc-2259	106	7	between	between	ADP
dpc-2259	106	8	the	the	DET
dpc-2259	106	9	history	history	NOUN
dpc-2259	106	10	of	of	ADP
dpc-2259	106	11	close	close	ADJ
dpc-2259	106	12	contact	contact	NOUN
dpc-2259	106	13	to	to	ADP
dpc-2259	106	14	someone	someone	PRON
dpc-2259	106	15	with	with	ADP
dpc-2259	106	16	a	a	DET
dpc-2259	106	17	confirmed	confirm	VERB
dpc-2259	106	18	covid-19	covid-19	PROPN
dpc-2259	106	19	diagnosis	diagnosis	NOUN
dpc-2259	106	20	and	and	CCONJ
dpc-2259	106	21	covid-19	covid-19	PROPN
dpc-2259	106	22	rt	rt	PROPN
dpc-2259	106	23	-	-	PUNCT
dpc-2259	106	24	pcr	pcr	PROPN
dpc-2259	106	25	positivity	positivity	NOUN
dpc-2259	106	26	(	(	PUNCT
dpc-2259	106	27	p	p	X
dpc-2259	106	28	<	<	X
dpc-2259	106	29	0.001	0.001	NUM
dpc-2259	106	30	)	)	PUNCT
dpc-2259	106	31	(	(	PUNCT
dpc-2259	106	32	table	table	NOUN
dpc-2259	106	33	5	5	NUM
dpc-2259	106	34	)	)	PUNCT
dpc-2259	106	35	.	.	PUNCT
dpc-2259	107	1	no	no	DET
dpc-2259	107	2	patient	patient	NOUN
dpc-2259	107	3	was	be	AUX
dpc-2259	107	4	hospitalized	hospitalize	VERB
dpc-2259	107	5	for	for	ADP
dpc-2259	107	6	severe	severe	ADJ
dpc-2259	107	7	covid-19	covid-19	PROPN
dpc-2259	107	8	infection	infection	NOUN
dpc-2259	107	9	.	.	PUNCT
dpc-2259	108	1	binary	binary	ADJ
dpc-2259	108	2	logistic	logistic	ADJ
dpc-2259	108	3	regression	regression	NOUN
dpc-2259	108	4	analyses	analysis	NOUN
dpc-2259	108	5	(	(	PUNCT
dpc-2259	108	6	in	in	ADP
dpc-2259	108	7	which	which	PRON
dpc-2259	108	8	age	age	NOUN
dpc-2259	108	9	,	,	PUNCT
dpc-2259	108	10	gender	gender	NOUN
dpc-2259	108	11	,	,	PUNCT
dpc-2259	108	12	bmi	bmi	PROPN
dpc-2259	108	13	,	,	PUNCT
dpc-2259	108	14	the	the	DET
dpc-2259	108	15	presence	presence	NOUN
dpc-2259	108	16	of	of	ADP
dpc-2259	108	17	any	any	DET
dpc-2259	108	18	other	other	ADJ
dpc-2259	108	19	systemic	systemic	ADJ
dpc-2259	108	20	disease	disease	NOUN
dpc-2259	108	21	and	and	CCONJ
dpc-2259	108	22	smoking	smoking	NOUN
dpc-2259	108	23	were	be	AUX
dpc-2259	108	24	included	include	VERB
dpc-2259	108	25	as	as	ADP
dpc-2259	108	26	independent	independent	ADJ
dpc-2259	108	27	variables	variable	NOUN
dpc-2259	108	28	)	)	PUNCT
dpc-2259	108	29	were	be	AUX
dpc-2259	108	30	performed	perform	VERB
dpc-2259	108	31	nephrological	nephrological	ADJ
dpc-2259	108	32	diseases	disease	NOUN
dpc-2259	108	33	,	,	PUNCT
dpc-2259	108	34	endocrinologic	endocrinologic	ADJ
dpc-2259	108	35	and	and	CCONJ
dpc-2259	108	36	rheumatologic	rheumatologic	ADJ
dpc-2259	108	37	disorders	disorder	NOUN
dpc-2259	108	38	(	(	PUNCT
dpc-2259	108	39	p	p	X
dpc-2259	108	40	>	>	X
dpc-2259	108	41	0.05	0.05	NUM
dpc-2259	108	42	)	)	PUNCT
dpc-2259	108	43	.	.	PUNCT
dpc-2259	109	1	patients	patient	NOUN
dpc-2259	109	2	having	have	VERB
dpc-2259	109	3	covid-19	covid-19	PROPN
dpc-2259	109	4	related	related	ADJ
dpc-2259	109	5	symptoms	symptom	NOUN
dpc-2259	109	6	were	be	AUX
dpc-2259	109	7	shown	show	VERB
dpc-2259	109	8	to	to	PART
dpc-2259	109	9	have	have	VERB
dpc-2259	109	10	statistically	statistically	ADV
dpc-2259	109	11	significantly	significantly	ADV
dpc-2259	109	12	higher	high	ADJ
dpc-2259	109	13	mean	mean	ADJ
dpc-2259	109	14	age	age	NOUN
dpc-2259	109	15	compared	compare	VERB
dpc-2259	109	16	to	to	ADP
dpc-2259	109	17	the	the	DET
dpc-2259	109	18	ones	one	NOUN
dpc-2259	109	19	who	who	PRON
dpc-2259	109	20	did	do	AUX
dpc-2259	109	21	not	not	PART
dpc-2259	109	22	have	have	VERB
dpc-2259	109	23	any	any	DET
dpc-2259	109	24	symptoms	symptom	NOUN
dpc-2259	109	25	(	(	PUNCT
dpc-2259	109	26	p	p	X
dpc-2259	109	27	 	 	SPACE
dpc-2259	109	28	=	=	NOUN
dpc-2259	109	29	 	 	SPACE
dpc-2259	109	30	0.031	0.031	NUM
dpc-2259	109	31	)	)	PUNCT
dpc-2259	109	32	.	.	PUNCT
dpc-2259	110	1	the	the	DET
dpc-2259	110	2	percentage	percentage	NOUN
dpc-2259	110	3	of	of	ADP
dpc-2259	110	4	patients	patient	NOUN
dpc-2259	110	5	with	with	ADP
dpc-2259	110	6	covid-19	covid-19	PROPN
dpc-2259	110	7	related	related	ADJ
dpc-2259	110	8	symptoms	symptom	NOUN
dpc-2259	110	9	according	accord	VERB
dpc-2259	110	10	to	to	ADP
dpc-2259	110	11	the	the	DET
dpc-2259	110	12	treatment	treatment	NOUN
dpc-2259	110	13	type	type	NOUN
dpc-2259	110	14	was	be	AUX
dpc-2259	110	15	shown	show	VERB
dpc-2259	110	16	in	in	ADP
dpc-2259	110	17	figure	figure	NOUN
dpc-2259	110	18	2	2	NUM
dpc-2259	110	19	.	.	PUNCT
dpc-2259	111	1	we	we	PRON
dpc-2259	111	2	found	find	VERB
dpc-2259	111	3	no	no	DET
dpc-2259	111	4	statistically	statistically	ADV
dpc-2259	111	5	significant	significant	ADJ
dpc-2259	111	6	relationship	relationship	NOUN
dpc-2259	111	7	between	between	ADP
dpc-2259	111	8	the	the	DET
dpc-2259	111	9	presence	presence	NOUN
dpc-2259	111	10	of	of	ADP
dpc-2259	111	11	covid-19	covid-19	PROPN
dpc-2259	111	12	symptoms	symptom	NOUN
dpc-2259	111	13	and	and	CCONJ
dpc-2259	111	14	the	the	DET
dpc-2259	111	15	gender	gender	NOUN
dpc-2259	111	16	(	(	PUNCT
dpc-2259	111	17	p	p	X
dpc-2259	111	18	 	 	SPACE
dpc-2259	111	19	=	=	NOUN
dpc-2259	111	20	 	 	SPACE
dpc-2259	111	21	0.241	0.241	NUM
dpc-2259	111	22	)	)	PUNCT
dpc-2259	111	23	,	,	PUNCT
dpc-2259	111	24	bmi	bmi	X
dpc-2259	111	25	(	(	PUNCT
dpc-2259	111	26	p	p	X
dpc-2259	111	27	=	=	NOUN
dpc-2259	111	28	0.472	0.472	NUM
dpc-2259	111	29	)	)	PUNCT
dpc-2259	111	30	,	,	PUNCT
dpc-2259	111	31	cigarette	cigarette	NOUN
dpc-2259	111	32	smoking	smoking	NOUN
dpc-2259	111	33	(	(	PUNCT
dpc-2259	111	34	p	p	X
dpc-2259	111	35	 	 	SPACE
dpc-2259	111	36	=	=	NOUN
dpc-2259	111	37	 	 	SPACE
dpc-2259	111	38	0.272	0.272	NUM
dpc-2259	111	39	)	)	PUNCT
dpc-2259	111	40	,	,	PUNCT
dpc-2259	111	41	treatment	treatment	NOUN
dpc-2259	111	42	duration	duration	NOUN
dpc-2259	111	43	(	(	PUNCT
dpc-2259	111	44	p	p	X
dpc-2259	111	45	=	=	NOUN
dpc-2259	111	46	0.353	0.353	NUM
dpc-2259	111	47	)	)	PUNCT
dpc-2259	111	48	,	,	PUNCT
dpc-2259	111	49	disease	disease	NOUN
dpc-2259	111	50	duration	duration	NOUN
dpc-2259	111	51	(	(	PUNCT
dpc-2259	111	52	p	p	X
dpc-2259	111	53	=	=	NOUN
dpc-2259	111	54	0.850	0.850	NUM
dpc-2259	111	55	)	)	PUNCT
dpc-2259	111	56	and	and	CCONJ
dpc-2259	111	57	given	give	VERB
dpc-2259	111	58	treatment	treatment	NOUN
dpc-2259	111	59	type	type	NOUN
dpc-2259	111	60	when	when	SCONJ
dpc-2259	111	61	grouped	group	VERB
dpc-2259	111	62	as	as	ADP
dpc-2259	111	63	oral	oral	ADJ
dpc-2259	111	64	antibiotics±	antibiotics±	NOUN
dpc-2259	111	65	topical	topical	ADJ
dpc-2259	111	66	antibiotics	antibiotic	NOUN
dpc-2259	111	67	,	,	PUNCT
dpc-2259	111	68	oral	oral	ADJ
dpc-2259	111	69	retinoids	retinoid	NOUN
dpc-2259	111	70	,	,	PUNCT
dpc-2259	111	71	tnf	tnf	PROPN
dpc-2259	111	72	-	-	PUNCT
dpc-2259	111	73	α	α	PROPN
dpc-2259	111	74	inhibitors	inhibitor	NOUN
dpc-2259	111	75	±	±	NOUN
dpc-2259	111	76	oral	oral	ADJ
dpc-2259	111	77	/	/	SYM
dpc-2259	111	78	topical	topical	ADJ
dpc-2259	111	79	antibiotics	antibiotic	NOUN
dpc-2259	111	80	,	,	PUNCT
dpc-2259	111	81	colchicine	colchicine	NOUN
dpc-2259	111	82	and	and	CCONJ
dpc-2259	111	83	topical	topical	ADJ
dpc-2259	111	84	antibiotics	antibiotic	NOUN
dpc-2259	111	85	(	(	PUNCT
dpc-2259	111	86	p	p	X
dpc-2259	111	87	=	=	NOUN
dpc-2259	111	88	0.124	0.124	NUM
dpc-2259	111	89	)	)	PUNCT
dpc-2259	111	90	.	.	PUNCT
dpc-2259	112	1	patients	patient	NOUN
dpc-2259	112	2	with	with	ADP
dpc-2259	112	3	cardiovascular	cardiovascular	ADJ
dpc-2259	112	4	disease	disease	NOUN
dpc-2259	112	5	were	be	AUX
dpc-2259	112	6	shown	show	VERB
dpc-2259	112	7	to	to	PART
dpc-2259	112	8	present	present	VERB
dpc-2259	112	9	with	with	ADP
dpc-2259	112	10	covid-19	covid-19	PROPN
dpc-2259	112	11	related	related	ADJ
dpc-2259	112	12	symptoms	symptom	NOUN
dpc-2259	112	13	compared	compare	VERB
dpc-2259	112	14	to	to	ADP
dpc-2259	112	15	the	the	DET
dpc-2259	112	16	ones	one	NOUN
dpc-2259	112	17	with	with	ADP
dpc-2259	112	18	no	no	DET
dpc-2259	112	19	accompanying	accompany	VERB
dpc-2259	112	20	cardiovascular	cardiovascular	ADJ
dpc-2259	112	21	disease	disease	NOUN
dpc-2259	112	22	(	(	PUNCT
dpc-2259	112	23	p	p	X
dpc-2259	112	24	=	=	NOUN
dpc-2259	112	25	0.035	0.035	NUM
dpc-2259	112	26	)	)	PUNCT
dpc-2259	112	27	.	.	PUNCT
dpc-2259	113	1	additionally	additionally	ADV
dpc-2259	113	2	,	,	PUNCT
dpc-2259	113	3	patients	patient	NOUN
dpc-2259	113	4	who	who	PRON
dpc-2259	113	5	had	have	VERB
dpc-2259	113	6	at	at	ADV
dpc-2259	113	7	least	least	ADV
dpc-2259	113	8	one	one	NUM
dpc-2259	113	9	systemic	systemic	ADJ
dpc-2259	113	10	disease	disease	NOUN
dpc-2259	113	11	(	(	PUNCT
dpc-2259	113	12	classified	classify	VERB
dpc-2259	113	13	as	as	ADP
dpc-2259	113	14	respiratory	respiratory	ADJ
dpc-2259	113	15	,	,	PUNCT
dpc-2259	113	16	nephrologic	nephrologic	ADJ
dpc-2259	113	17	,	,	PUNCT
dpc-2259	113	18	cardiovascular	cardiovascular	ADJ
dpc-2259	113	19	,	,	PUNCT
dpc-2259	113	20	rheumatologic	rheumatologic	NOUN
dpc-2259	113	21	,	,	PUNCT
dpc-2259	113	22	gastroenterologic	gastroenterologic	NOUN
dpc-2259	113	23	,	,	PUNCT
dpc-2259	113	24	endocrinologic	endocrinologic	ADJ
dpc-2259	113	25	disorders	disorder	NOUN
dpc-2259	113	26	)	)	PUNCT
dpc-2259	113	27	had	have	VERB
dpc-2259	113	28	higher	high	ADJ
dpc-2259	113	29	probability	probability	NOUN
dpc-2259	113	30	to	to	PART
dpc-2259	113	31	exhibit	exhibit	VERB
dpc-2259	113	32	covid-19	covid-19	PROPN
dpc-2259	113	33	symptoms	symptom	NOUN
dpc-2259	113	34	(	(	PUNCT
dpc-2259	113	35	figure	figure	NOUN
dpc-2259	113	36	3	3	NUM
dpc-2259	113	37	)	)	PUNCT
dpc-2259	113	38	.	.	PUNCT
dpc-2259	114	1	lastly	lastly	ADV
dpc-2259	114	2	,	,	PUNCT
dpc-2259	114	3	patients	patient	NOUN
dpc-2259	114	4	who	who	PRON
dpc-2259	114	5	reported	report	VERB
dpc-2259	114	6	to	to	PART
dpc-2259	114	7	have	have	VERB
dpc-2259	114	8	covid-19	covid-19	PROPN
dpc-2259	114	9	related	related	ADJ
dpc-2259	114	10	symptoms	symptom	NOUN
dpc-2259	114	11	were	be	AUX
dpc-2259	114	12	shown	show	VERB
dpc-2259	114	13	to	to	PART
dpc-2259	114	14	present	present	VERB
dpc-2259	114	15	with	with	ADP
dpc-2259	114	16	p	p	PROPN
dpc-2259	114	17	er	er	INTJ
dpc-2259	114	18	c	c	X
dpc-2259	114	19	en	en	X
dpc-2259	114	20	ta	ta	PROPN
dpc-2259	115	1	g	g	PROPN
dpc-2259	115	2	e	e	PROPN
dpc-2259	115	3	o	o	X
dpc-2259	115	4	f	f	X
dpc-2259	116	1	p	p	X
dpc-2259	116	2	a	a	DET
dpc-2259	116	3	ti	ti	NOUN
dpc-2259	116	4	en	en	X
dpc-2259	116	5	ts	ts	X
dpc-2259	117	1	w	w	PROPN
dpc-2259	117	2	it	it	PRON
dpc-2259	118	1	h	h	NOUN
dpc-2259	118	2	p	p	X
dpc-2259	118	3	o	o	X
dpc-2259	118	4	si	si	X
dpc-2259	118	5	ti	ti	X
dpc-2259	118	6	v	v	X
dpc-2259	118	7	e	e	NOUN
dpc-2259	118	8	c	c	NOUN
dpc-2259	118	9	o	o	X
dpc-2259	118	10	v	v	INTJ
dpc-2259	118	11	i	i	PROPN
dpc-2259	118	12	d	d	PROPN
dpc-2259	118	13	-1	-1	PROPN
dpc-2259	118	14	9	9	NUM
dpc-2259	118	15	r	r	NOUN
dpc-2259	118	16	tp	tp	NOUN
dpc-2259	118	17	c	c	NOUN
dpc-2259	118	18	r	r	NOUN
dpc-2259	118	19	percentage	percentage	NOUN
dpc-2259	118	20	of	of	ADP
dpc-2259	118	21	patients	patient	NOUN
dpc-2259	118	22	with	with	ADP
dpc-2259	118	23	positive	positive	ADJ
dpc-2259	118	24	covid-19	covid-19	PROPN
dpc-2259	118	25	rt	rt	PROPN
dpc-2259	118	26	-	-	PUNCT
dpc-2259	118	27	pcr	pcr	PROPN
dpc-2259	118	28	vs	vs	ADP
dpc-2259	118	29	treatment	treatment	NOUN
dpc-2259	118	30	type	type	NOUN
dpc-2259	118	31	treatment	treatment	NOUN
dpc-2259	118	32	type	type	NOUN
dpc-2259	118	33	50.0	50.0	NUM
dpc-2259	118	34	%	%	NOUN
dpc-2259	118	35	45.0	45.0	NUM
dpc-2259	118	36	%	%	NOUN
dpc-2259	118	37	25.9	25.9	NUM
dpc-2259	118	38	%	%	NOUN
dpc-2259	118	39	21.1	21.1	NUM
dpc-2259	118	40	%	%	NOUN
dpc-2259	118	41	33.0	33.0	NUM
dpc-2259	118	42	%	%	NOUN
dpc-2259	118	43	18.2	18.2	NUM
dpc-2259	118	44	%	%	NOUN
dpc-2259	118	45	40.0	40.0	NUM
dpc-2259	118	46	%	%	NOUN
dpc-2259	118	47	35.0	35.0	NUM
dpc-2259	118	48	%	%	NOUN
dpc-2259	118	49	30.0	30.0	NUM
dpc-2259	118	50	%	%	NOUN
dpc-2259	118	51	25.0	25.0	NUM
dpc-2259	118	52	%	%	NOUN
dpc-2259	118	53	20.0	20.0	NUM
dpc-2259	118	54	%	%	NOUN
dpc-2259	118	55	15.0	15.0	NUM
dpc-2259	118	56	%	%	NOUN
dpc-2259	118	57	10.0	10.0	NUM
dpc-2259	118	58	%	%	NOUN
dpc-2259	118	59	5.0	5.0	NUM
dpc-2259	118	60	%	%	NOUN
dpc-2259	118	61	0.0	0.0	NUM
dpc-2259	118	62	%	%	NOUN
dpc-2259	118	63	oral	oral	ADJ
dpc-2259	118	64	antibiotics	antibiotic	NOUN
dpc-2259	118	65	(	(	PUNCT
dpc-2259	118	66	n=27	n=27	NOUN
dpc-2259	118	67	)	)	PUNCT
dpc-2259	118	68	topical	topical	ADJ
dpc-2259	118	69	antibiotics	antibiotic	NOUN
dpc-2259	118	70	(	(	PUNCT
dpc-2259	118	71	n=11	n=11	X
dpc-2259	118	72	)	)	PUNCT
dpc-2259	118	73	oral	oral	ADJ
dpc-2259	118	74	retinoids	retinoid	NOUN
dpc-2259	118	75	(	(	PUNCT
dpc-2259	118	76	n=19	n=19	PROPN
dpc-2259	118	77	)	)	PUNCT
dpc-2259	118	78	tnf	tnf	PROPN
dpc-2259	118	79	-	-	PUNCT
dpc-2259	118	80	alfa	alfa	NOUN
dpc-2259	118	81	inhibitors	inhibitor	NOUN
dpc-2259	118	82	(	(	PUNCT
dpc-2259	118	83	n=52	n=52	NOUN
dpc-2259	118	84	)	)	PUNCT
dpc-2259	118	85	figure	figure	NOUN
dpc-2259	118	86	1	1	NUM
dpc-2259	118	87	.	.	PUNCT
dpc-2259	119	1	the	the	DET
dpc-2259	119	2	percentage	percentage	NOUN
dpc-2259	119	3	of	of	ADP
dpc-2259	119	4	the	the	DET
dpc-2259	119	5	patients	patient	NOUN
dpc-2259	119	6	with	with	ADP
dpc-2259	119	7	a	a	DET
dpc-2259	119	8	positive	positive	ADJ
dpc-2259	119	9	covid-19	covid-19	PROPN
dpc-2259	119	10	real	real	ADJ
dpc-2259	119	11	-	-	PUNCT
dpc-2259	119	12	time	time	NOUN
dpc-2259	119	13	polymerase	polymerase	NOUN
dpc-2259	119	14	chain	chain	NOUN
dpc-2259	119	15	reaction	reaction	NOUN
dpc-2259	119	16	(	(	PUNCT
dpc-2259	119	17	rt	rt	ADJ
dpc-2259	119	18	-	-	PUNCT
dpc-2259	119	19	pcr	pcr	NOUN
dpc-2259	119	20	)	)	PUNCT
dpc-2259	119	21	result	result	NOUN
dpc-2259	119	22	according	accord	VERB
dpc-2259	119	23	to	to	ADP
dpc-2259	119	24	the	the	DET
dpc-2259	119	25	treatment	treatment	NOUN
dpc-2259	119	26	type	type	NOUN
dpc-2259	119	27	.	.	PUNCT
dpc-2259	120	1	6	6	NUM
dpc-2259	120	2	original	original	ADJ
dpc-2259	120	3	article	article	NOUN
dpc-2259	120	4	|	|	ADV
dpc-2259	120	5	dermatol	dermatol	ADJ
dpc-2259	120	6	pract	pract	NOUN
dpc-2259	120	7	concept	concept	NOUN
dpc-2259	120	8	.	.	PUNCT
dpc-2259	121	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	121	2	the	the	DET
dpc-2259	121	3	presence	presence	NOUN
dpc-2259	121	4	of	of	ADP
dpc-2259	121	5	any	any	DET
dpc-2259	121	6	other	other	ADJ
dpc-2259	121	7	systemic	systemic	ADJ
dpc-2259	121	8	disease	disease	NOUN
dpc-2259	121	9	were	be	AUX
dpc-2259	121	10	considered	consider	VERB
dpc-2259	121	11	as	as	ADP
dpc-2259	121	12	independent	independent	ADJ
dpc-2259	121	13	variables	variable	NOUN
dpc-2259	121	14	)	)	PUNCT
dpc-2259	121	15	were	be	AUX
dpc-2259	121	16	also	also	ADV
dpc-2259	121	17	carried	carry	VERB
dpc-2259	121	18	out	out	ADP
dpc-2259	121	19	by	by	ADP
dpc-2259	121	20	taking	take	VERB
dpc-2259	121	21	covid-19	covid-19	PROPN
dpc-2259	121	22	rt	rt	PROPN
dpc-2259	121	23	-	-	PUNCT
dpc-2259	121	24	pcr	pcr	ADJ
dpc-2259	121	25	result	result	NOUN
dpc-2259	121	26	(	(	PUNCT
dpc-2259	121	27	positive	positive	ADJ
dpc-2259	121	28	or	or	CCONJ
dpc-2259	121	29	negative	negative	ADJ
dpc-2259	121	30	)	)	PUNCT
dpc-2259	121	31	as	as	ADP
dpc-2259	121	32	the	the	DET
dpc-2259	121	33	dependent	dependent	ADJ
dpc-2259	121	34	variable	variable	NOUN
dpc-2259	121	35	.	.	PUNCT
dpc-2259	122	1	as	as	ADP
dpc-2259	122	2	a	a	DET
dpc-2259	122	3	result	result	NOUN
dpc-2259	122	4	,	,	PUNCT
dpc-2259	122	5	it	it	PRON
dpc-2259	122	6	was	be	AUX
dpc-2259	122	7	found	find	VERB
dpc-2259	122	8	that	that	SCONJ
dpc-2259	122	9	age	age	NOUN
dpc-2259	122	10	,	,	PUNCT
dpc-2259	122	11	gender	gender	NOUN
dpc-2259	122	12	,	,	PUNCT
dpc-2259	122	13	bmi	bmi	NOUN
dpc-2259	122	14	and	and	CCONJ
dpc-2259	122	15	the	the	DET
dpc-2259	122	16	presence	presence	NOUN
dpc-2259	122	17	of	of	ADP
dpc-2259	122	18	at	at	ADV
dpc-2259	122	19	least	least	ADV
dpc-2259	122	20	one	one	NUM
dpc-2259	122	21	systemic	systemic	ADJ
dpc-2259	122	22	illness	illness	NOUN
dpc-2259	122	23	did	do	AUX
dpc-2259	122	24	not	not	PART
dpc-2259	122	25	contribute	contribute	VERB
dpc-2259	122	26	significantly	significantly	ADV
dpc-2259	122	27	to	to	ADP
dpc-2259	122	28	the	the	DET
dpc-2259	122	29	outcome	outcome	NOUN
dpc-2259	122	30	of	of	ADP
dpc-2259	122	31	covid-19	covid-19	PROPN
dpc-2259	122	32	test	test	NOUN
dpc-2259	122	33	result	result	NOUN
dpc-2259	122	34	.	.	PUNCT
dpc-2259	123	1	taking	take	VERB
dpc-2259	123	2	the	the	DET
dpc-2259	123	3	presence	presence	NOUN
dpc-2259	123	4	of	of	ADP
dpc-2259	123	5	covid-19	covid-19	PROPN
dpc-2259	123	6	symptoms	symptom	NOUN
dpc-2259	123	7	as	as	ADP
dpc-2259	123	8	the	the	DET
dpc-2259	123	9	dependent	dependent	ADJ
dpc-2259	123	10	variable	variable	NOUN
dpc-2259	123	11	.	.	PUNCT
dpc-2259	124	1	smoking	smoking	NOUN
dpc-2259	124	2	(	(	PUNCT
dpc-2259	124	3	odds	odd	NOUN
dpc-2259	124	4	ratio	ratio	NOUN
dpc-2259	124	5	[	[	X
dpc-2259	124	6	or	or	CCONJ
dpc-2259	124	7	]	]	PUNCT
dpc-2259	124	8	2.595	2.595	NUM
dpc-2259	124	9	;	;	PUNCT
dpc-2259	124	10	95	95	NUM
dpc-2259	124	11	%	%	NOUN
dpc-2259	124	12	confidence	confidence	NOUN
dpc-2259	124	13	interval	interval	NOUN
dpc-2259	124	14	:	:	PUNCT
dpc-2259	124	15	1.009	1.009	NUM
dpc-2259	124	16	-	-	SYM
dpc-2259	124	17	6.674	6.674	NUM
dpc-2259	124	18	;	;	PUNCT
dpc-2259	124	19	p	p	X
dpc-2259	124	20	=	=	NOUN
dpc-2259	124	21	0.048	0.048	NUM
dpc-2259	124	22	)	)	PUNCT
dpc-2259	124	23	and	and	CCONJ
dpc-2259	124	24	the	the	DET
dpc-2259	124	25	presence	presence	NOUN
dpc-2259	124	26	of	of	ADP
dpc-2259	124	27	any	any	DET
dpc-2259	124	28	other	other	ADJ
dpc-2259	124	29	systemic	systemic	ADJ
dpc-2259	124	30	illness	illness	NOUN
dpc-2259	124	31	(	(	PUNCT
dpc-2259	124	32	or	or	CCONJ
dpc-2259	124	33	6.968	6.968	NUM
dpc-2259	124	34	;	;	PUNCT
dpc-2259	124	35	95	95	NUM
dpc-2259	124	36	%	%	NOUN
dpc-2259	124	37	interval	interval	NOUN
dpc-2259	124	38	:	:	PUNCT
dpc-2259	124	39	2.754	2.754	NUM
dpc-2259	124	40	-	-	SYM
dpc-2259	124	41	17.631	17.631	NUM
dpc-2259	124	42	;	;	PUNCT
dpc-2259	125	1	p	p	X
dpc-2259	125	2	<	<	X
dpc-2259	125	3	 	 	SPACE
dpc-2259	125	4	0.001	0.001	NUM
dpc-2259	125	5	)	)	PUNCT
dpc-2259	125	6	were	be	AUX
dpc-2259	125	7	associated	associate	VERB
dpc-2259	125	8	with	with	ADP
dpc-2259	125	9	an	an	DET
dpc-2259	125	10	increased	increase	VERB
dpc-2259	125	11	risk	risk	NOUN
dpc-2259	125	12	of	of	ADP
dpc-2259	125	13	developing	develop	VERB
dpc-2259	125	14	covid-19	covid-19	PROPN
dpc-2259	125	15	related	related	ADJ
dpc-2259	125	16	symptoms	symptom	NOUN
dpc-2259	125	17	.	.	PUNCT
dpc-2259	126	1	in	in	ADP
dpc-2259	126	2	addition	addition	NOUN
dpc-2259	126	3	,	,	PUNCT
dpc-2259	126	4	logistic	logistic	ADJ
dpc-2259	126	5	regression	regression	NOUN
dpc-2259	126	6	analyses	analysis	NOUN
dpc-2259	126	7	(	(	PUNCT
dpc-2259	126	8	in	in	ADP
dpc-2259	126	9	which	which	PRON
dpc-2259	126	10	age	age	NOUN
dpc-2259	126	11	,	,	PUNCT
dpc-2259	126	12	gender	gender	NOUN
dpc-2259	126	13	,	,	PUNCT
dpc-2259	126	14	bmi	bmi	NOUN
dpc-2259	126	15	and	and	CCONJ
dpc-2259	126	16	p	p	X
dpc-2259	126	17	er	er	INTJ
dpc-2259	126	18	c	c	X
dpc-2259	126	19	en	en	X
dpc-2259	126	20	ta	ta	PROPN
dpc-2259	126	21	g	g	PROPN
dpc-2259	126	22	e	e	PROPN
dpc-2259	127	1	o	o	X
dpc-2259	128	1	f	f	X
dpc-2259	129	1	p	p	X
dpc-2259	129	2	a	a	DET
dpc-2259	129	3	ti	ti	NOUN
dpc-2259	129	4	en	en	X
dpc-2259	129	5	ts	ts	X
dpc-2259	130	1	w	w	PROPN
dpc-2259	130	2	it	it	PRON
dpc-2259	131	1	h	h	NOUN
dpc-2259	132	1	c	c	NOUN
dpc-2259	132	2	o	o	NOUN
dpc-2259	132	3	v	v	INTJ
dpc-2259	132	4	i	i	PROPN
dpc-2259	132	5	d	d	PROPN
dpc-2259	132	6	-1	-1	PROPN
dpc-2259	132	7	9	9	NUM
dpc-2259	132	8	r	r	NOUN
dpc-2259	132	9	el	el	PROPN
dpc-2259	132	10	a	a	PRON
dpc-2259	133	1	te	te	PROPN
dpc-2259	133	2	d	d	X
dpc-2259	133	3	s	s	PROPN
dpc-2259	133	4	y	y	NOUN
dpc-2259	133	5	m	m	PROPN
dpc-2259	133	6	p	p	ADJ
dpc-2259	133	7	to	to	ADP
dpc-2259	133	8	m	m	PROPN
dpc-2259	133	9	s	s	NOUN
dpc-2259	133	10	treatment	treatment	NOUN
dpc-2259	133	11	type	type	NOUN
dpc-2259	133	12	oral	oral	ADJ
dpc-2259	133	13	antibiotics	antibiotic	NOUN
dpc-2259	133	14	(	(	PUNCT
dpc-2259	133	15	n=27	n=27	NOUN
dpc-2259	133	16	)	)	PUNCT
dpc-2259	133	17	topical	topical	ADJ
dpc-2259	133	18	antibiotics	antibiotic	NOUN
dpc-2259	133	19	(	(	PUNCT
dpc-2259	133	20	n=11	n=11	X
dpc-2259	133	21	)	)	PUNCT
dpc-2259	133	22	oral	oral	ADJ
dpc-2259	133	23	retinoids	retinoid	NOUN
dpc-2259	133	24	(	(	PUNCT
dpc-2259	133	25	n=19	n=19	PROPN
dpc-2259	133	26	)	)	PUNCT
dpc-2259	133	27	100.0	100.0	NUM
dpc-2259	133	28	%	%	NOUN
dpc-2259	133	29	35.4	35.4	NUM
dpc-2259	133	30	%	%	NOUN
dpc-2259	133	31	40.0	40.0	NUM
dpc-2259	133	32	%	%	NOUN
dpc-2259	133	33	55.0	55.0	NUM
dpc-2259	133	34	%	%	NOUN
dpc-2259	133	35	53.3	53.3	NUM
dpc-2259	133	36	%	%	NOUN
dpc-2259	133	37	90.0	90.0	NUM
dpc-2259	133	38	%	%	NOUN
dpc-2259	133	39	80.0	80.0	NUM
dpc-2259	133	40	%	%	NOUN
dpc-2259	133	41	70.0	70.0	NUM
dpc-2259	133	42	%	%	NOUN
dpc-2259	133	43	60.0	60.0	NUM
dpc-2259	133	44	%	%	NOUN
dpc-2259	133	45	50.0	50.0	NUM
dpc-2259	133	46	%	%	NOUN
dpc-2259	133	47	40.0	40.0	NUM
dpc-2259	133	48	%	%	NOUN
dpc-2259	133	49	30.0	30.0	NUM
dpc-2259	133	50	%	%	NOUN
dpc-2259	133	51	20.0	20.0	NUM
dpc-2259	133	52	%	%	NOUN
dpc-2259	133	53	10.0	10.0	NUM
dpc-2259	133	54	%	%	NOUN
dpc-2259	133	55	0.0	0.0	NUM
dpc-2259	133	56	%	%	NOUN
dpc-2259	133	57	tnf	tnf	PROPN
dpc-2259	133	58	-	-	PUNCT
dpc-2259	133	59	alfa	alfa	NOUN
dpc-2259	133	60	inhibitors	inhibitor	NOUN
dpc-2259	133	61	(	(	PUNCT
dpc-2259	133	62	n=52	n=52	NOUN
dpc-2259	133	63	)	)	PUNCT
dpc-2259	133	64	percentage	percentage	NOUN
dpc-2259	133	65	of	of	ADP
dpc-2259	133	66	patients	patient	NOUN
dpc-2259	133	67	with	with	ADP
dpc-2259	133	68	covid-19	covid-19	PROPN
dpc-2259	133	69	related	related	ADJ
dpc-2259	133	70	symptoms	symptom	NOUN
dpc-2259	133	71	vs	vs	ADP
dpc-2259	133	72	treatment	treatment	NOUN
dpc-2259	133	73	type	type	NOUN
dpc-2259	133	74	figure	figure	NOUN
dpc-2259	133	75	2	2	NUM
dpc-2259	133	76	.	.	PUNCT
dpc-2259	134	1	the	the	DET
dpc-2259	134	2	percentage	percentage	NOUN
dpc-2259	134	3	of	of	ADP
dpc-2259	134	4	the	the	DET
dpc-2259	134	5	patients	patient	NOUN
dpc-2259	134	6	with	with	ADP
dpc-2259	134	7	covid-19	covid-19	PROPN
dpc-2259	134	8	related	related	ADJ
dpc-2259	134	9	symptoms	symptom	NOUN
dpc-2259	134	10	according	accord	VERB
dpc-2259	134	11	to	to	ADP
dpc-2259	134	12	the	the	DET
dpc-2259	134	13	treatment	treatment	NOUN
dpc-2259	134	14	type	type	NOUN
dpc-2259	134	15	.	.	PUNCT
dpc-2259	135	1	60	60	NUM
dpc-2259	135	2	%	%	NOUN
dpc-2259	135	3	40	40	NUM
dpc-2259	135	4	%	%	NOUN
dpc-2259	135	5	62	62	NUM
dpc-2259	135	6	%	%	NOUN
dpc-2259	135	7	a	a	DET
dpc-2259	135	8	bpatients	bpatient	NOUN
dpc-2259	135	9	without	without	ADP
dpc-2259	135	10	any	any	DET
dpc-2259	135	11	systematic	systematic	ADJ
dpc-2259	135	12	disease	disease	NOUN
dpc-2259	135	13	(	(	PUNCT
dpc-2259	135	14	n=103	n=103	NOUN
dpc-2259	135	15	)	)	PUNCT
dpc-2259	135	16	patients	patient	NOUN
dpc-2259	135	17	with	with	ADP
dpc-2259	135	18	at	at	ADV
dpc-2259	135	19	least	least	ADV
dpc-2259	135	20	one	one	NUM
dpc-2259	135	21	systemic	systemic	ADJ
dpc-2259	135	22	disease	disease	NOUN
dpc-2259	135	23	(	(	PUNCT
dpc-2259	135	24	n=75	n=75	PROPN
dpc-2259	135	25	)	)	PUNCT
dpc-2259	135	26	38	38	NUM
dpc-2259	135	27	%	%	NOUN
dpc-2259	135	28	absent	absent	ADJ
dpc-2259	135	29	covid-19	covid-19	PROPN
dpc-2259	135	30	symptomsabsent	symptomsabsent	NOUN
dpc-2259	135	31	covid-19	covid-19	PROPN
dpc-2259	135	32	symptoms	symptom	NOUN
dpc-2259	135	33	present	present	ADJ
dpc-2259	135	34	covid-19	covid-19	PROPN
dpc-2259	135	35	symptomspresent	symptomspresent	NOUN
dpc-2259	135	36	covid-19	covid-19	PROPN
dpc-2259	135	37	symptoms	symptom	NOUN
dpc-2259	135	38	figure	figure	VERB
dpc-2259	135	39	3	3	NUM
dpc-2259	135	40	.	.	PUNCT
dpc-2259	136	1	the	the	DET
dpc-2259	136	2	distribution	distribution	NOUN
dpc-2259	136	3	of	of	ADP
dpc-2259	136	4	the	the	DET
dpc-2259	136	5	percentages	percentage	NOUN
dpc-2259	136	6	of	of	ADP
dpc-2259	136	7	the	the	DET
dpc-2259	136	8	patients	patient	NOUN
dpc-2259	136	9	with	with	ADP
dpc-2259	136	10	absent	absent	ADJ
dpc-2259	136	11	and	and	CCONJ
dpc-2259	136	12	present	present	ADJ
dpc-2259	136	13	covid-19	covid-19	PROPN
dpc-2259	136	14	related	related	ADJ
dpc-2259	136	15	symptoms	symptom	NOUN
dpc-2259	136	16	among	among	ADP
dpc-2259	136	17	the	the	DET
dpc-2259	136	18	participants	participant	NOUN
dpc-2259	136	19	without	without	ADP
dpc-2259	136	20	any	any	DET
dpc-2259	136	21	systematic	systematic	ADJ
dpc-2259	136	22	disease	disease	NOUN
dpc-2259	136	23	(	(	PUNCT
dpc-2259	136	24	a	a	NOUN
dpc-2259	136	25	)	)	PUNCT
dpc-2259	136	26	and	and	CCONJ
dpc-2259	136	27	among	among	ADP
dpc-2259	136	28	the	the	DET
dpc-2259	136	29	participants	participant	NOUN
dpc-2259	136	30	with	with	ADP
dpc-2259	136	31	at	at	ADV
dpc-2259	136	32	least	least	ADV
dpc-2259	136	33	one	one	NUM
dpc-2259	136	34	systematic	systematic	ADJ
dpc-2259	136	35	disease	disease	NOUN
dpc-2259	136	36	(	(	PUNCT
dpc-2259	136	37	b	b	NOUN
dpc-2259	136	38	)	)	PUNCT
dpc-2259	136	39	original	original	ADJ
dpc-2259	136	40	article	article	NOUN
dpc-2259	136	41	|	|	ADV
dpc-2259	136	42	dermatol	dermatol	ADJ
dpc-2259	136	43	pract	pract	NOUN
dpc-2259	136	44	concept	concept	NOUN
dpc-2259	136	45	.	.	PUNCT
dpc-2259	137	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	137	2	7	7	NUM
dpc-2259	137	3	females	female	NOUN
dpc-2259	137	4	compared	compare	VERB
dpc-2259	137	5	to	to	ADP
dpc-2259	137	6	males	male	NOUN
dpc-2259	137	7	with	with	ADP
dpc-2259	137	8	a	a	DET
dpc-2259	137	9	ratio	ratio	NOUN
dpc-2259	137	10	of	of	ADP
dpc-2259	137	11	3:1	3:1	NUM
dpc-2259	137	12	[	[	X
dpc-2259	137	13	6,14	6,14	NUM
dpc-2259	137	14	]	]	PUNCT
dpc-2259	137	15	.	.	PUNCT
dpc-2259	138	1	since	since	SCONJ
dpc-2259	138	2	patients	patient	NOUN
dpc-2259	138	3	with	with	ADP
dpc-2259	138	4	hs	hs	PROPN
dpc-2259	138	5	suffer	suffer	VERB
dpc-2259	138	6	from	from	ADP
dpc-2259	138	7	acute	acute	ADJ
dpc-2259	138	8	(	(	PUNCT
dpc-2259	138	9	bacterial	bacterial	ADJ
dpc-2259	138	10	superinfections	superinfection	NOUN
dpc-2259	138	11	,	,	PUNCT
dpc-2259	138	12	lymphadenopathy	lymphadenopathy	ADJ
dpc-2259	138	13	)	)	PUNCT
dpc-2259	138	14	and	and	CCONJ
dpc-2259	138	15	chronic	chronic	ADJ
dpc-2259	138	16	complications	complication	NOUN
dpc-2259	138	17	of	of	ADP
dpc-2259	138	18	the	the	DET
dpc-2259	138	19	disease	disease	NOUN
dpc-2259	138	20	(	(	PUNCT
dpc-2259	138	21	amyloidosis	amyloidosis	NOUN
dpc-2259	138	22	,	,	PUNCT
dpc-2259	138	23	chronic	chronic	ADJ
dpc-2259	138	24	disease	disease	NOUN
dpc-2259	138	25	anemia	anemia	NOUN
dpc-2259	138	26	,	,	PUNCT
dpc-2259	138	27	lymphedema	lymphedema	NOUN
dpc-2259	138	28	,	,	PUNCT
dpc-2259	138	29	lymphatic	lymphatic	ADJ
dpc-2259	138	30	obstruction	obstruction	NOUN
dpc-2259	138	31	,	,	PUNCT
dpc-2259	138	32	significant	significant	ADJ
dpc-2259	138	33	scarring	scarring	NOUN
dpc-2259	138	34	,	,	PUNCT
dpc-2259	138	35	chronic	chronic	ADJ
dpc-2259	138	36	pain	pain	NOUN
dpc-2259	138	37	,	,	PUNCT
dpc-2259	138	38	malodor	malodor	NOUN
dpc-2259	138	39	and	and	CCONJ
dpc-2259	138	40	fistula	fistula	NOUN
dpc-2259	138	41	formation	formation	NOUN
dpc-2259	138	42	)	)	PUNCT
dpc-2259	139	1	[	[	X
dpc-2259	139	2	15	15	NUM
dpc-2259	139	3	]	]	PUNCT
dpc-2259	139	4	;	;	PUNCT
dpc-2259	139	5	early	early	ADJ
dpc-2259	139	6	diagnosis	diagnosis	NOUN
dpc-2259	139	7	and	and	CCONJ
dpc-2259	139	8	adequate	adequate	ADJ
dpc-2259	139	9	treatment	treatment	NOUN
dpc-2259	139	10	of	of	ADP
dpc-2259	139	11	this	this	DET
dpc-2259	139	12	debilitating	debilitate	VERB
dpc-2259	139	13	disease	disease	NOUN
dpc-2259	139	14	are	be	AUX
dpc-2259	139	15	quite	quite	ADV
dpc-2259	139	16	essential	essential	ADJ
dpc-2259	139	17	.	.	PUNCT
dpc-2259	140	1	topical	topical	ADJ
dpc-2259	140	2	and	and	CCONJ
dpc-2259	140	3	systemic	systemic	ADJ
dpc-2259	140	4	antibiotics	antibiotic	NOUN
dpc-2259	140	5	,	,	PUNCT
dpc-2259	140	6	anti	anti	ADJ
dpc-2259	140	7	-	-	ADJ
dpc-2259	140	8	inflammatory	inflammatory	ADJ
dpc-2259	140	9	agents	agent	NOUN
dpc-2259	140	10	,	,	PUNCT
dpc-2259	140	11	anti	anti	ADJ
dpc-2259	140	12	-	-	ADJ
dpc-2259	140	13	androgens	androgens	ADJ
dpc-2259	140	14	,	,	PUNCT
dpc-2259	140	15	oral	oral	ADJ
dpc-2259	140	16	retinoids	retinoid	NOUN
dpc-2259	140	17	,	,	PUNCT
dpc-2259	140	18	immunosuppressive	immunosuppressive	ADJ
dpc-2259	140	19	treatments	treatment	NOUN
dpc-2259	140	20	,	,	PUNCT
dpc-2259	140	21	tnf	tnf	PROPN
dpc-2259	140	22	-	-	PUNCT
dpc-2259	140	23	α	α	PROPN
dpc-2259	140	24	inhibitors	inhibitor	NOUN
dpc-2259	140	25	(	(	PUNCT
dpc-2259	140	26	especially	especially	ADV
dpc-2259	140	27	adalimumab	adalimumab	NOUN
dpc-2259	140	28	and	and	CCONJ
dpc-2259	140	29	infliximab	infliximab	NOUN
dpc-2259	140	30	)	)	PUNCT
dpc-2259	140	31	,	,	PUNCT
dpc-2259	140	32	apremilast	apremilast	ADJ
dpc-2259	140	33	,	,	PUNCT
dpc-2259	140	34	surgical	surgical	ADJ
dpc-2259	140	35	intervention	intervention	NOUN
dpc-2259	140	36	and	and	CCONJ
dpc-2259	140	37	laser	laser	NOUN
dpc-2259	140	38	excision	excision	NOUN
dpc-2259	140	39	repair	repair	NOUN
dpc-2259	140	40	are	be	AUX
dpc-2259	140	41	among	among	ADP
dpc-2259	140	42	the	the	DET
dpc-2259	140	43	miscellaneous	miscellaneous	ADJ
dpc-2259	140	44	therapeutic	therapeutic	ADJ
dpc-2259	140	45	interventions	intervention	NOUN
dpc-2259	140	46	used	use	VERB
dpc-2259	140	47	for	for	ADP
dpc-2259	140	48	hs	hs	PROPN
dpc-2259	141	1	[	[	X
dpc-2259	141	2	16	16	NUM
dpc-2259	141	3	]	]	PUNCT
dpc-2259	141	4	.	.	PUNCT
dpc-2259	142	1	generally	generally	ADV
dpc-2259	142	2	,	,	PUNCT
dpc-2259	142	3	hurley	hurley	PROPN
dpc-2259	142	4	stage	stage	NOUN
dpc-2259	142	5	1	1	NUM
dpc-2259	142	6	hs	hs	PROPN
dpc-2259	142	7	is	be	AUX
dpc-2259	142	8	treated	treat	VERB
dpc-2259	142	9	conclusions	conclusion	NOUN
dpc-2259	142	10	hs	hs	PROPN
dpc-2259	142	11	is	be	AUX
dpc-2259	142	12	one	one	NUM
dpc-2259	142	13	of	of	ADP
dpc-2259	142	14	the	the	DET
dpc-2259	142	15	most	most	ADV
dpc-2259	142	16	challenging	challenging	ADJ
dpc-2259	142	17	diseases	disease	NOUN
dpc-2259	142	18	of	of	ADP
dpc-2259	142	19	dermatology	dermatology	NOUN
dpc-2259	142	20	,	,	PUNCT
dpc-2259	142	21	which	which	PRON
dpc-2259	142	22	has	have	VERB
dpc-2259	142	23	a	a	DET
dpc-2259	142	24	great	great	ADJ
dpc-2259	142	25	impact	impact	NOUN
dpc-2259	142	26	on	on	ADP
dpc-2259	142	27	patients	patient	NOUN
dpc-2259	142	28	quality	quality	NOUN
dpc-2259	142	29	of	of	ADP
dpc-2259	142	30	life	life	NOUN
dpc-2259	142	31	and	and	CCONJ
dpc-2259	142	32	presents	present	NOUN
dpc-2259	142	33	with	with	ADP
dpc-2259	142	34	various	various	ADJ
dpc-2259	142	35	associated	associated	ADJ
dpc-2259	142	36	comorbidities	comorbiditie	NOUN
dpc-2259	142	37	.	.	PUNCT
dpc-2259	143	1	the	the	DET
dpc-2259	143	2	disease	disease	NOUN
dpc-2259	143	3	is	be	AUX
dpc-2259	143	4	characterized	characterize	VERB
dpc-2259	143	5	by	by	ADP
dpc-2259	143	6	deep	deep	ADJ
dpc-2259	143	7	-	-	PUNCT
dpc-2259	143	8	seated	seat	VERB
dpc-2259	143	9	,	,	PUNCT
dpc-2259	143	10	tender	tender	NOUN
dpc-2259	143	11	,	,	PUNCT
dpc-2259	143	12	inflamed	inflame	VERB
dpc-2259	143	13	,	,	PUNCT
dpc-2259	143	14	draining	drain	VERB
dpc-2259	143	15	nodules	nodule	NOUN
dpc-2259	143	16	and	and	CCONJ
dpc-2259	143	17	abscesses	abscess	NOUN
dpc-2259	143	18	subsequently	subsequently	ADV
dpc-2259	143	19	leading	lead	VERB
dpc-2259	143	20	to	to	ADP
dpc-2259	143	21	sinus	sinus	NOUN
dpc-2259	143	22	tract	tract	NOUN
dpc-2259	143	23	and	and	CCONJ
dpc-2259	143	24	scar	scar	ADJ
dpc-2259	143	25	formation	formation	NOUN
dpc-2259	143	26	mainly	mainly	ADV
dpc-2259	143	27	in	in	ADP
dpc-2259	143	28	the	the	DET
dpc-2259	143	29	flexural	flexural	ADJ
dpc-2259	143	30	areas	area	NOUN
dpc-2259	143	31	of	of	ADP
dpc-2259	143	32	the	the	DET
dpc-2259	143	33	body	body	NOUN
dpc-2259	143	34	[	[	X
dpc-2259	143	35	11	11	NUM
dpc-2259	143	36	]	]	PUNCT
dpc-2259	143	37	.	.	PUNCT
dpc-2259	144	1	hs	hs	PROPN
dpc-2259	144	2	is	be	AUX
dpc-2259	144	3	most	most	ADV
dpc-2259	144	4	commonly	commonly	ADV
dpc-2259	144	5	seen	see	VERB
dpc-2259	144	6	in	in	ADP
dpc-2259	144	7	the	the	DET
dpc-2259	144	8	third	third	ADJ
dpc-2259	144	9	and	and	CCONJ
dpc-2259	144	10	fourth	fourth	ADJ
dpc-2259	144	11	decades	decade	NOUN
dpc-2259	144	12	of	of	ADP
dpc-2259	144	13	life	life	NOUN
dpc-2259	144	14	[	[	X
dpc-2259	144	15	12	12	NUM
dpc-2259	144	16	]	]	PUNCT
dpc-2259	144	17	.	.	PUNCT
dpc-2259	145	1	since	since	SCONJ
dpc-2259	145	2	different	different	ADJ
dpc-2259	145	3	clinical	clinical	ADJ
dpc-2259	145	4	entities	entity	NOUN
dpc-2259	145	5	including	include	VERB
dpc-2259	145	6	furunculosis	furunculosis	NOUN
dpc-2259	145	7	,	,	PUNCT
dpc-2259	145	8	nodulocystic	nodulocystic	ADJ
dpc-2259	145	9	acne	acne	NOUN
dpc-2259	145	10	,	,	PUNCT
dpc-2259	145	11	epidermoid	epidermoid	NOUN
dpc-2259	145	12	cyst	cyst	NOUN
dpc-2259	145	13	,	,	PUNCT
dpc-2259	145	14	cutaneous	cutaneous	ADJ
dpc-2259	145	15	crohn	crohn	PROPN
dpc-2259	145	16	disease	disease	NOUN
dpc-2259	145	17	may	may	AUX
dpc-2259	145	18	be	be	AUX
dpc-2259	145	19	considered	consider	VERB
dpc-2259	145	20	in	in	ADP
dpc-2259	145	21	the	the	DET
dpc-2259	145	22	differential	differential	ADJ
dpc-2259	145	23	diagnoses	diagnosis	NOUN
dpc-2259	145	24	of	of	ADP
dpc-2259	145	25	hs	hs	PROPN
dpc-2259	145	26	,	,	PUNCT
dpc-2259	145	27	a	a	DET
dpc-2259	145	28	mean	mean	ADJ
dpc-2259	145	29	diagnostic	diagnostic	ADJ
dpc-2259	145	30	delay	delay	NOUN
dpc-2259	145	31	of	of	ADP
dpc-2259	145	32	7.2	7.2	NUM
dpc-2259	145	33	years	year	NOUN
dpc-2259	145	34	has	have	AUX
dpc-2259	145	35	been	be	AUX
dpc-2259	145	36	reported	report	VERB
dpc-2259	145	37	in	in	ADP
dpc-2259	145	38	a	a	DET
dpc-2259	145	39	study	study	NOUN
dpc-2259	145	40	[	[	X
dpc-2259	145	41	13	13	NUM
dpc-2259	145	42	]	]	PUNCT
dpc-2259	145	43	.	.	PUNCT
dpc-2259	146	1	the	the	DET
dpc-2259	146	2	disease	disease	NOUN
dpc-2259	146	3	is	be	AUX
dpc-2259	146	4	more	more	ADV
dpc-2259	146	5	commonly	commonly	ADV
dpc-2259	146	6	observed	observe	VERB
dpc-2259	146	7	in	in	ADP
dpc-2259	146	8	70	70	NUM
dpc-2259	146	9	60	60	NUM
dpc-2259	146	10	50	50	NUM
dpc-2259	146	11	40	40	NUM
dpc-2259	146	12	30	30	NUM
dpc-2259	146	13	32	32	NUM
dpc-2259	146	14	33	33	NUM
dpc-2259	146	15	3	3	NUM
dpc-2259	146	16	present	present	NOUN
dpc-2259	146	17	absent	absent	ADJ
dpc-2259	146	18	21	21	NUM
dpc-2259	146	19	15	15	NUM
dpc-2259	146	20	10	10	NUM
dpc-2259	146	21	60	60	NUM
dpc-2259	146	22	20	20	NUM
dpc-2259	146	23	20	20	NUM
dpc-2259	146	24	10	10	NUM
dpc-2259	146	25	10	10	NUM
dpc-2259	146	26	0	0	NUM
dpc-2259	146	27	5	5	NUM
dpc-2259	146	28	pack	pack	NOUN
dpc-2259	146	29	-	-	PUNCT
dpc-2259	146	30	years	year	NOUN
dpc-2259	146	31	of	of	ADP
dpc-2259	146	32	smoking	smoking	NOUN
dpc-2259	146	33	vs.	vs.	ADP
dpc-2259	146	34	covid-19	covid-19	PROPN
dpc-2259	146	35	symptoms	symptom	NOUN
dpc-2259	146	36	p=0.024	p=0.024	PUNCT
dpc-2259	146	37	covid-19	covid-19	PROPN
dpc-2259	146	38	symptoms	symptom	VERB
dpc-2259	146	39	p	p	NOUN
dpc-2259	147	1	a	a	PRON
dpc-2259	147	2	c	c	NOUN
dpc-2259	147	3	k	k	PROPN
dpc-2259	147	4	-y	-y	PROPN
dpc-2259	147	5	ea	ea	NOUN
dpc-2259	148	1	r	r	NOUN
dpc-2259	148	2	s	s	NOUN
dpc-2259	148	3	o	o	X
dpc-2259	149	1	f	f	NOUN
dpc-2259	150	1	sm	sm	INTJ
dpc-2259	150	2	o	o	X
dpc-2259	150	3	k	k	X
dpc-2259	150	4	in	in	ADP
dpc-2259	150	5	g	g	PROPN
dpc-2259	150	6	figure	figure	NOUN
dpc-2259	150	7	4	4	NUM
dpc-2259	150	8	.	.	PUNCT
dpc-2259	151	1	the	the	DET
dpc-2259	151	2	pack	pack	NOUN
dpc-2259	151	3	-	-	PUNCT
dpc-2259	151	4	years	year	NOUN
dpc-2259	151	5	of	of	ADP
dpc-2259	151	6	smoking	smoking	NOUN
dpc-2259	151	7	according	accord	VERB
dpc-2259	151	8	to	to	ADP
dpc-2259	151	9	the	the	DET
dpc-2259	151	10	absence	absence	NOUN
dpc-2259	151	11	and	and	CCONJ
dpc-2259	151	12	presence	presence	NOUN
dpc-2259	151	13	of	of	ADP
dpc-2259	151	14	covid-19	covid-19	PROPN
dpc-2259	151	15	symptoms	symptom	NOUN
dpc-2259	151	16	:	:	PUNCT
dpc-2259	151	17	boxplot	boxplot	NOUN
dpc-2259	151	18	representing	represent	VERB
dpc-2259	151	19	median	median	ADJ
dpc-2259	151	20	values	value	NOUN
dpc-2259	151	21	,	,	PUNCT
dpc-2259	151	22	25	25	NUM
dpc-2259	151	23	-	-	SYM
dpc-2259	151	24	75	75	NUM
dpc-2259	151	25	%	%	NOUN
dpc-2259	151	26	range	range	NOUN
dpc-2259	151	27	(	(	PUNCT
dpc-2259	151	28	box	box	NOUN
dpc-2259	151	29	)	)	PUNCT
dpc-2259	151	30	and	and	CCONJ
dpc-2259	151	31	minimum	minimum	ADJ
dpc-2259	151	32	-	-	PUNCT
dpc-2259	151	33	maximum	maximum	ADJ
dpc-2259	151	34	range	range	NOUN
dpc-2259	151	35	(	(	PUNCT
dpc-2259	151	36	bars	bar	NOUN
dpc-2259	151	37	)	)	PUNCT
dpc-2259	151	38	of	of	ADP
dpc-2259	151	39	the	the	DET
dpc-2259	151	40	pack	pack	NOUN
dpc-2259	151	41	-	-	PUNCT
dpc-2259	151	42	years	year	NOUN
dpc-2259	151	43	of	of	ADP
dpc-2259	151	44	smoking	smoking	NOUN
dpc-2259	151	45	with	with	ADP
dpc-2259	151	46	respect	respect	NOUN
dpc-2259	151	47	to	to	ADP
dpc-2259	151	48	the	the	DET
dpc-2259	151	49	patients	patient	NOUN
dpc-2259	151	50	with	with	ADP
dpc-2259	151	51	covid-19	covid-19	PROPN
dpc-2259	151	52	-	-	PUNCT
dpc-2259	151	53	related	relate	VERB
dpc-2259	151	54	symptoms	symptom	NOUN
dpc-2259	151	55	and	and	CCONJ
dpc-2259	151	56	patients	patient	NOUN
dpc-2259	151	57	without	without	ADP
dpc-2259	151	58	any	any	DET
dpc-2259	151	59	covid-19	covid-19	PROPN
dpc-2259	151	60	-	-	PUNCT
dpc-2259	151	61	related	relate	VERB
dpc-2259	151	62	symptoms	symptom	NOUN
dpc-2259	151	63	.	.	PUNCT
dpc-2259	152	1	table	table	NOUN
dpc-2259	152	2	5	5	NUM
dpc-2259	152	3	.	.	PUNCT
dpc-2259	153	1	covid-19	covid-19	PROPN
dpc-2259	153	2	real	real	ADJ
dpc-2259	153	3	-	-	PUNCT
dpc-2259	153	4	time	time	NOUN
dpc-2259	153	5	pcr	pcr	NOUN
dpc-2259	153	6	results	result	NOUN
dpc-2259	153	7	with	with	ADP
dpc-2259	153	8	respect	respect	NOUN
dpc-2259	153	9	to	to	ADP
dpc-2259	153	10	the	the	DET
dpc-2259	153	11	presence	presence	NOUN
dpc-2259	153	12	of	of	ADP
dpc-2259	153	13	covid-19	covid-19	PROPN
dpc-2259	153	14	-	-	PUNCT
dpc-2259	153	15	related	relate	VERB
dpc-2259	153	16	symptoms	symptom	NOUN
dpc-2259	153	17	and	and	CCONJ
dpc-2259	153	18	close	close	ADJ
dpc-2259	153	19	contact	contact	NOUN
dpc-2259	153	20	to	to	ADP
dpc-2259	153	21	someone	someone	PRON
dpc-2259	153	22	with	with	ADP
dpc-2259	153	23	a	a	DET
dpc-2259	153	24	diagnosis	diagnosis	NOUN
dpc-2259	153	25	of	of	ADP
dpc-2259	153	26	covid-19	covid-19	PROPN
dpc-2259	153	27	.	.	PUNCT
dpc-2259	154	1	covid-19	covid-19	PROPN
dpc-2259	154	2	real	real	ADJ
dpc-2259	154	3	time	time	NOUN
dpc-2259	154	4	-	-	PUNCT
dpc-2259	154	5	pcr	pcr	ADJ
dpc-2259	154	6	results	result	NOUN
dpc-2259	154	7	covid-19	covid-19	PROPN
dpc-2259	154	8	related	related	ADJ
dpc-2259	154	9	symptoms	symptom	NOUN
dpc-2259	154	10	n	n	CCONJ
dpc-2259	154	11	(	(	PUNCT
dpc-2259	154	12	%	%	INTJ
dpc-2259	154	13	)	)	PUNCT
dpc-2259	155	1	close	close	ADJ
dpc-2259	155	2	contact	contact	NOUN
dpc-2259	155	3	to	to	ADP
dpc-2259	155	4	someone	someone	PRON
dpc-2259	155	5	with	with	ADP
dpc-2259	155	6	a	a	DET
dpc-2259	155	7	diagnosis	diagnosis	NOUN
dpc-2259	155	8	of	of	ADP
dpc-2259	155	9	covid-19	covid-19	PROPN
dpc-2259	155	10	n	n	PROPN
dpc-2259	155	11	(	(	PUNCT
dpc-2259	155	12	%	%	INTJ
dpc-2259	155	13	)	)	PUNCT
dpc-2259	155	14	not	not	PART
dpc-2259	155	15	present	present	ADJ
dpc-2259	155	16	present	present	ADJ
dpc-2259	155	17	not	not	PART
dpc-2259	155	18	present	present	ADJ
dpc-2259	155	19	present	present	ADJ
dpc-2259	155	20	total	total	ADJ
dpc-2259	155	21	negative	negative	ADJ
dpc-2259	155	22	34	34	NUM
dpc-2259	155	23	(	(	PUNCT
dpc-2259	155	24	100	100	NUM
dpc-2259	155	25	)	)	PUNCT
dpc-2259	155	26	45	45	NUM
dpc-2259	155	27	(	(	PUNCT
dpc-2259	155	28	60	60	NUM
dpc-2259	155	29	)	)	PUNCT
dpc-2259	155	30	63	63	NUM
dpc-2259	155	31	(	(	PUNCT
dpc-2259	155	32	95.5	95.5	NUM
dpc-2259	155	33	)	)	PUNCT
dpc-2259	155	34	16	16	NUM
dpc-2259	155	35	(	(	PUNCT
dpc-2259	155	36	37.2	37.2	NUM
dpc-2259	155	37	)	)	PUNCT
dpc-2259	155	38	79	79	NUM
dpc-2259	155	39	(	(	PUNCT
dpc-2259	155	40	72.5	72.5	NUM
dpc-2259	155	41	)	)	PUNCT
dpc-2259	155	42	positive	positive	ADJ
dpc-2259	155	43	0	0	PUNCT
dpc-2259	155	44	(	(	PUNCT
dpc-2259	155	45	0	0	NUM
dpc-2259	155	46	)	)	PUNCT
dpc-2259	155	47	30	30	NUM
dpc-2259	155	48	(	(	PUNCT
dpc-2259	155	49	40	40	NUM
dpc-2259	155	50	)	)	PUNCT
dpc-2259	155	51	3	3	NUM
dpc-2259	155	52	(	(	PUNCT
dpc-2259	155	53	4.5	4.5	NUM
dpc-2259	155	54	)	)	PUNCT
dpc-2259	155	55	27	27	NUM
dpc-2259	155	56	(	(	PUNCT
dpc-2259	155	57	62.8	62.8	NUM
dpc-2259	155	58	)	)	PUNCT
dpc-2259	155	59	30	30	NUM
dpc-2259	155	60	(	(	PUNCT
dpc-2259	155	61	27.5	27.5	NUM
dpc-2259	155	62	)	)	PUNCT
dpc-2259	155	63	total	total	NOUN
dpc-2259	155	64	34	34	NUM
dpc-2259	155	65	(	(	PUNCT
dpc-2259	155	66	100	100	NUM
dpc-2259	155	67	)	)	PUNCT
dpc-2259	155	68	75	75	NUM
dpc-2259	155	69	(	(	PUNCT
dpc-2259	155	70	100	100	NUM
dpc-2259	155	71	)	)	PUNCT
dpc-2259	155	72	66	66	NUM
dpc-2259	155	73	(	(	PUNCT
dpc-2259	155	74	100	100	NUM
dpc-2259	155	75	)	)	PUNCT
dpc-2259	155	76	43	43	NUM
dpc-2259	155	77	(	(	PUNCT
dpc-2259	155	78	100	100	NUM
dpc-2259	155	79	)	)	PUNCT
dpc-2259	155	80	109	109	NUM
dpc-2259	155	81	(	(	PUNCT
dpc-2259	155	82	100	100	NUM
dpc-2259	155	83	)	)	PUNCT
dpc-2259	156	1	p	p	X
dpc-2259	156	2	<	<	X
dpc-2259	156	3	0.001	0.001	NUM
dpc-2259	156	4	p	p	X
dpc-2259	156	5	<	<	X
dpc-2259	156	6	0.001	0.001	NUM
dpc-2259	156	7	statistically	statistically	ADV
dpc-2259	156	8	significant	significant	ADJ
dpc-2259	156	9	relationships	relationship	NOUN
dpc-2259	156	10	were	be	AUX
dpc-2259	156	11	found	find	VERB
dpc-2259	156	12	between	between	ADP
dpc-2259	156	13	covid-19	covid-19	PROPN
dpc-2259	156	14	real	real	ADJ
dpc-2259	156	15	time	time	NOUN
dpc-2259	156	16	-	-	PUNCT
dpc-2259	156	17	pcr	pcr	ADJ
dpc-2259	156	18	positivity	positivity	NOUN
dpc-2259	156	19	versus	versus	ADP
dpc-2259	156	20	history	history	NOUN
dpc-2259	156	21	of	of	ADP
dpc-2259	156	22	close	close	ADJ
dpc-2259	156	23	contact	contact	NOUN
dpc-2259	156	24	to	to	ADP
dpc-2259	156	25	someone	someone	PRON
dpc-2259	156	26	with	with	ADP
dpc-2259	156	27	a	a	DET
dpc-2259	156	28	confirmed	confirm	VERB
dpc-2259	156	29	covid-19	covid-19	PROPN
dpc-2259	156	30	diagnosis	diagnosis	NOUN
dpc-2259	156	31	(	(	PUNCT
dpc-2259	156	32	p	p	X
dpc-2259	156	33	<	<	X
dpc-2259	156	34	0.001	0.001	NUM
dpc-2259	156	35	)	)	PUNCT
dpc-2259	156	36	and	and	CCONJ
dpc-2259	156	37	between	between	ADP
dpc-2259	156	38	covid-19	covid-19	PROPN
dpc-2259	156	39	real	real	ADJ
dpc-2259	156	40	time	time	NOUN
dpc-2259	156	41	-	-	PUNCT
dpc-2259	156	42	pcr	pcr	ADJ
dpc-2259	156	43	positivity	positivity	NOUN
dpc-2259	156	44	versus	versus	ADP
dpc-2259	156	45	the	the	DET
dpc-2259	156	46	presence	presence	NOUN
dpc-2259	156	47	of	of	ADP
dpc-2259	156	48	covid-19	covid-19	PROPN
dpc-2259	156	49	related	related	ADJ
dpc-2259	156	50	symptoms	symptom	NOUN
dpc-2259	156	51	(	(	PUNCT
dpc-2259	156	52	p	p	X
dpc-2259	156	53	<	<	X
dpc-2259	156	54	0.001	0.001	NUM
dpc-2259	156	55	)	)	PUNCT
dpc-2259	156	56	.	.	PUNCT
dpc-2259	157	1	8	8	NUM
dpc-2259	157	2	original	original	ADJ
dpc-2259	157	3	article	article	NOUN
dpc-2259	157	4	|	|	ADV
dpc-2259	157	5	dermatol	dermatol	ADJ
dpc-2259	157	6	pract	pract	NOUN
dpc-2259	157	7	concept	concept	NOUN
dpc-2259	157	8	.	.	PUNCT
dpc-2259	158	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	158	2	patients	patient	NOUN
dpc-2259	158	3	with	with	ADP
dpc-2259	158	4	hs	hs	PRON
dpc-2259	158	5	have	have	VERB
dpc-2259	158	6	multiple	multiple	ADJ
dpc-2259	158	7	associated	associate	VERB
dpc-2259	158	8	comorbidities	comorbiditie	NOUN
dpc-2259	158	9	including	include	VERB
dpc-2259	158	10	metabolic	metabolic	NOUN
dpc-2259	158	11	syndrome	syndrome	NOUN
dpc-2259	158	12	,	,	PUNCT
dpc-2259	158	13	obesity	obesity	NOUN
dpc-2259	158	14	,	,	PUNCT
dpc-2259	158	15	diabetes	diabetes	NOUN
dpc-2259	158	16	mellitus	mellitus	NOUN
dpc-2259	158	17	,	,	PUNCT
dpc-2259	158	18	dyslipidemia	dyslipidemia	NOUN
dpc-2259	158	19	,	,	PUNCT
dpc-2259	158	20	polycystic	polycystic	ADJ
dpc-2259	158	21	ovarian	ovarian	ADJ
dpc-2259	158	22	syndrome	syndrome	NOUN
dpc-2259	158	23	,	,	PUNCT
dpc-2259	158	24	thyroidal	thyroidal	ADJ
dpc-2259	158	25	dysfunction	dysfunction	NOUN
dpc-2259	158	26	,	,	PUNCT
dpc-2259	158	27	axial	axial	ADJ
dpc-2259	158	28	spondyloarthropathy	spondyloarthropathy	NOUN
dpc-2259	158	29	and	and	CCONJ
dpc-2259	158	30	cardiovascular	cardiovascular	ADJ
dpc-2259	158	31	associated	associate	VERB
dpc-2259	158	32	adverse	adverse	ADJ
dpc-2259	158	33	events	event	NOUN
dpc-2259	158	34	[	[	X
dpc-2259	158	35	22	22	NUM
dpc-2259	158	36	]	]	PUNCT
dpc-2259	158	37	.	.	PUNCT
dpc-2259	159	1	a	a	DET
dpc-2259	159	2	recent	recent	ADJ
dpc-2259	159	3	meta	meta	ADJ
dpc-2259	159	4	-	-	PUNCT
dpc-2259	159	5	analysis	analysis	NOUN
dpc-2259	159	6	revealed	reveal	VERB
dpc-2259	159	7	that	that	SCONJ
dpc-2259	159	8	cardiovascular	cardiovascular	ADJ
dpc-2259	159	9	diseases	disease	NOUN
dpc-2259	159	10	,	,	PUNCT
dpc-2259	159	11	obesity	obesity	NOUN
dpc-2259	159	12	,	,	PUNCT
dpc-2259	159	13	hypertension	hypertension	NOUN
dpc-2259	159	14	,	,	PUNCT
dpc-2259	159	15	history	history	NOUN
dpc-2259	159	16	of	of	ADP
dpc-2259	159	17	smoking	smoking	NOUN
dpc-2259	159	18	,	,	PUNCT
dpc-2259	159	19	old	old	ADJ
dpc-2259	159	20	age	age	NOUN
dpc-2259	159	21	are	be	AUX
dpc-2259	159	22	also	also	ADV
dpc-2259	159	23	risk	risk	NOUN
dpc-2259	159	24	factors	factor	NOUN
dpc-2259	159	25	for	for	ADP
dpc-2259	159	26	critical	critical	ADJ
dpc-2259	159	27	and	and	CCONJ
dpc-2259	159	28	mortal	mortal	ADJ
dpc-2259	159	29	cases	case	NOUN
dpc-2259	159	30	of	of	ADP
dpc-2259	159	31	covid-19	covid-19	PROPN
dpc-2259	159	32	infection	infection	NOUN
dpc-2259	159	33	[	[	X
dpc-2259	159	34	23	23	NUM
dpc-2259	159	35	]	]	PUNCT
dpc-2259	159	36	.	.	PUNCT
dpc-2259	160	1	being	be	AUX
dpc-2259	160	2	male	male	NOUN
dpc-2259	160	3	,	,	PUNCT
dpc-2259	160	4	smoking	smoking	NOUN
dpc-2259	160	5	and	and	CCONJ
dpc-2259	160	6	being	be	AUX
dpc-2259	160	7	at	at	ADP
dpc-2259	160	8	an	an	DET
dpc-2259	160	9	age	age	NOUN
dpc-2259	160	10	greater	great	ADJ
dpc-2259	160	11	than	than	ADP
dpc-2259	160	12	65	65	NUM
dpc-2259	160	13	years	year	NOUN
dpc-2259	160	14	were	be	AUX
dpc-2259	160	15	shown	show	VERB
dpc-2259	160	16	to	to	PART
dpc-2259	160	17	be	be	AUX
dpc-2259	160	18	associated	associate	VERB
dpc-2259	160	19	with	with	ADP
dpc-2259	160	20	covid-19	covid-19	PROPN
dpc-2259	160	21	disease	disease	NOUN
dpc-2259	160	22	progression	progression	NOUN
dpc-2259	161	1	[	[	X
dpc-2259	161	2	23	23	NUM
dpc-2259	161	3	]	]	PUNCT
dpc-2259	161	4	.	.	PUNCT
dpc-2259	162	1	critical	critical	ADJ
dpc-2259	162	2	covid-19	covid-19	PROPN
dpc-2259	162	3	cases	case	NOUN
dpc-2259	162	4	had	have	VERB
dpc-2259	162	5	higher	high	ADJ
dpc-2259	162	6	rates	rate	NOUN
dpc-2259	162	7	of	of	ADP
dpc-2259	162	8	having	have	VERB
dpc-2259	162	9	underlying	underlie	VERB
dpc-2259	162	10	diseases	disease	NOUN
dpc-2259	162	11	such	such	ADJ
dpc-2259	162	12	as	as	ADP
dpc-2259	162	13	hypertension	hypertension	NOUN
dpc-2259	162	14	,	,	PUNCT
dpc-2259	162	15	cardiovascular	cardiovascular	ADJ
dpc-2259	162	16	disease	disease	NOUN
dpc-2259	162	17	and	and	CCONJ
dpc-2259	162	18	diabetes	diabetes	NOUN
dpc-2259	162	19	mellitus	mellitus	NOUN
dpc-2259	162	20	compared	compare	VERB
dpc-2259	162	21	to	to	ADP
dpc-2259	162	22	the	the	DET
dpc-2259	162	23	non	non	ADJ
dpc-2259	162	24	-	-	ADJ
dpc-2259	162	25	critical	critical	ADJ
dpc-2259	162	26	covid-19	covid-19	PROPN
dpc-2259	162	27	patients	patient	NOUN
dpc-2259	162	28	[	[	X
dpc-2259	162	29	23	23	NUM
dpc-2259	162	30	]	]	PUNCT
dpc-2259	162	31	.	.	PUNCT
dpc-2259	163	1	even	even	ADV
dpc-2259	163	2	though	though	ADV
dpc-2259	163	3	,	,	PUNCT
dpc-2259	163	4	in	in	ADP
dpc-2259	163	5	our	our	PRON
dpc-2259	163	6	cohort	cohort	NOUN
dpc-2259	163	7	no	no	DET
dpc-2259	163	8	patient	patient	NOUN
dpc-2259	163	9	was	be	AUX
dpc-2259	163	10	needed	need	VERB
dpc-2259	163	11	to	to	PART
dpc-2259	163	12	be	be	AUX
dpc-2259	163	13	hospitalized	hospitalize	VERB
dpc-2259	163	14	for	for	ADP
dpc-2259	163	15	severe	severe	ADJ
dpc-2259	163	16	covid-19	covid-19	PROPN
dpc-2259	163	17	,	,	PUNCT
dpc-2259	163	18	we	we	PRON
dpc-2259	163	19	found	find	VERB
dpc-2259	163	20	that	that	SCONJ
dpc-2259	163	21	the	the	DET
dpc-2259	163	22	mean	mean	ADJ
dpc-2259	163	23	age	age	NOUN
dpc-2259	163	24	of	of	ADP
dpc-2259	163	25	the	the	DET
dpc-2259	163	26	patients	patient	NOUN
dpc-2259	163	27	with	with	ADP
dpc-2259	163	28	positive	positive	ADJ
dpc-2259	163	29	results	result	NOUN
dpc-2259	163	30	of	of	ADP
dpc-2259	163	31	covid	covid	PROPN
dpc-2259	163	32	rt	rt	PROPN
dpc-2259	163	33	-	-	PUNCT
dpc-2259	163	34	pcr	pcr	PROPN
dpc-2259	163	35	was	be	AUX
dpc-2259	163	36	statistically	statistically	ADV
dpc-2259	163	37	significantly	significantly	ADV
dpc-2259	163	38	higher	high	ADJ
dpc-2259	163	39	compared	compare	VERB
dpc-2259	163	40	to	to	ADP
dpc-2259	163	41	the	the	DET
dpc-2259	163	42	ones	one	NOUN
dpc-2259	163	43	with	with	ADP
dpc-2259	163	44	negative	negative	ADJ
dpc-2259	163	45	results	result	NOUN
dpc-2259	163	46	(	(	PUNCT
dpc-2259	163	47	p	p	X
dpc-2259	163	48	<	<	X
dpc-2259	163	49	0.007	0.007	NUM
dpc-2259	163	50	)	)	PUNCT
dpc-2259	163	51	.	.	PUNCT
dpc-2259	164	1	additionally	additionally	ADV
dpc-2259	164	2	,	,	PUNCT
dpc-2259	164	3	patients	patient	NOUN
dpc-2259	164	4	who	who	PRON
dpc-2259	164	5	demonstrated	demonstrate	VERB
dpc-2259	164	6	covid-19	covid-19	PROPN
dpc-2259	164	7	related	related	ADJ
dpc-2259	164	8	symptoms	symptom	NOUN
dpc-2259	164	9	were	be	AUX
dpc-2259	164	10	shown	show	VERB
dpc-2259	164	11	to	to	PART
dpc-2259	164	12	have	have	VERB
dpc-2259	164	13	statistically	statistically	ADV
dpc-2259	164	14	significantly	significantly	ADV
dpc-2259	164	15	higher	high	ADJ
dpc-2259	164	16	average	average	ADJ
dpc-2259	164	17	age	age	NOUN
dpc-2259	164	18	compared	compare	VERB
dpc-2259	164	19	to	to	ADP
dpc-2259	164	20	the	the	DET
dpc-2259	164	21	ones	one	NOUN
dpc-2259	164	22	who	who	PRON
dpc-2259	164	23	did	do	AUX
dpc-2259	164	24	not	not	PART
dpc-2259	164	25	demonstrate	demonstrate	VERB
dpc-2259	164	26	any	any	DET
dpc-2259	164	27	symptoms	symptom	NOUN
dpc-2259	164	28	(	(	PUNCT
dpc-2259	164	29	p	p	X
dpc-2259	164	30	 	 	SPACE
dpc-2259	164	31	=	=	NOUN
dpc-2259	164	32	 	 	SPACE
dpc-2259	164	33	0.031	0.031	NUM
dpc-2259	164	34	)	)	PUNCT
dpc-2259	164	35	.	.	PUNCT
dpc-2259	165	1	in	in	ADP
dpc-2259	165	2	line	line	NOUN
dpc-2259	165	3	with	with	ADP
dpc-2259	165	4	the	the	DET
dpc-2259	165	5	data	datum	NOUN
dpc-2259	165	6	in	in	ADP
dpc-2259	165	7	the	the	DET
dpc-2259	165	8	literature	literature	NOUN
dpc-2259	165	9	,	,	PUNCT
dpc-2259	165	10	patients	patient	NOUN
dpc-2259	165	11	who	who	PRON
dpc-2259	165	12	had	have	VERB
dpc-2259	165	13	any	any	DET
dpc-2259	165	14	cardiovascular	cardiovascular	ADJ
dpc-2259	165	15	disease	disease	NOUN
dpc-2259	165	16	(	(	PUNCT
dpc-2259	165	17	most	most	ADV
dpc-2259	165	18	common	common	ADJ
dpc-2259	165	19	one	one	NUM
dpc-2259	165	20	being	be	AUX
dpc-2259	165	21	hypertension	hypertension	NOUN
dpc-2259	165	22	)	)	PUNCT
dpc-2259	165	23	were	be	AUX
dpc-2259	165	24	shown	show	VERB
dpc-2259	165	25	to	to	PART
dpc-2259	165	26	have	have	VERB
dpc-2259	165	27	covid-19	covid-19	PROPN
dpc-2259	165	28	related	related	ADJ
dpc-2259	165	29	symptoms	symptom	NOUN
dpc-2259	165	30	at	at	ADP
dpc-2259	165	31	a	a	DET
dpc-2259	165	32	higher	high	ADJ
dpc-2259	165	33	rate	rate	NOUN
dpc-2259	165	34	compared	compare	VERB
dpc-2259	165	35	to	to	ADP
dpc-2259	165	36	the	the	DET
dpc-2259	165	37	ones	one	NOUN
dpc-2259	165	38	with	with	ADP
dpc-2259	165	39	no	no	DET
dpc-2259	165	40	accompanying	accompany	VERB
dpc-2259	165	41	cardiovascular	cardiovascular	ADJ
dpc-2259	165	42	disease	disease	NOUN
dpc-2259	165	43	(	(	PUNCT
dpc-2259	165	44	p	p	X
dpc-2259	165	45	=	=	NOUN
dpc-2259	165	46	0.035	0.035	NUM
dpc-2259	165	47	)	)	PUNCT
dpc-2259	165	48	.	.	PUNCT
dpc-2259	166	1	wang	wang	PROPN
dpc-2259	166	2	et	et	PROPN
dpc-2259	166	3	al	al	PROPN
dpc-2259	167	1	[	[	X
dpc-2259	167	2	24	24	NUM
dpc-2259	167	3	]	]	PUNCT
dpc-2259	167	4	showed	show	VERB
dpc-2259	167	5	that	that	SCONJ
dpc-2259	167	6	hypertension	hypertension	NOUN
dpc-2259	167	7	prevalence	prevalence	NOUN
dpc-2259	167	8	was	be	AUX
dpc-2259	167	9	higher	high	ADJ
dpc-2259	167	10	in	in	ADP
dpc-2259	167	11	covid-19	covid-19	PROPN
dpc-2259	167	12	patients	patient	NOUN
dpc-2259	167	13	admitted	admit	VERB
dpc-2259	167	14	to	to	ADP
dpc-2259	167	15	intensive	intensive	ADJ
dpc-2259	167	16	care	care	NOUN
dpc-2259	167	17	unit	unit	NOUN
dpc-2259	167	18	compared	compare	VERB
dpc-2259	167	19	to	to	ADP
dpc-2259	167	20	ones	one	NOUN
dpc-2259	167	21	who	who	PRON
dpc-2259	167	22	did	do	VERB
dpc-2259	167	23	not	not	PART
dpc-2259	167	24	.	.	PUNCT
dpc-2259	168	1	in	in	ADP
dpc-2259	168	2	our	our	PRON
dpc-2259	168	3	study	study	NOUN
dpc-2259	168	4	,	,	PUNCT
dpc-2259	168	5	we	we	PRON
dpc-2259	168	6	have	have	AUX
dpc-2259	168	7	also	also	ADV
dpc-2259	168	8	showed	show	VERB
dpc-2259	168	9	that	that	SCONJ
dpc-2259	168	10	patients	patient	NOUN
dpc-2259	168	11	who	who	PRON
dpc-2259	168	12	had	have	VERB
dpc-2259	168	13	at	at	ADV
dpc-2259	168	14	least	least	ADV
dpc-2259	168	15	one	one	NUM
dpc-2259	168	16	systemic	systemic	ADJ
dpc-2259	168	17	disease	disease	NOUN
dpc-2259	168	18	had	have	VERB
dpc-2259	168	19	higher	high	ADJ
dpc-2259	168	20	proportions	proportion	NOUN
dpc-2259	168	21	of	of	ADP
dpc-2259	168	22	demonstrating	demonstrate	VERB
dpc-2259	168	23	covid-19	covid-19	PROPN
dpc-2259	168	24	symptoms	symptom	NOUN
dpc-2259	168	25	compared	compare	VERB
dpc-2259	168	26	to	to	ADP
dpc-2259	168	27	the	the	DET
dpc-2259	168	28	ones	one	NOUN
dpc-2259	168	29	who	who	PRON
dpc-2259	168	30	did	do	AUX
dpc-2259	168	31	not	not	PART
dpc-2259	168	32	have	have	VERB
dpc-2259	168	33	any	any	DET
dpc-2259	168	34	known	know	VERB
dpc-2259	168	35	systemic	systemic	ADJ
dpc-2259	168	36	comorbidity	comorbidity	NOUN
dpc-2259	168	37	.	.	PUNCT
dpc-2259	169	1	a	a	DET
dpc-2259	169	2	recent	recent	ADJ
dpc-2259	169	3	study	study	NOUN
dpc-2259	169	4	by	by	ADP
dpc-2259	169	5	lowe	lowe	PROPN
dpc-2259	169	6	et	et	PROPN
dpc-2259	169	7	al	al	PROPN
dpc-2259	170	1	[	[	X
dpc-2259	170	2	25	25	NUM
dpc-2259	170	3	]	]	PUNCT
dpc-2259	170	4	revealed	reveal	VERB
dpc-2259	170	5	that	that	SCONJ
dpc-2259	170	6	patients	patient	NOUN
dpc-2259	170	7	with	with	ADP
dpc-2259	170	8	>	>	SYM
dpc-2259	170	9	30	30	NUM
dpc-2259	170	10	pack	pack	NOUN
dpc-2259	170	11	-	-	PUNCT
dpc-2259	170	12	years	year	NOUN
dpc-2259	170	13	of	of	ADP
dpc-2259	170	14	smoking	smoking	NOUN
dpc-2259	170	15	were	be	AUX
dpc-2259	170	16	2.25	2.25	NUM
dpc-2259	170	17	times	time	NOUN
dpc-2259	170	18	more	more	ADV
dpc-2259	170	19	likely	likely	ADJ
dpc-2259	170	20	to	to	PART
dpc-2259	170	21	be	be	AUX
dpc-2259	170	22	hospitalized	hospitalize	VERB
dpc-2259	170	23	.	.	PUNCT
dpc-2259	171	1	even	even	ADV
dpc-2259	171	2	though	though	ADV
dpc-2259	171	3	,	,	PUNCT
dpc-2259	171	4	we	we	PRON
dpc-2259	171	5	did	do	AUX
dpc-2259	171	6	not	not	PART
dpc-2259	171	7	have	have	VERB
dpc-2259	171	8	any	any	DET
dpc-2259	171	9	patient	patient	NOUN
dpc-2259	171	10	who	who	PRON
dpc-2259	171	11	was	be	AUX
dpc-2259	171	12	hospitalized	hospitalize	VERB
dpc-2259	171	13	for	for	ADP
dpc-2259	171	14	covid-19	covid-19	PROPN
dpc-2259	171	15	,	,	PUNCT
dpc-2259	171	16	our	our	PRON
dpc-2259	171	17	study	study	NOUN
dpc-2259	171	18	disclosed	disclose	VERB
dpc-2259	171	19	that	that	SCONJ
dpc-2259	171	20	patients	patient	NOUN
dpc-2259	171	21	with	with	ADP
dpc-2259	171	22	covid-19	covid-19	PROPN
dpc-2259	171	23	symptoms	symptom	NOUN
dpc-2259	171	24	were	be	AUX
dpc-2259	171	25	shown	show	VERB
dpc-2259	171	26	to	to	PART
dpc-2259	171	27	have	have	VERB
dpc-2259	171	28	statistically	statistically	ADV
dpc-2259	171	29	significantly	significantly	ADV
dpc-2259	171	30	higher	high	ADJ
dpc-2259	171	31	pack	pack	NOUN
dpc-2259	171	32	-	-	PUNCT
dpc-2259	171	33	years	year	NOUN
dpc-2259	171	34	of	of	ADP
dpc-2259	171	35	smoking	smoking	NOUN
dpc-2259	171	36	compared	compare	VERB
dpc-2259	171	37	to	to	ADP
dpc-2259	171	38	the	the	DET
dpc-2259	171	39	ones	one	NOUN
dpc-2259	171	40	without	without	ADP
dpc-2259	171	41	any	any	DET
dpc-2259	171	42	symptoms	symptom	NOUN
dpc-2259	171	43	(	(	PUNCT
dpc-2259	171	44	p	p	NOUN
dpc-2259	171	45	=	=	NOUN
dpc-2259	171	46	0.024	0.024	NUM
dpc-2259	171	47	)	)	PUNCT
dpc-2259	171	48	.	.	PUNCT
dpc-2259	172	1	lastly	lastly	ADV
dpc-2259	172	2	,	,	PUNCT
dpc-2259	172	3	we	we	PRON
dpc-2259	172	4	found	find	VERB
dpc-2259	172	5	no	no	DET
dpc-2259	172	6	statistically	statistically	ADV
dpc-2259	172	7	significant	significant	ADJ
dpc-2259	172	8	relationship	relationship	NOUN
dpc-2259	172	9	between	between	ADP
dpc-2259	172	10	the	the	DET
dpc-2259	172	11	presence	presence	NOUN
dpc-2259	172	12	of	of	ADP
dpc-2259	172	13	covid-19	covid-19	PROPN
dpc-2259	172	14	symptoms	symptom	NOUN
dpc-2259	172	15	/	/	SYM
dpc-2259	172	16	covid-19	covid-19	PROPN
dpc-2259	172	17	rt	rt	PROPN
dpc-2259	172	18	-	-	PUNCT
dpc-2259	172	19	pcr	pcr	PROPN
dpc-2259	172	20	positivity	positivity	NOUN
dpc-2259	172	21	and	and	CCONJ
dpc-2259	172	22	gender	gender	NOUN
dpc-2259	172	23	,	,	PUNCT
dpc-2259	172	24	bmi	bmi	NOUN
dpc-2259	172	25	,	,	PUNCT
dpc-2259	172	26	smoking	smoking	NOUN
dpc-2259	172	27	status	status	NOUN
dpc-2259	172	28	(	(	PUNCT
dpc-2259	172	29	current	current	ADJ
dpc-2259	172	30	smoker	smoker	NOUN
dpc-2259	172	31	vs	vs	ADP
dpc-2259	172	32	non	non	ADJ
dpc-2259	172	33	-	-	ADJ
dpc-2259	172	34	smoker	smoker	ADJ
dpc-2259	172	35	)	)	PUNCT
dpc-2259	172	36	and	and	CCONJ
dpc-2259	172	37	treatment	treatment	NOUN
dpc-2259	172	38	duration	duration	NOUN
dpc-2259	172	39	(	(	PUNCT
dpc-2259	172	40	p	p	X
dpc-2259	172	41	>	>	X
dpc-2259	172	42	0.05	0.05	NUM
dpc-2259	172	43	)	)	PUNCT
dpc-2259	172	44	.	.	PUNCT
dpc-2259	173	1	in	in	ADP
dpc-2259	173	2	contrast	contrast	NOUN
dpc-2259	173	3	,	,	PUNCT
dpc-2259	173	4	a	a	DET
dpc-2259	173	5	study	study	NOUN
dpc-2259	173	6	which	which	PRON
dpc-2259	173	7	investigated	investigate	VERB
dpc-2259	173	8	the	the	DET
dpc-2259	173	9	relationship	relationship	NOUN
dpc-2259	173	10	between	between	ADP
dpc-2259	173	11	covid-19	covid-19	PROPN
dpc-2259	173	12	and	and	CCONJ
dpc-2259	173	13	metabolic	metabolic	NOUN
dpc-2259	173	14	associated	associate	VERB
dpc-2259	173	15	fatty	fatty	NOUN
dpc-2259	173	16	liver	liver	NOUN
dpc-2259	173	17	disease	disease	NOUN
dpc-2259	173	18	,	,	PUNCT
dpc-2259	173	19	showed	show	VERB
dpc-2259	173	20	that	that	SCONJ
dpc-2259	173	21	obesity	obesity	NOUN
dpc-2259	173	22	significantly	significantly	ADV
dpc-2259	173	23	increases	increase	VERB
dpc-2259	173	24	the	the	DET
dpc-2259	173	25	risk	risk	NOUN
dpc-2259	173	26	of	of	ADP
dpc-2259	173	27	having	have	VERB
dpc-2259	173	28	severe	severe	ADJ
dpc-2259	173	29	covid-19	covid-19	PROPN
dpc-2259	173	30	disease	disease	NOUN
dpc-2259	173	31	[	[	X
dpc-2259	173	32	26	26	NUM
dpc-2259	173	33	]	]	PUNCT
dpc-2259	173	34	.	.	PUNCT
dpc-2259	174	1	since	since	SCONJ
dpc-2259	174	2	in	in	ADP
dpc-2259	174	3	our	our	PRON
dpc-2259	174	4	cohort	cohort	NOUN
dpc-2259	174	5	population	population	NOUN
dpc-2259	174	6	,	,	PUNCT
dpc-2259	174	7	not	not	PART
dpc-2259	174	8	all	all	DET
dpc-2259	174	9	the	the	DET
dpc-2259	174	10	patients	patient	NOUN
dpc-2259	174	11	with	with	ADP
dpc-2259	174	12	covid-19	covid-19	PROPN
dpc-2259	174	13	related	related	ADJ
dpc-2259	174	14	symptoms	symptom	NOUN
dpc-2259	174	15	and	and	CCONJ
dpc-2259	174	16	with	with	ADP
dpc-2259	174	17	a	a	DET
dpc-2259	174	18	history	history	NOUN
dpc-2259	174	19	of	of	ADP
dpc-2259	174	20	close	close	ADJ
dpc-2259	174	21	contact	contact	NOUN
dpc-2259	174	22	to	to	ADP
dpc-2259	174	23	someone	someone	PRON
dpc-2259	174	24	with	with	ADP
dpc-2259	174	25	a	a	DET
dpc-2259	174	26	confirmed	confirm	VERB
dpc-2259	174	27	diagnosis	diagnosis	NOUN
dpc-2259	174	28	of	of	ADP
dpc-2259	174	29	covid-19	covid-19	PROPN
dpc-2259	174	30	,	,	PUNCT
dpc-2259	174	31	were	be	AUX
dpc-2259	174	32	tested	test	VERB
dpc-2259	174	33	for	for	ADP
dpc-2259	174	34	covid-19	covid-19	PROPN
dpc-2259	174	35	we	we	PRON
dpc-2259	174	36	might	might	AUX
dpc-2259	174	37	have	have	AUX
dpc-2259	174	38	missed	miss	VERB
dpc-2259	174	39	some	some	DET
dpc-2259	174	40	real	real	ADJ
dpc-2259	174	41	positive	positive	ADJ
dpc-2259	174	42	covid-19	covid-19	PROPN
dpc-2259	174	43	cases	case	NOUN
dpc-2259	174	44	which	which	PRON
dpc-2259	174	45	might	might	AUX
dpc-2259	174	46	have	have	AUX
dpc-2259	174	47	limited	limit	VERB
dpc-2259	174	48	our	our	PRON
dpc-2259	174	49	findings	finding	NOUN
dpc-2259	174	50	.	.	PUNCT
dpc-2259	175	1	with	with	ADP
dpc-2259	175	2	topical	topical	ADJ
dpc-2259	175	3	and	and	CCONJ
dpc-2259	175	4	systemic	systemic	ADJ
dpc-2259	175	5	antibiotics	antibiotic	NOUN
dpc-2259	175	6	,	,	PUNCT
dpc-2259	175	7	surgical	surgical	ADJ
dpc-2259	175	8	procedures	procedure	NOUN
dpc-2259	175	9	;	;	PUNCT
dpc-2259	175	10	systemic	systemic	ADJ
dpc-2259	175	11	antibiotics	antibiotic	NOUN
dpc-2259	175	12	,	,	PUNCT
dpc-2259	175	13	oral	oral	ADJ
dpc-2259	175	14	retinoids	retinoid	NOUN
dpc-2259	175	15	,	,	PUNCT
dpc-2259	175	16	anti	anti	ADJ
dpc-2259	175	17	-	-	ADJ
dpc-2259	175	18	tnfα	tnfα	ADJ
dpc-2259	175	19	agents	agent	NOUN
dpc-2259	175	20	,	,	PUNCT
dpc-2259	175	21	surgical	surgical	ADJ
dpc-2259	175	22	deroofing	deroofing	NOUN
dpc-2259	175	23	or	or	CCONJ
dpc-2259	175	24	laser	laser	NOUN
dpc-2259	175	25	excision	excision	NOUN
dpc-2259	175	26	are	be	AUX
dpc-2259	175	27	used	use	VERB
dpc-2259	175	28	for	for	ADP
dpc-2259	175	29	stage	stage	NOUN
dpc-2259	175	30	2	2	NUM
dpc-2259	175	31	and	and	CCONJ
dpc-2259	175	32	3	3	NUM
dpc-2259	175	33	disease	disease	NOUN
dpc-2259	175	34	[	[	X
dpc-2259	175	35	16	16	NUM
dpc-2259	175	36	]	]	PUNCT
dpc-2259	175	37	.	.	PUNCT
dpc-2259	176	1	from	from	ADP
dpc-2259	176	2	the	the	DET
dpc-2259	176	3	start	start	NOUN
dpc-2259	176	4	of	of	ADP
dpc-2259	176	5	covid-19	covid-19	PROPN
dpc-2259	176	6	outbreak	outbreak	NOUN
dpc-2259	176	7	in	in	ADP
dpc-2259	176	8	december	december	PROPN
dpc-2259	176	9	2019	2019	NUM
dpc-2259	176	10	,	,	PUNCT
dpc-2259	176	11	the	the	DET
dpc-2259	176	12	effect	effect	NOUN
dpc-2259	176	13	of	of	ADP
dpc-2259	176	14	immunosuppressive	immunosuppressive	ADJ
dpc-2259	176	15	agents	agent	NOUN
dpc-2259	176	16	on	on	ADP
dpc-2259	176	17	the	the	DET
dpc-2259	176	18	clinical	clinical	ADJ
dpc-2259	176	19	course	course	NOUN
dpc-2259	176	20	of	of	ADP
dpc-2259	176	21	covid-19	covid-19	PROPN
dpc-2259	176	22	is	be	AUX
dpc-2259	176	23	gradually	gradually	ADV
dpc-2259	176	24	being	be	AUX
dpc-2259	176	25	questioned	question	VERB
dpc-2259	176	26	by	by	ADP
dpc-2259	176	27	both	both	DET
dpc-2259	176	28	physicians	physician	NOUN
dpc-2259	176	29	and	and	CCONJ
dpc-2259	176	30	patients	patient	NOUN
dpc-2259	176	31	[	[	X
dpc-2259	176	32	17	17	NUM
dpc-2259	176	33	]	]	PUNCT
dpc-2259	176	34	.	.	PUNCT
dpc-2259	177	1	covid-19	covid-19	PROPN
dpc-2259	177	2	infection	infection	NOUN
dpc-2259	177	3	is	be	AUX
dpc-2259	177	4	a	a	DET
dpc-2259	177	5	multiphasic	multiphasic	NOUN
dpc-2259	177	6	viral	viral	ADJ
dpc-2259	177	7	disease	disease	NOUN
dpc-2259	177	8	which	which	PRON
dpc-2259	177	9	commences	commence	VERB
dpc-2259	177	10	with	with	ADP
dpc-2259	177	11	an	an	DET
dpc-2259	177	12	antiviral	antiviral	ADJ
dpc-2259	177	13	response	response	NOUN
dpc-2259	177	14	phase	phase	NOUN
dpc-2259	177	15	followed	follow	VERB
dpc-2259	177	16	by	by	ADP
dpc-2259	177	17	an	an	DET
dpc-2259	177	18	hyperinflammatory	hyperinflammatory	ADJ
dpc-2259	177	19	state	state	NOUN
dpc-2259	177	20	[	[	X
dpc-2259	177	21	17,18	17,18	NUM
dpc-2259	177	22	]	]	PUNCT
dpc-2259	177	23	.	.	PUNCT
dpc-2259	178	1	the	the	DET
dpc-2259	178	2	main	main	ADJ
dpc-2259	178	3	cytokines	cytokine	NOUN
dpc-2259	178	4	that	that	PRON
dpc-2259	178	5	dominate	dominate	VERB
dpc-2259	178	6	the	the	DET
dpc-2259	178	7	first	first	ADJ
dpc-2259	178	8	(	(	PUNCT
dpc-2259	178	9	antiviral	antiviral	ADJ
dpc-2259	178	10	)	)	PUNCT
dpc-2259	178	11	phase	phase	NOUN
dpc-2259	178	12	differ	differ	VERB
dpc-2259	178	13	from	from	ADP
dpc-2259	178	14	the	the	DET
dpc-2259	178	15	cytokines	cytokine	NOUN
dpc-2259	178	16	which	which	PRON
dpc-2259	178	17	prevail	prevail	VERB
dpc-2259	178	18	the	the	DET
dpc-2259	178	19	hyperinflammatory	hyperinflammatory	ADJ
dpc-2259	178	20	phase	phase	NOUN
dpc-2259	178	21	[	[	X
dpc-2259	178	22	18	18	NUM
dpc-2259	178	23	]	]	PUNCT
dpc-2259	178	24	.	.	PUNCT
dpc-2259	179	1	interleukin	interleukin	NOUN
dpc-2259	179	2	(	(	PUNCT
dpc-2259	179	3	il)-15	il)-15	PROPN
dpc-2259	179	4	,	,	PUNCT
dpc-2259	179	5	interferon	interferon	NOUN
dpc-2259	179	6	-	-	PUNCT
dpc-2259	179	7	α	α	NOUN
dpc-2259	179	8	,	,	PUNCT
dpc-2259	179	9	interferon	interferon	NOUN
dpc-2259	179	10	-	-	PUNCT
dpc-2259	179	11	β	β	X
dpc-2259	179	12	and	and	CCONJ
dpc-2259	179	13	interferon	interferon	ADJ
dpc-2259	179	14	-	-	PUNCT
dpc-2259	179	15	γ	γ	NOUN
dpc-2259	179	16	 	 	SPACE
dpc-2259	179	17	are	be	AUX
dpc-2259	179	18	the	the	DET
dpc-2259	179	19	major	major	ADJ
dpc-2259	179	20	cytokines	cytokine	NOUN
dpc-2259	179	21	responsible	responsible	ADJ
dpc-2259	179	22	for	for	ADP
dpc-2259	179	23	viral	viral	ADJ
dpc-2259	179	24	clearance	clearance	NOUN
dpc-2259	179	25	whereas	whereas	SCONJ
dpc-2259	179	26	tnf	tnf	PROPN
dpc-2259	179	27	-	-	PUNCT
dpc-2259	179	28	α	α	PROPN
dpc-2259	179	29	,	,	PUNCT
dpc-2259	179	30	il-17	il-17	X
dpc-2259	179	31	,	,	PUNCT
dpc-2259	179	32	il-6	il-6	NOUN
dpc-2259	179	33	and	and	CCONJ
dpc-2259	179	34	granulocyte	granulocyte	ADJ
dpc-2259	179	35	-	-	PUNCT
dpc-2259	179	36	monocyte	monocyte	NOUN
dpc-2259	179	37	colony	colony	NOUN
dpc-2259	179	38	stimulating	stimulate	VERB
dpc-2259	179	39	factor	factor	NOUN
dpc-2259	179	40	preponderate	preponderate	NOUN
dpc-2259	179	41	during	during	ADP
dpc-2259	179	42	the	the	DET
dpc-2259	179	43	hyperinflammatory	hyperinflammatory	ADJ
dpc-2259	179	44	phase	phase	NOUN
dpc-2259	179	45	[	[	X
dpc-2259	179	46	17,18	17,18	X
dpc-2259	179	47	]	]	X
dpc-2259	179	48	.	.	PUNCT
dpc-2259	180	1	therefore	therefore	ADV
dpc-2259	180	2	,	,	PUNCT
dpc-2259	180	3	it	it	PRON
dpc-2259	180	4	seems	seem	VERB
dpc-2259	180	5	reasonable	reasonable	ADJ
dpc-2259	180	6	to	to	PART
dpc-2259	180	7	use	use	VERB
dpc-2259	180	8	anti	anti	ADJ
dpc-2259	180	9	-	-	ADJ
dpc-2259	180	10	tnfα	tnfα	ADJ
dpc-2259	180	11	and	and	CCONJ
dpc-2259	180	12	anti	anti	ADJ
dpc-2259	180	13	-	-	ADJ
dpc-2259	180	14	il-17	il-17	ADJ
dpc-2259	180	15	agents	agent	NOUN
dpc-2259	180	16	during	during	ADP
dpc-2259	180	17	the	the	DET
dpc-2259	180	18	hyperinflammatory	hyperinflammatory	ADJ
dpc-2259	180	19	state	state	NOUN
dpc-2259	180	20	of	of	ADP
dpc-2259	180	21	covid-19	covid-19	PROPN
dpc-2259	180	22	since	since	SCONJ
dpc-2259	180	23	these	these	DET
dpc-2259	180	24	agents	agent	NOUN
dpc-2259	180	25	do	do	AUX
dpc-2259	180	26	not	not	PART
dpc-2259	180	27	seem	seem	VERB
dpc-2259	180	28	to	to	PART
dpc-2259	180	29	affect	affect	VERB
dpc-2259	180	30	the	the	DET
dpc-2259	180	31	course	course	NOUN
dpc-2259	180	32	of	of	ADP
dpc-2259	180	33	the	the	DET
dpc-2259	180	34	antiviral	antiviral	ADJ
dpc-2259	180	35	phase	phase	NOUN
dpc-2259	180	36	[	[	X
dpc-2259	180	37	18	18	NUM
dpc-2259	180	38	]	]	PUNCT
dpc-2259	180	39	.	.	PUNCT
dpc-2259	181	1	in	in	ADP
dpc-2259	181	2	phase	phase	NOUN
dpc-2259	181	3	3	3	NUM
dpc-2259	181	4	trials	trial	NOUN
dpc-2259	181	5	of	of	ADP
dpc-2259	181	6	adalimumab	adalimumab	NOUN
dpc-2259	181	7	for	for	ADP
dpc-2259	181	8	hs	hs	PROPN
dpc-2259	181	9	,	,	PUNCT
dpc-2259	181	10	it	it	PRON
dpc-2259	181	11	was	be	AUX
dpc-2259	181	12	shown	show	VERB
dpc-2259	181	13	that	that	SCONJ
dpc-2259	181	14	there	there	PRON
dpc-2259	181	15	is	be	VERB
dpc-2259	181	16	a	a	DET
dpc-2259	181	17	slightly	slightly	ADV
dpc-2259	181	18	escalated	escalate	VERB
dpc-2259	181	19	risk	risk	NOUN
dpc-2259	181	20	for	for	ADP
dpc-2259	181	21	total	total	ADJ
dpc-2259	181	22	infections	infection	NOUN
dpc-2259	181	23	and	and	CCONJ
dpc-2259	181	24	nasopharyngitis	nasopharyngitis	NOUN
dpc-2259	181	25	by	by	ADP
dpc-2259	181	26	2.5	2.5	NUM
dpc-2259	181	27	%	%	NOUN
dpc-2259	181	28	but	but	CCONJ
dpc-2259	181	29	there	there	PRON
dpc-2259	181	30	was	be	VERB
dpc-2259	181	31	no	no	DET
dpc-2259	181	32	significant	significant	ADJ
dpc-2259	181	33	difference	difference	NOUN
dpc-2259	181	34	between	between	ADP
dpc-2259	181	35	adalimumab	adalimumab	NOUN
dpc-2259	181	36	and	and	CCONJ
dpc-2259	181	37	placebo	placebo	NOUN
dpc-2259	181	38	group	group	NOUN
dpc-2259	181	39	in	in	ADP
dpc-2259	181	40	terms	term	NOUN
dpc-2259	181	41	of	of	ADP
dpc-2259	181	42	upper	upper	ADJ
dpc-2259	181	43	respiratory	respiratory	ADJ
dpc-2259	181	44	tract	tract	NOUN
dpc-2259	181	45	infections	infection	NOUN
dpc-2259	181	46	[	[	X
dpc-2259	181	47	19	19	NUM
dpc-2259	181	48	]	]	PUNCT
dpc-2259	181	49	.	.	PUNCT
dpc-2259	182	1	in	in	ADP
dpc-2259	182	2	line	line	NOUN
dpc-2259	182	3	with	with	ADP
dpc-2259	182	4	this	this	DET
dpc-2259	182	5	observation	observation	NOUN
dpc-2259	182	6	,	,	PUNCT
dpc-2259	182	7	in	in	ADP
dpc-2259	182	8	our	our	PRON
dpc-2259	182	9	study	study	NOUN
dpc-2259	182	10	we	we	PRON
dpc-2259	182	11	found	find	VERB
dpc-2259	182	12	that	that	SCONJ
dpc-2259	182	13	no	no	DET
dpc-2259	182	14	statistically	statistically	ADV
dpc-2259	182	15	significant	significant	ADJ
dpc-2259	182	16	relationship	relationship	NOUN
dpc-2259	182	17	exists	exist	VERB
dpc-2259	182	18	between	between	ADP
dpc-2259	182	19	covid-19	covid-19	PROPN
dpc-2259	182	20	real	real	ADJ
dpc-2259	182	21	-	-	PUNCT
dpc-2259	182	22	time	time	NOUN
dpc-2259	182	23	pcr	pcr	NOUN
dpc-2259	182	24	positivity	positivity	NOUN
dpc-2259	182	25	and	and	CCONJ
dpc-2259	182	26	the	the	DET
dpc-2259	182	27	therapeutic	therapeutic	ADJ
dpc-2259	182	28	interventions	intervention	NOUN
dpc-2259	182	29	used	use	VERB
dpc-2259	182	30	for	for	ADP
dpc-2259	182	31	hs	hs	PRON
dpc-2259	182	32	when	when	SCONJ
dpc-2259	182	33	the	the	DET
dpc-2259	182	34	treatment	treatment	NOUN
dpc-2259	182	35	modalities	modality	NOUN
dpc-2259	182	36	are	be	AUX
dpc-2259	182	37	divided	divide	VERB
dpc-2259	182	38	into	into	ADP
dpc-2259	182	39	four	four	NUM
dpc-2259	182	40	categories	category	NOUN
dpc-2259	182	41	as	as	ADP
dpc-2259	182	42	oral	oral	ADJ
dpc-2259	182	43	antibiotics	antibiotic	NOUN
dpc-2259	182	44	±	±	NOUN
dpc-2259	182	45	topical	topical	ADJ
dpc-2259	182	46	antibiotics	antibiotic	NOUN
dpc-2259	182	47	,	,	PUNCT
dpc-2259	182	48	oral	oral	ADJ
dpc-2259	182	49	retinoids	retinoid	NOUN
dpc-2259	182	50	±	±	NOUN
dpc-2259	182	51	topical	topical	ADJ
dpc-2259	182	52	antibiotics	antibiotic	NOUN
dpc-2259	182	53	,	,	PUNCT
dpc-2259	182	54	tnf	tnf	PROPN
dpc-2259	182	55	-	-	PUNCT
dpc-2259	182	56	α	α	PROPN
dpc-2259	182	57	inhibitors	inhibitor	NOUN
dpc-2259	182	58	±	±	NOUN
dpc-2259	182	59	oral	oral	ADJ
dpc-2259	182	60	/	/	SYM
dpc-2259	182	61	topical	topical	ADJ
dpc-2259	182	62	antibiotics	antibiotic	NOUN
dpc-2259	182	63	and	and	CCONJ
dpc-2259	182	64	only	only	ADV
dpc-2259	182	65	topical	topical	ADJ
dpc-2259	182	66	antibiotics	antibiotic	NOUN
dpc-2259	182	67	(	(	PUNCT
dpc-2259	182	68	p	p	X
dpc-2259	182	69	=	=	NOUN
dpc-2259	182	70	0.657	0.657	NUM
dpc-2259	182	71	)	)	PUNCT
dpc-2259	182	72	.	.	PUNCT
dpc-2259	183	1	also	also	ADV
dpc-2259	183	2	,	,	PUNCT
dpc-2259	183	3	similar	similar	ADJ
dpc-2259	183	4	to	to	ADP
dpc-2259	183	5	our	our	PRON
dpc-2259	183	6	study	study	NOUN
dpc-2259	183	7	,	,	PUNCT
dpc-2259	183	8	marasca	marasca	PROPN
dpc-2259	183	9	et	et	PROPN
dpc-2259	183	10	al	al	PROPN
dpc-2259	184	1	[	[	X
dpc-2259	184	2	20	20	NUM
dpc-2259	184	3	]	]	PUNCT
dpc-2259	184	4	reported	report	VERB
dpc-2259	184	5	their	their	PRON
dpc-2259	184	6	experience	experience	NOUN
dpc-2259	184	7	with	with	ADP
dpc-2259	184	8	93	93	NUM
dpc-2259	184	9	hs	hs	PROPN
dpc-2259	184	10	patients	patient	NOUN
dpc-2259	184	11	during	during	ADP
dpc-2259	184	12	covid-19	covid-19	PROPN
dpc-2259	184	13	pandemic	pandemic	NOUN
dpc-2259	184	14	.	.	PUNCT
dpc-2259	185	1	in	in	ADP
dpc-2259	185	2	this	this	DET
dpc-2259	185	3	study	study	NOUN
dpc-2259	185	4	,	,	PUNCT
dpc-2259	185	5	75	75	NUM
dpc-2259	185	6	patients	patient	NOUN
dpc-2259	185	7	were	be	AUX
dpc-2259	185	8	on	on	ADP
dpc-2259	185	9	adalimumab	adalimumab	NOUN
dpc-2259	185	10	treatment	treatment	NOUN
dpc-2259	185	11	,	,	PUNCT
dpc-2259	185	12	15	15	NUM
dpc-2259	185	13	  	  	SPACE
dpc-2259	185	14	patients	patient	NOUN
dpc-2259	185	15	were	be	AUX
dpc-2259	185	16	using	use	VERB
dpc-2259	185	17	oral	oral	ADJ
dpc-2259	185	18	antibiotics	antibiotic	NOUN
dpc-2259	185	19	and	and	CCONJ
dpc-2259	185	20	3	3	NUM
dpc-2259	185	21	patients	patient	NOUN
dpc-2259	185	22	were	be	AUX
dpc-2259	185	23	not	not	PART
dpc-2259	185	24	on	on	ADP
dpc-2259	185	25	any	any	DET
dpc-2259	185	26	treatment	treatment	NOUN
dpc-2259	185	27	[	[	X
dpc-2259	185	28	20	20	NUM
dpc-2259	185	29	]	]	PUNCT
dpc-2259	185	30	.	.	PUNCT
dpc-2259	186	1	only	only	ADV
dpc-2259	186	2	one	one	NUM
dpc-2259	186	3	patient	patient	NOUN
dpc-2259	186	4	reported	report	VERB
dpc-2259	186	5	covid-19	covid-19	PROPN
dpc-2259	186	6	related	related	ADJ
dpc-2259	186	7	symptoms	symptom	NOUN
dpc-2259	186	8	which	which	PRON
dpc-2259	186	9	subsided	subside	VERB
dpc-2259	186	10	immediately	immediately	ADV
dpc-2259	186	11	and	and	CCONJ
dpc-2259	186	12	three	three	NUM
dpc-2259	186	13	patients	patient	NOUN
dpc-2259	186	14	(	(	PUNCT
dpc-2259	186	15	one	one	NUM
dpc-2259	186	16	under	under	ADP
dpc-2259	186	17	rifampicin+clindamycin	rifampicin+clindamycin	PROPN
dpc-2259	186	18	treatment	treatment	NOUN
dpc-2259	186	19	,	,	PUNCT
dpc-2259	186	20	the	the	DET
dpc-2259	186	21	two	two	NUM
dpc-2259	186	22	others	other	NOUN
dpc-2259	186	23	under	under	ADP
dpc-2259	186	24	adalimumab	adalimumab	NOUN
dpc-2259	186	25	treatment	treatment	NOUN
dpc-2259	186	26	)	)	PUNCT
dpc-2259	186	27	had	have	AUX
dpc-2259	186	28	been	be	AUX
dpc-2259	186	29	isolated	isolate	VERB
dpc-2259	186	30	due	due	ADP
dpc-2259	186	31	to	to	ADP
dpc-2259	186	32	a	a	DET
dpc-2259	186	33	close	close	ADJ
dpc-2259	186	34	contact	contact	NOUN
dpc-2259	186	35	to	to	ADP
dpc-2259	186	36	someone	someone	PRON
dpc-2259	186	37	with	with	ADP
dpc-2259	186	38	a	a	DET
dpc-2259	186	39	suspected	suspect	VERB
dpc-2259	186	40	diagnosis	diagnosis	NOUN
dpc-2259	186	41	of	of	ADP
dpc-2259	186	42	covid-19	covid-19	PROPN
dpc-2259	186	43	,	,	PUNCT
dpc-2259	186	44	without	without	ADP
dpc-2259	186	45	having	have	VERB
dpc-2259	186	46	positive	positive	ADJ
dpc-2259	186	47	real	real	ADJ
dpc-2259	186	48	-	-	PUNCT
dpc-2259	186	49	time	time	NOUN
dpc-2259	186	50	pcr	pcr	PROPN
dpc-2259	186	51	test	test	NOUN
dpc-2259	186	52	result	result	NOUN
dpc-2259	186	53	[	[	X
dpc-2259	186	54	20	20	NUM
dpc-2259	186	55	]	]	PUNCT
dpc-2259	186	56	.	.	PUNCT
dpc-2259	187	1	furthermore	furthermore	ADV
dpc-2259	187	2	,	,	PUNCT
dpc-2259	187	3	molinelli	molinelli	NOUN
dpc-2259	187	4	et	et	PROPN
dpc-2259	187	5	al	al	PROPN
dpc-2259	187	6	[	[	X
dpc-2259	187	7	21	21	NUM
dpc-2259	187	8	]	]	PUNCT
dpc-2259	187	9	declared	declare	VERB
dpc-2259	187	10	that	that	SCONJ
dpc-2259	187	11	none	none	NOUN
dpc-2259	187	12	of	of	ADP
dpc-2259	187	13	the	the	DET
dpc-2259	187	14	35	35	NUM
dpc-2259	187	15	patients	patient	NOUN
dpc-2259	187	16	treated	treat	VERB
dpc-2259	187	17	with	with	ADP
dpc-2259	187	18	adalimumab	adalimumab	NOUN
dpc-2259	187	19	for	for	ADP
dpc-2259	187	20	hs	hs	PROPN
dpc-2259	187	21	in	in	ADP
dpc-2259	187	22	their	their	PRON
dpc-2259	187	23	cohort	cohort	NOUN
dpc-2259	187	24	group	group	NOUN
dpc-2259	187	25	had	have	VERB
dpc-2259	187	26	any	any	DET
dpc-2259	187	27	symptoms	symptom	NOUN
dpc-2259	187	28	related	relate	VERB
dpc-2259	187	29	to	to	ADP
dpc-2259	187	30	covid-19	covid-19	PROPN
dpc-2259	187	31	and	and	CCONJ
dpc-2259	187	32	the	the	DET
dpc-2259	187	33	ongoing	ongoing	ADJ
dpc-2259	187	34	biologic	biologic	NOUN
dpc-2259	187	35	treatment	treatment	NOUN
dpc-2259	187	36	was	be	AUX
dpc-2259	187	37	not	not	PART
dpc-2259	187	38	discontinued	discontinue	VERB
dpc-2259	187	39	in	in	ADP
dpc-2259	187	40	any	any	DET
dpc-2259	187	41	patient	patient	NOUN
dpc-2259	187	42	.	.	PUNCT
dpc-2259	188	1	supporting	support	VERB
dpc-2259	188	2	the	the	DET
dpc-2259	188	3	findings	finding	NOUN
dpc-2259	188	4	of	of	ADP
dpc-2259	188	5	this	this	DET
dpc-2259	188	6	study	study	NOUN
dpc-2259	188	7	,	,	PUNCT
dpc-2259	188	8	we	we	PRON
dpc-2259	188	9	also	also	ADV
dpc-2259	188	10	did	do	AUX
dpc-2259	188	11	not	not	PART
dpc-2259	188	12	find	find	VERB
dpc-2259	188	13	any	any	DET
dpc-2259	188	14	statistically	statistically	ADV
dpc-2259	188	15	significant	significant	ADJ
dpc-2259	188	16	difference	difference	NOUN
dpc-2259	188	17	between	between	ADP
dpc-2259	188	18	the	the	DET
dpc-2259	188	19	presence	presence	NOUN
dpc-2259	188	20	of	of	ADP
dpc-2259	188	21	covid-19	covid-19	PROPN
dpc-2259	188	22	symptoms	symptom	NOUN
dpc-2259	188	23	and	and	CCONJ
dpc-2259	188	24	the	the	DET
dpc-2259	188	25	given	give	VERB
dpc-2259	188	26	treatment	treatment	NOUN
dpc-2259	188	27	modalities	modality	NOUN
dpc-2259	188	28	when	when	SCONJ
dpc-2259	188	29	categorized	categorize	VERB
dpc-2259	188	30	as	as	ADP
dpc-2259	188	31	oral	oral	ADJ
dpc-2259	188	32	antibiotics±	antibiotics±	NOUN
dpc-2259	188	33	topical	topical	ADJ
dpc-2259	188	34	antibiotics	antibiotic	NOUN
dpc-2259	188	35	,	,	PUNCT
dpc-2259	188	36	oral	oral	ADJ
dpc-2259	188	37	retinoid	retinoid	NOUN
dpc-2259	188	38	,	,	PUNCT
dpc-2259	188	39	tnf	tnf	PROPN
dpc-2259	188	40	-	-	PUNCT
dpc-2259	188	41	α	α	PROPN
dpc-2259	188	42	inhibitors	inhibitor	NOUN
dpc-2259	188	43	±	±	NOUN
dpc-2259	188	44	oral	oral	ADJ
dpc-2259	188	45	/	/	SYM
dpc-2259	188	46	topical	topical	ADJ
dpc-2259	188	47	antibiotics	antibiotic	NOUN
dpc-2259	188	48	and	and	CCONJ
dpc-2259	188	49	topical	topical	ADJ
dpc-2259	188	50	antibiotics	antibiotic	NOUN
dpc-2259	188	51	(	(	PUNCT
dpc-2259	188	52	p	p	X
dpc-2259	188	53	=	=	NOUN
dpc-2259	188	54	0.124	0.124	NUM
dpc-2259	188	55	)	)	PUNCT
dpc-2259	188	56	.	.	PUNCT
dpc-2259	189	1	original	original	ADJ
dpc-2259	189	2	article	article	NOUN
dpc-2259	189	3	|	|	ADV
dpc-2259	189	4	dermatol	dermatol	ADJ
dpc-2259	189	5	pract	pract	NOUN
dpc-2259	189	6	concept	concept	NOUN
dpc-2259	189	7	.	.	PUNCT
dpc-2259	190	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	190	2	9	9	NUM
dpc-2259	190	3	10	10	NUM
dpc-2259	190	4	.	.	PUNCT
dpc-2259	191	1	giamarellos	giamarello	NOUN
dpc-2259	191	2	-	-	PUNCT
dpc-2259	191	3	bourboulis	bourboulis	PROPN
dpc-2259	191	4	ej	ej	PROPN
dpc-2259	191	5	,	,	PUNCT
dpc-2259	191	6	bettoli	bettoli	ADP
dpc-2259	191	7	v	v	NOUN
dpc-2259	191	8	,	,	PUNCT
dpc-2259	191	9	jemec	jemec	PROPN
dpc-2259	191	10	gbe	gbe	PROPN
dpc-2259	191	11	,	,	PUNCT
dpc-2259	191	12	et	et	PROPN
dpc-2259	191	13	al	al	PROPN
dpc-2259	191	14	.	.	PUNCT
dpc-2259	192	1	anti	anti	ADJ
dpc-2259	192	2	-	-	ADJ
dpc-2259	192	3	covid-19	covid-19	ADJ
dpc-2259	192	4	measurements	measurement	NOUN
dpc-2259	192	5	for	for	ADP
dpc-2259	192	6	hidradenitis	hidradenitis	PROPN
dpc-2259	192	7	suppurativa	suppurativa	NOUN
dpc-2259	192	8	patients	patient	NOUN
dpc-2259	192	9	.	.	PUNCT
dpc-2259	193	1	exp	exp	NOUN
dpc-2259	193	2	dermatol	dermatol	NOUN
dpc-2259	193	3	.	.	PUNCT
dpc-2259	194	1	2021;30	2021;30	NUM
dpc-2259	194	2	suppl	suppl	ADJ
dpc-2259	195	1	1(suppl	1(suppl	NUM
dpc-2259	195	2	1):18	1):18	NUM
dpc-2259	195	3	-	-	SYM
dpc-2259	195	4	22	22	NUM
dpc-2259	195	5	.	.	PUNCT
dpc-2259	196	1	doi	doi	NOUN
dpc-2259	196	2	:	:	PUNCT
dpc-2259	196	3	10.1111	10.1111	NUM
dpc-2259	196	4	/	/	SYM
dpc-2259	196	5	exd.14339	exd.14339	PROPN
dpc-2259	196	6	.	.	PUNCT
dpc-2259	197	1	pmid	pmid	NOUN
dpc-2259	197	2	:	:	PUNCT
dpc-2259	197	3	34085330	34085330	NUM
dpc-2259	197	4	.	.	PUNCT
dpc-2259	198	1	pmcid	pmcid	NOUN
dpc-2259	198	2	:	:	PUNCT
dpc-2259	198	3	pmc8207032	pmc8207032	ADJ
dpc-2259	198	4	.	.	PUNCT
dpc-2259	199	1	11	11	NUM
dpc-2259	199	2	.	.	PUNCT
dpc-2259	200	1	wolk	wolk	PROPN
dpc-2259	200	2	k	k	PROPN
dpc-2259	200	3	,	,	PUNCT
dpc-2259	200	4	join	join	NOUN
dpc-2259	200	5	-	-	PUNCT
dpc-2259	200	6	lambert	lambert	PROPN
dpc-2259	200	7	o	o	PROPN
dpc-2259	200	8	,	,	PUNCT
dpc-2259	200	9	sabat	sabat	PROPN
dpc-2259	200	10	r.	r.	PROPN
dpc-2259	200	11	aetiology	aetiology	PROPN
dpc-2259	200	12	and	and	CCONJ
dpc-2259	200	13	pathogenesis	pathogenesis	NOUN
dpc-2259	200	14	of	of	ADP
dpc-2259	200	15	hidradenitis	hidradenitis	PROPN
dpc-2259	200	16	suppurativa	suppurativa	PROPN
dpc-2259	200	17	.	.	PUNCT
dpc-2259	201	1	br	br	PROPN
dpc-2259	201	2	j	j	PROPN
dpc-2259	201	3	dermatol	dermatol	NOUN
dpc-2259	201	4	.	.	PUNCT
dpc-2259	202	1	2020;183(6):999	2020;183(6):999	NUM
dpc-2259	202	2	-	-	SYM
dpc-2259	202	3	1010	1010	NUM
dpc-2259	202	4	.	.	PUNCT
dpc-2259	203	1	doi	doi	NOUN
dpc-2259	203	2	:	:	PUNCT
dpc-2259	203	3	10.1111	10.1111	NUM
dpc-2259	203	4	/	/	SYM
dpc-2259	203	5	bjd.19556	bjd.19556	PROPN
dpc-2259	203	6	.	.	PUNCT
dpc-2259	203	7	pmid	pmid	NOUN
dpc-2259	203	8	:	:	PUNCT
dpc-2259	203	9	33048349	33048349	NUM
dpc-2259	203	10	.	.	PUNCT
dpc-2259	204	1	12	12	NUM
dpc-2259	204	2	.	.	PUNCT
dpc-2259	205	1	vazquez	vazquez	PROPN
dpc-2259	205	2	bg	bg	PROPN
dpc-2259	205	3	,	,	PUNCT
dpc-2259	205	4	alikhan	alikhan	ADV
dpc-2259	205	5	a	a	PRON
dpc-2259	205	6	,	,	PUNCT
dpc-2259	205	7	weaver	weaver	PROPN
dpc-2259	205	8	al	al	PROPN
dpc-2259	205	9	,	,	PUNCT
dpc-2259	205	10	wetter	wetter	ADJ
dpc-2259	205	11	da	da	PROPN
dpc-2259	205	12	,	,	PUNCT
dpc-2259	205	13	davis	davis	PROPN
dpc-2259	205	14	md	md	PROPN
dpc-2259	205	15	.	.	PROPN
dpc-2259	205	16	incidence	incidence	NOUN
dpc-2259	205	17	of	of	ADP
dpc-2259	205	18	hidradenitis	hidradenitis	PROPN
dpc-2259	205	19	suppurativa	suppurativa	NOUN
dpc-2259	205	20	and	and	CCONJ
dpc-2259	205	21	associated	associated	ADJ
dpc-2259	205	22	factors	factor	NOUN
dpc-2259	205	23	:	:	PUNCT
dpc-2259	205	24	a	a	DET
dpc-2259	205	25	population	population	NOUN
dpc-2259	205	26	-	-	PUNCT
dpc-2259	205	27	based	base	VERB
dpc-2259	205	28	study	study	NOUN
dpc-2259	205	29	of	of	ADP
dpc-2259	205	30	olmsted	olmsted	PROPN
dpc-2259	205	31	county	county	PROPN
dpc-2259	205	32	,	,	PUNCT
dpc-2259	205	33	minnesota	minnesota	PROPN
dpc-2259	205	34	.	.	PUNCT
dpc-2259	206	1	j	j	PROPN
dpc-2259	206	2	invest	invest	VERB
dpc-2259	206	3	dermatol	dermatol	NOUN
dpc-2259	206	4	.	.	PUNCT
dpc-2259	207	1	2013;133(1):97	2013;133(1):97	NUM
dpc-2259	207	2	-	-	SYM
dpc-2259	207	3	103	103	NUM
dpc-2259	207	4	.	.	PUNCT
dpc-2259	208	1	doi	doi	NOUN
dpc-2259	208	2	:	:	PUNCT
dpc-2259	208	3	10.1038	10.1038	NUM
dpc-2259	208	4	/	/	SYM
dpc-2259	208	5	jid.2012.255	jid.2012.255	PROPN
dpc-2259	208	6	.	.	PUNCT
dpc-2259	209	1	pmid	pmid	NOUN
dpc-2259	209	2	:	:	PUNCT
dpc-2259	209	3	22931916	22931916	NUM
dpc-2259	209	4	.	.	PUNCT
dpc-2259	210	1	pmcid	pmcid	NOUN
dpc-2259	210	2	:	:	PUNCT
dpc-2259	210	3	pmc3541436	pmc3541436	NOUN
dpc-2259	210	4	.	.	PUNCT
dpc-2259	211	1	13	13	NUM
dpc-2259	211	2	.	.	X
dpc-2259	211	3	saunte	saunte	PROPN
dpc-2259	211	4	dm	dm	PROPN
dpc-2259	211	5	,	,	PUNCT
dpc-2259	211	6	boer	boer	PROPN
dpc-2259	211	7	j	j	PROPN
dpc-2259	211	8	,	,	PUNCT
dpc-2259	211	9	stratigos	stratigos	VERB
dpc-2259	211	10	a	a	PRON
dpc-2259	211	11	,	,	PUNCT
dpc-2259	211	12	et	et	PROPN
dpc-2259	211	13	al	al	PROPN
dpc-2259	211	14	.	.	PUNCT
dpc-2259	211	15	diagnostic	diagnostic	ADJ
dpc-2259	211	16	delay	delay	NOUN
dpc-2259	211	17	in	in	ADP
dpc-2259	211	18	hidradenitis	hidradenitis	PROPN
dpc-2259	211	19	suppurativa	suppurativa	PROPN
dpc-2259	211	20	is	be	AUX
dpc-2259	211	21	a	a	DET
dpc-2259	211	22	global	global	ADJ
dpc-2259	211	23	problem	problem	NOUN
dpc-2259	211	24	.	.	PUNCT
dpc-2259	212	1	br	br	PROPN
dpc-2259	212	2	j	j	PROPN
dpc-2259	212	3	dermatol	dermatol	NOUN
dpc-2259	212	4	.	.	PUNCT
dpc-2259	213	1	2015;173(6):1546	2015;173(6):1546	NUM
dpc-2259	213	2	-	-	SYM
dpc-2259	213	3	1549	1549	NUM
dpc-2259	213	4	.	.	PUNCT
dpc-2259	214	1	doi	doi	NOUN
dpc-2259	214	2	:	:	PUNCT
dpc-2259	214	3	10.1111	10.1111	NUM
dpc-2259	214	4	/	/	SYM
dpc-2259	214	5	bjd.14038	bjd.14038	PROPN
dpc-2259	214	6	.	.	PUNCT
dpc-2259	215	1	pmid	pmid	NOUN
dpc-2259	215	2	:	:	PUNCT
dpc-2259	215	3	26	26	NUM
dpc-2259	215	4	198191	198191	NUM
dpc-2259	215	5	.	.	PUNCT
dpc-2259	216	1	14	14	NUM
dpc-2259	216	2	.	.	PUNCT
dpc-2259	217	1	miller	miller	PROPN
dpc-2259	217	2	i	i	PRON
dpc-2259	217	3	m	m	PROPN
dpc-2259	217	4	,	,	PUNCT
dpc-2259	217	5	mcandrew	mcandrew	PROPN
dpc-2259	217	6	rj	rj	PROPN
dpc-2259	217	7	,	,	PUNCT
dpc-2259	217	8	hamzavi	hamzavi	PROPN
dpc-2259	217	9	i.	i.	PROPN
dpc-2259	217	10	prevalence	prevalence	PROPN
dpc-2259	217	11	,	,	PUNCT
dpc-2259	217	12	risk	risk	NOUN
dpc-2259	217	13	factors	factor	NOUN
dpc-2259	217	14	,	,	PUNCT
dpc-2259	217	15	and	and	CCONJ
dpc-2259	217	16	comorbidities	comorbiditie	NOUN
dpc-2259	217	17	of	of	ADP
dpc-2259	217	18	hidradenitis	hidradenitis	PROPN
dpc-2259	217	19	suppurativa	suppurativa	PROPN
dpc-2259	217	20	.	.	PUNCT
dpc-2259	218	1	dermatol	dermatol	PROPN
dpc-2259	218	2	clin	clin	PROPN
dpc-2259	218	3	.	.	PUNCT
dpc-2259	219	1	2016;34(1):7	2016;34(1):7	NUM
dpc-2259	219	2	-	-	SYM
dpc-2259	219	3	16	16	NUM
dpc-2259	219	4	.	.	PUNCT
dpc-2259	220	1	doi	doi	NOUN
dpc-2259	220	2	:	:	PUNCT
dpc-2259	220	3	10.1016	10.1016	NUM
dpc-2259	220	4	/	/	SYM
dpc-2259	220	5	j.det.2015.08.002	j.det.2015.08.002	NOUN
dpc-2259	220	6	.	.	PUNCT
dpc-2259	221	1	pmid	pmid	NOUN
dpc-2259	221	2	:	:	PUNCT
dpc-2259	221	3	26617352	26617352	NUM
dpc-2259	221	4	.	.	PUNCT
dpc-2259	222	1	15	15	NUM
dpc-2259	222	2	.	.	X
dpc-2259	222	3	yuan	yuan	PROPN
dpc-2259	222	4	jt	jt	PROPN
dpc-2259	222	5	,	,	PUNCT
dpc-2259	222	6	naik	naik	PROPN
dpc-2259	222	7	hb	hb	PROPN
dpc-2259	222	8	.	.	PUNCT
dpc-2259	222	9	complications	complication	NOUN
dpc-2259	222	10	of	of	ADP
dpc-2259	222	11	hidradenitis	hidradenitis	PROPN
dpc-2259	222	12	suppurativa	suppurativa	PROPN
dpc-2259	222	13	.	.	PUNCT
dpc-2259	223	1	semin	semin	PROPN
dpc-2259	223	2	cutan	cutan	PROPN
dpc-2259	223	3	med	med	PROPN
dpc-2259	223	4	surg	surg	NOUN
dpc-2259	223	5	.	.	PUNCT
dpc-2259	224	1	2017;36(2):79	2017;36(2):79	NUM
dpc-2259	224	2	-	-	SYM
dpc-2259	224	3	85	85	NUM
dpc-2259	224	4	.	.	PUNCT
dpc-2259	225	1	doi	doi	NOUN
dpc-2259	225	2	:	:	PUNCT
dpc-2259	225	3	10.12788	10.12788	NUM
dpc-2259	225	4	/	/	SYM
dpc-2259	225	5	j.	j.	PROPN
dpc-2259	225	6	sder.2017.022	sder.2017.022	PROPN
dpc-2259	225	7	.	.	PUNCT
dpc-2259	226	1	pmid	pmid	NOUN
dpc-2259	226	2	:	:	PUNCT
dpc-2259	226	3	28538749	28538749	NUM
dpc-2259	226	4	.	.	PUNCT
dpc-2259	227	1	16	16	NUM
dpc-2259	227	2	.	.	PUNCT
dpc-2259	228	1	agrawal	agrawal	PROPN
dpc-2259	228	2	a	a	PRON
dpc-2259	228	3	,	,	PUNCT
dpc-2259	228	4	sharma	sharma	PROPN
dpc-2259	228	5	yk	yk	PROPN
dpc-2259	228	6	.	.	PROPN
dpc-2259	229	1	errata	errata	PROPN
dpc-2259	229	2	:	:	PUNCT
dpc-2259	229	3	review	review	NOUN
dpc-2259	229	4	article	article	NOUN
dpc-2259	229	5	:	:	PUNCT
dpc-2259	229	6	hidradenitis	hidradenitis	PROPN
dpc-2259	229	7	suppurativa	suppurativa	PROPN
dpc-2259	229	8	:	:	PUNCT
dpc-2259	229	9	a	a	DET
dpc-2259	229	10	systematic	systematic	ADJ
dpc-2259	229	11	review	review	NOUN
dpc-2259	229	12	and	and	CCONJ
dpc-2259	229	13	meta	meta	NOUN
dpc-2259	229	14	-	-	PUNCT
dpc-2259	229	15	analysis	analysis	NOUN
dpc-2259	229	16	of	of	ADP
dpc-2259	229	17	therapeutic	therapeutic	ADJ
dpc-2259	229	18	interventions	intervention	NOUN
dpc-2259	229	19	.	.	PUNCT
dpc-2259	230	1	indian	indian	PROPN
dpc-2259	230	2	j	j	PROPN
dpc-2259	230	3	dermatol	dermatol	PROPN
dpc-2259	230	4	venereol	venereol	ADJ
dpc-2259	230	5	leprol	leprol	NOUN
dpc-2259	230	6	.	.	PUNCT
dpc-2259	231	1	2019;85(6):617	2019;85(6):617	NUM
dpc-2259	231	2	.	.	PUNCT
dpc-2259	232	1	doi	doi	NOUN
dpc-2259	232	2	:	:	PUNCT
dpc-2259	232	3	10.4103	10.4103	NUM
dpc-2259	232	4	/	/	SYM
dpc-2259	232	5	ijdvl.ijdvl_453_19	ijdvl.ijdvl_453_19	PROPN
dpc-2259	232	6	.	.	PUNCT
dpc-2259	233	1	pmid	pmid	NOUN
dpc-2259	233	2	:	:	PUNCT
dpc-2259	233	3	31512583	31512583	NUM
dpc-2259	233	4	.	.	PUNCT
dpc-2259	234	1	17	17	NUM
dpc-2259	234	2	.	.	PUNCT
dpc-2259	235	1	jones	jones	PROPN
dpc-2259	235	2	me	i	PRON
dpc-2259	235	3	,	,	PUNCT
dpc-2259	235	4	kohn	kohn	PROPN
dpc-2259	235	5	ah	ah	INTJ
dpc-2259	235	6	,	,	PUNCT
dpc-2259	235	7	pourali	pourali	PROPN
dpc-2259	235	8	sp	sp	PROPN
dpc-2259	235	9	,	,	PUNCT
dpc-2259	235	10	et	et	PROPN
dpc-2259	235	11	al	al	PROPN
dpc-2259	235	12	.	.	PUNCT
dpc-2259	236	1	the	the	DET
dpc-2259	236	2	use	use	NOUN
dpc-2259	236	3	of	of	ADP
dpc-2259	236	4	biologics	biologic	NOUN
dpc-2259	236	5	during	during	ADP
dpc-2259	236	6	the	the	DET
dpc-2259	236	7	covid-19	covid-19	PROPN
dpc-2259	236	8	pandemic	pandemic	NOUN
dpc-2259	236	9	.	.	PUNCT
dpc-2259	237	1	dermatol	dermatol	NOUN
dpc-2259	237	2	clin	clin	PROPN
dpc-2259	237	3	.	.	PUNCT
dpc-2259	238	1	2021;39(4):545	2021;39(4):545	NUM
dpc-2259	238	2	-	-	SYM
dpc-2259	238	3	553	553	NUM
dpc-2259	238	4	.	.	PUNCT
dpc-2259	239	1	doi	doi	NOUN
dpc-2259	239	2	:	:	PUNCT
dpc-2259	239	3	10.1016	10.1016	NUM
dpc-2259	239	4	/	/	SYM
dpc-2259	239	5	j.det.2021.05.010	j.det.2021.05.010	PROPN
dpc-2259	239	6	.	.	PUNCT
dpc-2259	240	1	pmid	pmid	NOUN
dpc-2259	240	2	:	:	PUNCT
dpc-2259	240	3	34556244	34556244	NUM
dpc-2259	240	4	.	.	PUNCT
dpc-2259	241	1	pmcid	pmcid	NOUN
dpc-2259	241	2	:	:	PUNCT
dpc-2259	241	3	pmc8166518	pmc8166518	NOUN
dpc-2259	241	4	.	.	PUNCT
dpc-2259	242	1	18	18	NUM
dpc-2259	242	2	.	.	PUNCT
dpc-2259	242	3	schett	schett	PROPN
dpc-2259	242	4	g	g	PROPN
dpc-2259	242	5	,	,	PUNCT
dpc-2259	242	6	sticherling	sticherle	VERB
dpc-2259	242	7	m	m	PROPN
dpc-2259	242	8	,	,	PUNCT
dpc-2259	242	9	neurath	neurath	PROPN
dpc-2259	242	10	mf	mf	PROPN
dpc-2259	242	11	.	.	PUNCT
dpc-2259	243	1	covid-19	covid-19	PROPN
dpc-2259	243	2	:	:	PUNCT
dpc-2259	243	3	risk	risk	NOUN
dpc-2259	243	4	for	for	ADP
dpc-2259	243	5	cytokine	cytokine	NOUN
dpc-2259	243	6	targeting	target	VERB
dpc-2259	243	7	in	in	ADP
dpc-2259	243	8	chronic	chronic	ADJ
dpc-2259	243	9	inflammatory	inflammatory	ADJ
dpc-2259	243	10	diseases	disease	NOUN
dpc-2259	243	11	?	?	PUNCT
dpc-2259	244	1	nat	nat	PROPN
dpc-2259	244	2	rev	rev	VERB
dpc-2259	244	3	immunol	immunol	NOUN
dpc-2259	244	4	.	.	PUNCT
dpc-2259	245	1	2020;20(5):271	2020;20(5):271	NOUN
dpc-2259	245	2	-	-	SYM
dpc-2259	245	3	272	272	NUM
dpc-2259	245	4	.	.	PUNCT
dpc-2259	246	1	doi	doi	NOUN
dpc-2259	246	2	:	:	PUNCT
dpc-2259	246	3	10.1038	10.1038	NUM
dpc-2259	246	4	/	/	SYM
dpc-2259	246	5	s41577	s41577	PROPN
dpc-2259	246	6	-	-	PUNCT
dpc-2259	246	7	020	020	NUM
dpc-2259	246	8	-	-	PUNCT
dpc-2259	246	9	0312	0312	NUM
dpc-2259	246	10	-	-	PUNCT
dpc-2259	246	11	7	7	NUM
dpc-2259	246	12	.	.	PUNCT
dpc-2259	247	1	pmid	pmid	NOUN
dpc-2259	247	2	:	:	PUNCT
dpc-2259	247	3	32296135	32296135	NUM
dpc-2259	247	4	.	.	PUNCT
dpc-2259	248	1	pmcid	pmcid	NOUN
dpc-2259	248	2	:	:	PUNCT
dpc-2259	248	3	pmc7186927	pmc7186927	PROPN
dpc-2259	248	4	.	.	PROPN
dpc-2259	249	1	19	19	NUM
dpc-2259	249	2	.	.	PUNCT
dpc-2259	250	1	kimball	kimball	PROPN
dpc-2259	250	2	ab	ab	PROPN
dpc-2259	250	3	,	,	PUNCT
dpc-2259	250	4	okun	okun	PROPN
dpc-2259	250	5	mm	mm	PROPN
dpc-2259	250	6	,	,	PUNCT
dpc-2259	250	7	williams	williams	PROPN
dpc-2259	250	8	da	da	PROPN
dpc-2259	250	9	,	,	PUNCT
dpc-2259	250	10	et	et	PROPN
dpc-2259	250	11	al	al	PROPN
dpc-2259	250	12	.	.	PROPN
dpc-2259	251	1	two	two	NUM
dpc-2259	251	2	phase	phase	NOUN
dpc-2259	251	3	3	3	NUM
dpc-2259	251	4	trials	trial	NOUN
dpc-2259	251	5	of	of	ADP
dpc-2259	251	6	adalimumab	adalimumab	NOUN
dpc-2259	251	7	for	for	ADP
dpc-2259	251	8	hidradenitis	hidradenitis	PROPN
dpc-2259	251	9	suppurativa	suppurativa	PROPN
dpc-2259	251	10	.	.	PUNCT
dpc-2259	252	1	n	n	PROPN
dpc-2259	252	2	engl	engl	PROPN
dpc-2259	252	3	j	j	PROPN
dpc-2259	252	4	med	med	PROPN
dpc-2259	252	5	.	.	PUNCT
dpc-2259	253	1	2016;375(5):422	2016;375(5):422	NUM
dpc-2259	253	2	-	-	SYM
dpc-2259	253	3	434	434	NUM
dpc-2259	253	4	.	.	PUNCT
dpc-2259	254	1	doi	doi	NOUN
dpc-2259	254	2	:	:	PUNCT
dpc-2259	254	3	10.1056	10.1056	NUM
dpc-2259	254	4	/	/	SYM
dpc-2259	254	5	nejmoa1504370	nejmoa1504370	PROPN
dpc-2259	254	6	.	.	PUNCT
dpc-2259	255	1	pmid	pmid	NOUN
dpc-2259	255	2	:	:	PUNCT
dpc-2259	255	3	27518661	27518661	NUM
dpc-2259	255	4	.	.	PUNCT
dpc-2259	256	1	20	20	NUM
dpc-2259	256	2	.	.	X
dpc-2259	257	1	marasca	marasca	PROPN
dpc-2259	257	2	c	c	PROPN
dpc-2259	257	3	,	,	PUNCT
dpc-2259	257	4	ruggiero	ruggiero	PROPN
dpc-2259	257	5	a	a	PRON
dpc-2259	257	6	,	,	PUNCT
dpc-2259	257	7	megna	megna	PROPN
dpc-2259	257	8	m	m	PROPN
dpc-2259	257	9	,	,	PUNCT
dpc-2259	257	10	annunziata	annunziata	PROPN
dpc-2259	257	11	mc	mc	PROPN
dpc-2259	257	12	,	,	PUNCT
dpc-2259	257	13	fabbrocini	fabbrocini	PROPN
dpc-2259	257	14	g.	g.	PROPN
dpc-2259	257	15	biologics	biologic	NOUN
dpc-2259	257	16	for	for	ADP
dpc-2259	257	17	patients	patient	NOUN
dpc-2259	257	18	affected	affect	VERB
dpc-2259	257	19	by	by	ADP
dpc-2259	257	20	hidradenitis	hidradenitis	PROPN
dpc-2259	257	21	suppurativa	suppurativa	NOUN
dpc-2259	257	22	in	in	ADP
dpc-2259	257	23	the	the	DET
dpc-2259	257	24	covid-19	covid-19	PROPN
dpc-2259	257	25	era	era	NOUN
dpc-2259	257	26	:	:	PUNCT
dpc-2259	257	27	data	datum	NOUN
dpc-2259	257	28	from	from	ADP
dpc-2259	257	29	a	a	DET
dpc-2259	257	30	referral	referral	ADJ
dpc-2259	257	31	center	center	NOUN
dpc-2259	257	32	of	of	ADP
dpc-2259	257	33	southern	southern	PROPN
dpc-2259	257	34	italy	italy	PROPN
dpc-2259	257	35	.	.	PUNCT
dpc-2259	258	1	j	j	PROPN
dpc-2259	258	2	dermatolog	dermatolog	PROPN
dpc-2259	258	3	treat	treat	NOUN
dpc-2259	258	4	.	.	PUNCT
dpc-2259	259	1	2022;33(1):592	2022;33(1):592	NOUN
dpc-2259	259	2	.	.	PUNCT
dpc-2259	260	1	doi	doi	NOUN
dpc-2259	260	2	:	:	PUNCT
dpc-2259	260	3	10.1080/09546634.2020.1769828	10.1080/09546634.2020.1769828	NUM
dpc-2259	260	4	.	.	PUNCT
dpc-2259	261	1	pmid	pmid	NOUN
dpc-2259	261	2	:	:	PUNCT
dpc-2259	261	3	32403954	32403954	NUM
dpc-2259	261	4	.	.	PUNCT
dpc-2259	262	1	21	21	NUM
dpc-2259	262	2	.	.	PUNCT
dpc-2259	263	1	molinelli	molinelli	PROPN
dpc-2259	263	2	e	e	PROPN
dpc-2259	263	3	,	,	PUNCT
dpc-2259	263	4	diotallevi	diotallevi	ADJ
dpc-2259	263	5	f	f	PROPN
dpc-2259	263	6	,	,	PUNCT
dpc-2259	263	7	simonetti	simonetti	PROPN
dpc-2259	263	8	o	o	PROPN
dpc-2259	263	9	,	,	PUNCT
dpc-2259	263	10	et	et	PROPN
dpc-2259	263	11	al	al	PROPN
dpc-2259	263	12	.	.	PUNCT
dpc-2259	263	13	management	management	NOUN
dpc-2259	263	14	of	of	ADP
dpc-2259	263	15	patients	patient	NOUN
dpc-2259	263	16	with	with	ADP
dpc-2259	263	17	hidradenitis	hidradenitis	PROPN
dpc-2259	263	18	suppurativa	suppurativa	NOUN
dpc-2259	263	19	during	during	ADP
dpc-2259	263	20	the	the	DET
dpc-2259	263	21	covid-19	covid-19	PROPN
dpc-2259	263	22	pandemic	pandemic	ADJ
dpc-2259	263	23	:	:	PUNCT
dpc-2259	263	24	risk	risk	NOUN
dpc-2259	263	25	and	and	CCONJ
dpc-2259	263	26	benefit	benefit	NOUN
dpc-2259	263	27	of	of	ADP
dpc-2259	263	28	immunomodulatory	immunomodulatory	ADJ
dpc-2259	263	29	therapy	therapy	NOUN
dpc-2259	263	30	.	.	PUNCT
dpc-2259	264	1	dermatol	dermatol	NOUN
dpc-2259	264	2	ther	ther	ADV
dpc-2259	264	3	.	.	PUNCT
dpc-2259	265	1	2020;33(6):e14256	2020;33(6):e14256	X
dpc-2259	265	2	.	.	PUNCT
dpc-2259	266	1	doi	doi	NOUN
dpc-2259	266	2	:	:	PUNCT
dpc-2259	266	3	10.1111	10.1111	NUM
dpc-2259	266	4	/	/	SYM
dpc-2259	266	5	dth.14256	dth.14256	PROPN
dpc-2259	266	6	.	.	PUNCT
dpc-2259	267	1	pmid	pmid	NOUN
dpc-2259	267	2	:	:	PUNCT
dpc-2259	267	3	32860474	32860474	NUM
dpc-2259	267	4	.	.	PUNCT
dpc-2259	268	1	22	22	NUM
dpc-2259	268	2	.	.	PUNCT
dpc-2259	269	1	cartron	cartron	PROPN
dpc-2259	269	2	a	a	PRON
dpc-2259	269	3	,	,	PUNCT
dpc-2259	269	4	driscoll	driscoll	PROPN
dpc-2259	269	5	ms	ms	PROPN
dpc-2259	269	6	.	.	PROPN
dpc-2259	269	7	comorbidities	comorbiditie	NOUN
dpc-2259	269	8	of	of	ADP
dpc-2259	269	9	hidradenitis	hidradenitis	PROPN
dpc-2259	269	10	suppurativa	suppurativa	NOUN
dpc-2259	269	11	:	:	PUNCT
dpc-2259	269	12	a	a	DET
dpc-2259	269	13	review	review	NOUN
dpc-2259	269	14	of	of	ADP
dpc-2259	269	15	the	the	DET
dpc-2259	269	16	literature	literature	NOUN
dpc-2259	269	17	.	.	PUNCT
dpc-2259	270	1	int	int	PROPN
dpc-2259	270	2	j	j	PROPN
dpc-2259	270	3	womens	womens	PROPN
dpc-2259	270	4	dermatol	dermatol	NOUN
dpc-2259	270	5	.	.	PUNCT
dpc-2259	271	1	2019;5(5):330	2019;5(5):330	NUM
dpc-2259	271	2	-	-	SYM
dpc-2259	271	3	334	334	NUM
dpc-2259	271	4	.	.	PUNCT
dpc-2259	272	1	doi	doi	NOUN
dpc-2259	272	2	:	:	PUNCT
dpc-2259	272	3	10.1016	10.1016	NUM
dpc-2259	272	4	/	/	SYM
dpc-2259	272	5	j.ijwd.2019.06.026	j.ijwd.2019.06.026	PROPN
dpc-2259	272	6	.	.	PUNCT
dpc-2259	273	1	pmid	pmid	NOUN
dpc-2259	273	2	:	:	PUNCT
dpc-2259	273	3	31909152	31909152	NUM
dpc-2259	273	4	.	.	PUNCT
dpc-2259	274	1	pmcid	pmcid	NOUN
dpc-2259	274	2	:	:	PUNCT
dpc-2259	274	3	pmc6938918	pmc6938918	NOUN
dpc-2259	274	4	.	.	PUNCT
dpc-2259	275	1	23	23	NUM
dpc-2259	275	2	.	.	PUNCT
dpc-2259	276	1	zheng	zheng	PROPN
dpc-2259	276	2	z	z	PROPN
dpc-2259	276	3	,	,	PUNCT
dpc-2259	276	4	peng	peng	PROPN
dpc-2259	276	5	f	f	PROPN
dpc-2259	276	6	,	,	PUNCT
dpc-2259	276	7	xu	xu	PROPN
dpc-2259	277	1	b	b	X
dpc-2259	277	2	,	,	PUNCT
dpc-2259	277	3	et	et	PROPN
dpc-2259	277	4	al	al	PROPN
dpc-2259	277	5	.	.	PUNCT
dpc-2259	277	6	risk	risk	NOUN
dpc-2259	277	7	factors	factor	NOUN
dpc-2259	277	8	of	of	ADP
dpc-2259	277	9	critical	critical	ADJ
dpc-2259	277	10	&	&	CCONJ
dpc-2259	277	11	mortal	mortal	ADJ
dpc-2259	277	12	covid-19	covid-19	PROPN
dpc-2259	277	13	cases	case	NOUN
dpc-2259	277	14	:	:	PUNCT
dpc-2259	277	15	a	a	DET
dpc-2259	277	16	systematic	systematic	ADJ
dpc-2259	277	17	literature	literature	NOUN
dpc-2259	277	18	review	review	NOUN
dpc-2259	277	19	and	and	CCONJ
dpc-2259	277	20	meta	meta	ADJ
dpc-2259	277	21	-	-	PUNCT
dpc-2259	277	22	analysis	analysis	NOUN
dpc-2259	277	23	.	.	PUNCT
dpc-2259	278	1	j	j	PROPN
dpc-2259	278	2	infect	infect	VERB
dpc-2259	278	3	.	.	PUNCT
dpc-2259	279	1	2020;81(2):e16	2020;81(2):e16	NUM
dpc-2259	279	2	-	-	NOUN
dpc-2259	279	3	e25	e25	NOUN
dpc-2259	279	4	.	.	PUNCT
dpc-2259	280	1	doi	doi	NOUN
dpc-2259	280	2	:	:	PUNCT
dpc-2259	280	3	10.1016	10.1016	NUM
dpc-2259	280	4	/	/	SYM
dpc-2259	280	5	j.	j.	PROPN
dpc-2259	280	6	jinf.2020.04.021	jinf.2020.04.021	PROPN
dpc-2259	280	7	.	.	PUNCT
dpc-2259	281	1	pmid	pmid	NOUN
dpc-2259	281	2	:	:	PUNCT
dpc-2259	281	3	32335169	32335169	NUM
dpc-2259	281	4	.	.	PUNCT
dpc-2259	282	1	pmcid	pmcid	NOUN
dpc-2259	282	2	:	:	PUNCT
dpc-2259	282	3	pmc7177098	pmc7177098	NOUN
dpc-2259	282	4	.	.	PUNCT
dpc-2259	283	1	24	24	NUM
dpc-2259	283	2	.	.	PUNCT
dpc-2259	284	1	wang	wang	PROPN
dpc-2259	284	2	d	d	PROPN
dpc-2259	284	3	,	,	PUNCT
dpc-2259	284	4	hu	hu	PROPN
dpc-2259	284	5	b	b	PROPN
dpc-2259	284	6	,	,	PUNCT
dpc-2259	284	7	hu	hu	PROPN
dpc-2259	285	1	c	c	X
dpc-2259	285	2	,	,	PUNCT
dpc-2259	285	3	et	et	PROPN
dpc-2259	285	4	al	al	PROPN
dpc-2259	285	5	.	.	PROPN
dpc-2259	286	1	clinical	clinical	ADJ
dpc-2259	286	2	characteristics	characteristic	NOUN
dpc-2259	286	3	of	of	ADP
dpc-2259	286	4	138	138	NUM
dpc-2259	286	5	hospitalized	hospitalize	VERB
dpc-2259	286	6	patients	patient	NOUN
dpc-2259	286	7	with	with	ADP
dpc-2259	286	8	2019	2019	NUM
dpc-2259	286	9	novel	novel	ADJ
dpc-2259	286	10	coronavirus	coronavirus	NOUN
dpc-2259	286	11	-	-	PUNCT
dpc-2259	286	12	infected	infect	VERB
dpc-2259	286	13	pneumonia	pneumonia	NOUN
dpc-2259	286	14	in	in	ADP
dpc-2259	286	15	wuhan	wuhan	PROPN
dpc-2259	286	16	,	,	PUNCT
dpc-2259	286	17	china	china	PROPN
dpc-2259	286	18	.	.	PUNCT
dpc-2259	287	1	jama	jama	PROPN
dpc-2259	287	2	.	.	PUNCT
dpc-2259	288	1	2020;323(11):1061	2020;323(11):1061	NUM
dpc-2259	288	2	-	-	SYM
dpc-2259	288	3	1069	1069	NUM
dpc-2259	288	4	.	.	PUNCT
dpc-2259	289	1	all	all	ADV
dpc-2259	289	2	in	in	ADP
dpc-2259	289	3	all	all	PRON
dpc-2259	289	4	,	,	PUNCT
dpc-2259	289	5	we	we	PRON
dpc-2259	289	6	would	would	AUX
dpc-2259	289	7	like	like	VERB
dpc-2259	289	8	underline	underline	VERB
dpc-2259	289	9	once	once	ADV
dpc-2259	289	10	again	again	ADV
dpc-2259	289	11	that	that	SCONJ
dpc-2259	289	12	hs	hs	PROPN
dpc-2259	289	13	patients	patient	NOUN
dpc-2259	289	14	have	have	VERB
dpc-2259	289	15	multiple	multiple	ADJ
dpc-2259	289	16	associated	associate	VERB
dpc-2259	289	17	comorbidities	comorbiditie	NOUN
dpc-2259	289	18	some	some	PRON
dpc-2259	289	19	of	of	ADP
dpc-2259	289	20	which	which	PRON
dpc-2259	289	21	are	be	AUX
dpc-2259	289	22	also	also	ADV
dpc-2259	289	23	risk	risk	NOUN
dpc-2259	289	24	factors	factor	NOUN
dpc-2259	289	25	for	for	ADP
dpc-2259	289	26	critical	critical	ADJ
dpc-2259	289	27	/	/	SYM
dpc-2259	289	28	mortal	mortal	ADJ
dpc-2259	289	29	covid-19	covid-19	PROPN
dpc-2259	289	30	disease	disease	NOUN
dpc-2259	289	31	.	.	PUNCT
dpc-2259	290	1	in	in	ADP
dpc-2259	290	2	our	our	PRON
dpc-2259	290	3	study	study	NOUN
dpc-2259	290	4	,	,	PUNCT
dpc-2259	290	5	older	old	ADJ
dpc-2259	290	6	age	age	NOUN
dpc-2259	290	7	,	,	PUNCT
dpc-2259	290	8	higher	high	ADJ
dpc-2259	290	9	pack	pack	NOUN
dpc-2259	290	10	-	-	PUNCT
dpc-2259	290	11	years	year	NOUN
dpc-2259	290	12	of	of	ADP
dpc-2259	290	13	smoking	smoking	NOUN
dpc-2259	290	14	,	,	PUNCT
dpc-2259	290	15	having	have	VERB
dpc-2259	290	16	at	at	ADV
dpc-2259	290	17	least	least	ADV
dpc-2259	290	18	one	one	NUM
dpc-2259	290	19	systemic	systemic	ADJ
dpc-2259	290	20	disease	disease	NOUN
dpc-2259	290	21	,	,	PUNCT
dpc-2259	290	22	having	have	VERB
dpc-2259	290	23	a	a	DET
dpc-2259	290	24	cardiovascular	cardiovascular	ADJ
dpc-2259	290	25	disease	disease	NOUN
dpc-2259	290	26	,	,	PUNCT
dpc-2259	290	27	were	be	AUX
dpc-2259	290	28	associated	associate	VERB
dpc-2259	290	29	with	with	ADP
dpc-2259	290	30	increased	increase	VERB
dpc-2259	290	31	risks	risk	NOUN
dpc-2259	290	32	of	of	ADP
dpc-2259	290	33	having	have	VERB
dpc-2259	290	34	covid-19	covid-19	PROPN
dpc-2259	290	35	related	related	ADJ
dpc-2259	290	36	symptoms	symptom	NOUN
dpc-2259	290	37	whereas	whereas	SCONJ
dpc-2259	290	38	higher	high	ADJ
dpc-2259	290	39	disease	disease	NOUN
dpc-2259	290	40	duration	duration	NOUN
dpc-2259	290	41	of	of	ADP
dpc-2259	290	42	hs	hs	PROPN
dpc-2259	290	43	and	and	CCONJ
dpc-2259	290	44	older	old	ADJ
dpc-2259	290	45	age	age	NOUN
dpc-2259	290	46	were	be	AUX
dpc-2259	290	47	correlated	correlate	VERB
dpc-2259	290	48	with	with	ADP
dpc-2259	290	49	significantly	significantly	ADV
dpc-2259	290	50	higher	high	ADJ
dpc-2259	290	51	levels	level	NOUN
dpc-2259	290	52	of	of	ADP
dpc-2259	290	53	covid-19	covid-19	PROPN
dpc-2259	290	54	rt	rt	PROPN
dpc-2259	290	55	-	-	PUNCT
dpc-2259	290	56	pcr	pcr	PROPN
dpc-2259	290	57	positivity	positivity	NOUN
dpc-2259	290	58	.	.	PUNCT
dpc-2259	291	1	treatment	treatment	NOUN
dpc-2259	291	2	type	type	NOUN
dpc-2259	291	3	did	do	AUX
dpc-2259	291	4	not	not	PART
dpc-2259	291	5	seem	seem	VERB
dpc-2259	291	6	to	to	PART
dpc-2259	291	7	contribute	contribute	VERB
dpc-2259	291	8	significantly	significantly	ADV
dpc-2259	291	9	to	to	ADP
dpc-2259	291	10	the	the	DET
dpc-2259	291	11	outcome	outcome	NOUN
dpc-2259	291	12	of	of	ADP
dpc-2259	291	13	covid-19	covid-19	PROPN
dpc-2259	291	14	rt	rt	PROPN
dpc-2259	291	15	-	-	PUNCT
dpc-2259	291	16	pcr	pcr	PROPN
dpc-2259	291	17	test	test	NOUN
dpc-2259	291	18	and	and	CCONJ
dpc-2259	291	19	the	the	DET
dpc-2259	291	20	incidence	incidence	NOUN
dpc-2259	291	21	of	of	ADP
dpc-2259	291	22	covid-19	covid-19	PROPN
dpc-2259	291	23	associated	associated	ADJ
dpc-2259	291	24	symptoms	symptom	NOUN
dpc-2259	291	25	.	.	PUNCT
dpc-2259	292	1	we	we	PRON
dpc-2259	292	2	suggest	suggest	VERB
dpc-2259	292	3	the	the	DET
dpc-2259	292	4	ongoing	ongoing	ADJ
dpc-2259	292	5	tnf	tnf	PROPN
dpc-2259	292	6	-	-	PUNCT
dpc-2259	292	7	α	α	PROPN
dpc-2259	292	8	inhibitor	inhibitor	NOUN
dpc-2259	292	9	treatment	treatment	NOUN
dpc-2259	292	10	should	should	AUX
dpc-2259	292	11	be	be	AUX
dpc-2259	292	12	continued	continue	VERB
dpc-2259	292	13	in	in	ADP
dpc-2259	292	14	patients	patient	NOUN
dpc-2259	292	15	with	with	ADP
dpc-2259	292	16	hs	hs	PROPN
dpc-2259	292	17	,	,	PUNCT
dpc-2259	292	18	unless	unless	SCONJ
dpc-2259	292	19	a	a	DET
dpc-2259	292	20	definitive	definitive	ADJ
dpc-2259	292	21	diagnosis	diagnosis	NOUN
dpc-2259	292	22	of	of	ADP
dpc-2259	292	23	covid-19	covid-19	PROPN
dpc-2259	292	24	is	be	AUX
dpc-2259	292	25	established	establish	VERB
dpc-2259	292	26	.	.	PUNCT
dpc-2259	293	1	our	our	PRON
dpc-2259	293	2	study	study	NOUN
dpc-2259	293	3	has	have	VERB
dpc-2259	293	4	some	some	DET
dpc-2259	293	5	limitations	limitation	NOUN
dpc-2259	293	6	since	since	SCONJ
dpc-2259	293	7	it	it	PRON
dpc-2259	293	8	was	be	AUX
dpc-2259	293	9	a	a	DET
dpc-2259	293	10	single	single	ADJ
dpc-2259	293	11	center	center	NOUN
dpc-2259	293	12	study	study	NOUN
dpc-2259	293	13	and	and	CCONJ
dpc-2259	293	14	no	no	DET
dpc-2259	293	15	control	control	NOUN
dpc-2259	293	16	group	group	NOUN
dpc-2259	293	17	was	be	AUX
dpc-2259	293	18	present	present	ADJ
dpc-2259	293	19	.	.	PUNCT
dpc-2259	294	1	further	further	ADJ
dpc-2259	294	2	multicenter	multicenter	NOUN
dpc-2259	294	3	,	,	PUNCT
dpc-2259	294	4	prospective	prospective	ADJ
dpc-2259	294	5	studies	study	NOUN
dpc-2259	294	6	with	with	ADP
dpc-2259	294	7	large	large	ADJ
dpc-2259	294	8	number	number	NOUN
dpc-2259	294	9	of	of	ADP
dpc-2259	294	10	patients	patient	NOUN
dpc-2259	294	11	are	be	AUX
dpc-2259	294	12	required	require	VERB
dpc-2259	294	13	to	to	PART
dpc-2259	294	14	support	support	VERB
dpc-2259	294	15	our	our	PRON
dpc-2259	294	16	findings	finding	NOUN
dpc-2259	294	17	.	.	PUNCT
dpc-2259	295	1	references	reference	NOUN
dpc-2259	295	2	1	1	NUM
dpc-2259	295	3	.	.	PUNCT
dpc-2259	295	4	lee	lee	PROPN
dpc-2259	295	5	ey	ey	PROPN
dpc-2259	295	6	,	,	PUNCT
dpc-2259	295	7	alhusayen	alhusayen	NOUN
dpc-2259	295	8	r	r	NOUN
dpc-2259	295	9	,	,	PUNCT
dpc-2259	295	10	lansang	lansang	NOUN
dpc-2259	295	11	p	p	NOUN
dpc-2259	295	12	,	,	PUNCT
dpc-2259	295	13	shear	shear	NOUN
dpc-2259	295	14	n	n	CCONJ
dpc-2259	295	15	,	,	PUNCT
dpc-2259	295	16	yeung	yeung	PROPN
dpc-2259	295	17	j.	j.	PROPN
dpc-2259	295	18	what	what	PRON
dpc-2259	295	19	is	be	AUX
dpc-2259	295	20	hidradenitis	hidradenitis	PROPN
dpc-2259	295	21	suppurativa	suppurativa	NOUN
dpc-2259	295	22	?	?	PUNCT
dpc-2259	295	23	can	can	AUX
dpc-2259	295	24	fam	fam	VERB
dpc-2259	295	25	physician	physician	NOUN
dpc-2259	295	26	.	.	PUNCT
dpc-2259	296	1	2017;63(2):114	2017;63(2):114	NUM
dpc-2259	296	2	-	-	SYM
dpc-2259	296	3	120	120	NUM
dpc-2259	296	4	.	.	PUNCT
dpc-2259	297	1	pmid	pmid	NOUN
dpc-2259	297	2	:	:	PUNCT
dpc-2259	297	3	28209676	28209676	NUM
dpc-2259	297	4	.	.	PUNCT
dpc-2259	298	1	pmcid	pmcid	ADJ
dpc-2259	298	2	:	:	PUNCT
dpc-2259	298	3	pmc5395382	pmc5395382	NOUN
dpc-2259	298	4	.	.	PUNCT
dpc-2259	299	1	2	2	X
dpc-2259	299	2	.	.	X
dpc-2259	299	3	ovadja	ovadja	PROPN
dpc-2259	299	4	zn	zn	PROPN
dpc-2259	299	5	,	,	PUNCT
dpc-2259	299	6	schuit	schuit	NOUN
dpc-2259	299	7	mm	mm	PROPN
dpc-2259	299	8	,	,	PUNCT
dpc-2259	299	9	van	van	PROPN
dpc-2259	299	10	der	der	PROPN
dpc-2259	299	11	horst	horst	PROPN
dpc-2259	299	12	cmam	cmam	PROPN
dpc-2259	299	13	,	,	PUNCT
dpc-2259	299	14	lapid	lapid	VERB
dpc-2259	299	15	o.	o.	PROPN
dpc-2259	299	16	inter	inter	PROPN
dpc-2259	299	17	and	and	CCONJ
dpc-2259	299	18	intrarater	intrarater	VERB
dpc-2259	299	19	reliability	reliability	NOUN
dpc-2259	299	20	of	of	ADP
dpc-2259	299	21	hurley	hurley	NOUN
dpc-2259	299	22	staging	stage	VERB
dpc-2259	299	23	for	for	ADP
dpc-2259	299	24	hidradenitis	hidradenitis	PROPN
dpc-2259	299	25	suppurativa	suppurativa	PROPN
dpc-2259	299	26	.	.	PUNCT
dpc-2259	300	1	br	br	PROPN
dpc-2259	300	2	j	j	PROPN
dpc-2259	300	3	dermatol	dermatol	NOUN
dpc-2259	300	4	.	.	PUNCT
dpc-2259	301	1	2019;181(2):344	2019;181(2):344	NUM
dpc-2259	301	2	-	-	SYM
dpc-2259	301	3	349	349	NUM
dpc-2259	301	4	.	.	PUNCT
dpc-2259	302	1	doi	doi	NOUN
dpc-2259	302	2	:	:	PUNCT
dpc-2259	302	3	10.1111/	10.1111/	NUM
dpc-2259	302	4	bjd.17588	bjd.17588	ADJ
dpc-2259	302	5	.	.	PUNCT
dpc-2259	303	1	pmid	pmid	NOUN
dpc-2259	303	2	:	:	PUNCT
dpc-2259	303	3	30585304	30585304	NUM
dpc-2259	303	4	;	;	PUNCT
dpc-2259	303	5	pmcid	pmcid	PROPN
dpc-2259	303	6	:	:	PUNCT
dpc-2259	303	7	pmc6850108	pmc6850108	PROPN
dpc-2259	303	8	.	.	PUNCT
dpc-2259	304	1	3	3	X
dpc-2259	304	2	.	.	X
dpc-2259	304	3	alikhan	alikhan	PROPN
dpc-2259	304	4	a	a	PRON
dpc-2259	304	5	,	,	PUNCT
dpc-2259	304	6	lynch	lynch	PROPN
dpc-2259	304	7	pj	pj	PROPN
dpc-2259	304	8	,	,	PUNCT
dpc-2259	304	9	eisen	eisen	PROPN
dpc-2259	304	10	db	db	PROPN
dpc-2259	304	11	.	.	PROPN
dpc-2259	304	12	hidradenitis	hidradenitis	PROPN
dpc-2259	304	13	suppurativa	suppurativa	PROPN
dpc-2259	304	14	:	:	PUNCT
dpc-2259	304	15	a	a	DET
dpc-2259	304	16	comprehensive	comprehensive	ADJ
dpc-2259	304	17	review	review	NOUN
dpc-2259	304	18	.	.	PUNCT
dpc-2259	305	1	j	j	PROPN
dpc-2259	305	2	am	be	AUX
dpc-2259	305	3	acad	acad	ADJ
dpc-2259	305	4	dermatol	dermatol	NOUN
dpc-2259	305	5	.	.	PUNCT
dpc-2259	306	1	2009;60(4):539	2009;60(4):539	NOUN
dpc-2259	306	2	-	-	PUNCT
dpc-2259	306	3	361	361	NUM
dpc-2259	306	4	.	.	PUNCT
dpc-2259	307	1	doi	doi	NOUN
dpc-2259	307	2	:	:	PUNCT
dpc-2259	307	3	10.1016	10.1016	NUM
dpc-2259	307	4	/	/	SYM
dpc-2259	307	5	j.jaad.2008.11.911	j.jaad.2008.11.911	PROPN
dpc-2259	307	6	.	.	PUNCT
dpc-2259	308	1	pmid	pmid	NOUN
dpc-2259	308	2	:	:	PUNCT
dpc-2259	308	3	19293006	19293006	NUM
dpc-2259	308	4	.	.	PUNCT
dpc-2259	309	1	4	4	X
dpc-2259	309	2	.	.	X
dpc-2259	309	3	pescitelli	pescitelli	PROPN
dpc-2259	309	4	l	l	PROPN
dpc-2259	309	5	,	,	PUNCT
dpc-2259	309	6	ricceri	ricceri	PROPN
dpc-2259	309	7	f	f	PROPN
dpc-2259	309	8	,	,	PUNCT
dpc-2259	309	9	prignano	prignano	PROPN
dpc-2259	309	10	f.	f.	PROPN
dpc-2259	309	11	hidradenitis	hidradenitis	PROPN
dpc-2259	309	12	suppurativa	suppurativa	PROPN
dpc-2259	309	13	and	and	CCONJ
dpc-2259	309	14	associated	associated	ADJ
dpc-2259	309	15	diseases	disease	NOUN
dpc-2259	309	16	.	.	PUNCT
dpc-2259	310	1	g	g	PROPN
dpc-2259	310	2	ital	ital	ADJ
dpc-2259	310	3	dermatol	dermatol	NOUN
dpc-2259	310	4	venereol	venereol	NOUN
dpc-2259	310	5	.	.	PUNCT
dpc-2259	311	1	2018;153(3	2018;153(3	NUM
dpc-2259	311	2	suppl	suppl	ADJ
dpc-2259	311	3	2	2	NUM
dpc-2259	311	4	):	):	PUNCT
dpc-2259	311	5	8	8	NUM
dpc-2259	311	6	-	-	SYM
dpc-2259	311	7	17	17	NUM
dpc-2259	311	8	.	.	PUNCT
dpc-2259	312	1	doi	doi	NOUN
dpc-2259	312	2	:	:	PUNCT
dpc-2259	312	3	10.23736	10.23736	NUM
dpc-2259	312	4	/	/	SYM
dpc-2259	312	5	s0392	s0392	NOUN
dpc-2259	312	6	-	-	PUNCT
dpc-2259	312	7	0488.17.05772	0488.17.05772	NUM
dpc-2259	312	8	-	-	PUNCT
dpc-2259	312	9	8	8	NUM
dpc-2259	312	10	.	.	PUNCT
dpc-2259	313	1	pmid	pmid	NOUN
dpc-2259	313	2	:	:	PUNCT
dpc-2259	313	3	30468375	30468375	NUM
dpc-2259	313	4	.	.	PUNCT
dpc-2259	314	1	5	5	X
dpc-2259	314	2	.	.	X
dpc-2259	314	3	kirby	kirby	PROPN
dpc-2259	314	4	js	js	PROPN
dpc-2259	314	5	,	,	PUNCT
dpc-2259	314	6	butt	butt	PROPN
dpc-2259	314	7	m	m	PROPN
dpc-2259	314	8	,	,	PUNCT
dpc-2259	314	9	esmann	esmann	PROPN
dpc-2259	314	10	s	s	PART
dpc-2259	314	11	,	,	PUNCT
dpc-2259	314	12	jemec	jemec	PROPN
dpc-2259	314	13	gbe	gbe	PROPN
dpc-2259	314	14	.	.	PROPN
dpc-2259	314	15	association	association	PROPN
dpc-2259	314	16	of	of	ADP
dpc-2259	314	17	resilience	resilience	NOUN
dpc-2259	314	18	with	with	ADP
dpc-2259	314	19	depression	depression	NOUN
dpc-2259	314	20	and	and	CCONJ
dpc-2259	314	21	health	health	NOUN
dpc-2259	314	22	-	-	PUNCT
dpc-2259	314	23	related	relate	VERB
dpc-2259	314	24	quality	quality	NOUN
dpc-2259	314	25	of	of	ADP
dpc-2259	314	26	life	life	NOUN
dpc-2259	314	27	for	for	ADP
dpc-2259	314	28	patients	patient	NOUN
dpc-2259	314	29	with	with	ADP
dpc-2259	314	30	hidradenitis	hidradenitis	PROPN
dpc-2259	314	31	suppurativa	suppurativa	PROPN
dpc-2259	314	32	.	.	PROPN
dpc-2259	314	33	jama	jama	PROPN
dpc-2259	314	34	dermatol	dermatol	NOUN
dpc-2259	314	35	.	.	PUNCT
dpc-2259	315	1	2017;153(12):1263	2017;153(12):1263	NUM
dpc-2259	315	2	-	-	SYM
dpc-2259	315	3	1269	1269	NUM
dpc-2259	315	4	.	.	PUNCT
dpc-2259	316	1	doi	doi	NOUN
dpc-2259	316	2	:	:	PUNCT
dpc-2259	316	3	10.1001	10.1001	NUM
dpc-2259	316	4	/	/	SYM
dpc-2259	316	5	jamadermatol.2017	jamadermatol.2017	PROPN
dpc-2259	316	6	.3596	.3596	PROPN
dpc-2259	316	7	.	.	PUNCT
dpc-2259	317	1	pmid	pmid	NOUN
dpc-2259	317	2	:	:	PUNCT
dpc-2259	317	3	29117300	29117300	NUM
dpc-2259	317	4	.	.	PUNCT
dpc-2259	318	1	pmcid	pmcid	NOUN
dpc-2259	318	2	:	:	PUNCT
dpc-2259	318	3	pmc5817438	pmc5817438	ADJ
dpc-2259	318	4	.	.	PUNCT
dpc-2259	319	1	6	6	X
dpc-2259	319	2	.	.	X
dpc-2259	319	3	nguyen	nguyen	PROPN
dpc-2259	319	4	tv	tv	PROPN
dpc-2259	319	5	,	,	PUNCT
dpc-2259	319	6	damiani	damiani	PROPN
dpc-2259	319	7	g	g	PROPN
dpc-2259	319	8	,	,	PUNCT
dpc-2259	319	9	orenstein	orenstein	ADJ
dpc-2259	319	10	lav	lav	PROPN
dpc-2259	319	11	,	,	PUNCT
dpc-2259	319	12	hamzavi	hamzavi	PROPN
dpc-2259	319	13	i	i	PRON
dpc-2259	319	14	,	,	PUNCT
dpc-2259	319	15	jemec	jemec	VERB
dpc-2259	319	16	gb	gb	ADP
dpc-2259	319	17	.	.	PUNCT
dpc-2259	320	1	hidradenitis	hidradenitis	PROPN
dpc-2259	320	2	suppurativa	suppurativa	PROPN
dpc-2259	320	3	:	:	PUNCT
dpc-2259	320	4	an	an	DET
dpc-2259	320	5	update	update	NOUN
dpc-2259	320	6	on	on	ADP
dpc-2259	320	7	epidemiology	epidemiology	NOUN
dpc-2259	320	8	,	,	PUNCT
dpc-2259	320	9	phenotypes	phenotype	NOUN
dpc-2259	320	10	,	,	PUNCT
dpc-2259	320	11	diagnosis	diagnosis	NOUN
dpc-2259	320	12	,	,	PUNCT
dpc-2259	320	13	pathogenesis	pathogenesis	NOUN
dpc-2259	320	14	,	,	PUNCT
dpc-2259	320	15	comorbidities	comorbiditie	NOUN
dpc-2259	320	16	and	and	CCONJ
dpc-2259	320	17	quality	quality	NOUN
dpc-2259	320	18	of	of	ADP
dpc-2259	320	19	life	life	NOUN
dpc-2259	320	20	.	.	PUNCT
dpc-2259	321	1	j	j	PROPN
dpc-2259	321	2	eur	eur	PROPN
dpc-2259	321	3	acad	acad	PROPN
dpc-2259	321	4	dermatol	dermatol	NOUN
dpc-2259	321	5	venereol	venereol	NOUN
dpc-2259	321	6	.	.	PUNCT
dpc-2259	322	1	2021;35(1):50	2021;35(1):50	X
dpc-2259	322	2	-	-	SYM
dpc-2259	322	3	61	61	NUM
dpc-2259	322	4	.	.	PUNCT
dpc-2259	323	1	doi	doi	NOUN
dpc-2259	323	2	:	:	PUNCT
dpc-2259	323	3	10.1111/	10.1111/	NUM
dpc-2259	323	4	jdv.16677	jdv.16677	NUM
dpc-2259	323	5	.	.	PUNCT
dpc-2259	324	1	pmid	pmid	NOUN
dpc-2259	324	2	:	:	PUNCT
dpc-2259	324	3	32460374	32460374	NUM
dpc-2259	324	4	.	.	PUNCT
dpc-2259	325	1	7	7	X
dpc-2259	325	2	.	.	X
dpc-2259	325	3	tchero	tchero	PROPN
dpc-2259	325	4	h	h	NOUN
dpc-2259	325	5	,	,	PUNCT
dpc-2259	325	6	herlin	herlin	NOUN
dpc-2259	325	7	c	c	NOUN
dpc-2259	325	8	,	,	PUNCT
dpc-2259	325	9	bekara	bekara	PROPN
dpc-2259	325	10	f	f	NOUN
dpc-2259	325	11	,	,	PUNCT
dpc-2259	325	12	fluieraru	fluieraru	NOUN
dpc-2259	325	13	s	s	PROPN
dpc-2259	325	14	,	,	PUNCT
dpc-2259	325	15	teot	teot	PROPN
dpc-2259	325	16	l.	l.	PROPN
dpc-2259	325	17	hidradenitis	hidradenitis	PROPN
dpc-2259	325	18	suppurativa	suppurativa	PROPN
dpc-2259	325	19	:	:	PUNCT
dpc-2259	325	20	a	a	DET
dpc-2259	325	21	systematic	systematic	ADJ
dpc-2259	325	22	review	review	NOUN
dpc-2259	325	23	and	and	CCONJ
dpc-2259	325	24	meta	meta	NOUN
dpc-2259	325	25	-	-	PUNCT
dpc-2259	325	26	analysis	analysis	NOUN
dpc-2259	325	27	of	of	ADP
dpc-2259	325	28	therapeutic	therapeutic	ADJ
dpc-2259	325	29	interventions	intervention	NOUN
dpc-2259	325	30	.	.	PUNCT
dpc-2259	326	1	indian	indian	PROPN
dpc-2259	326	2	j	j	PROPN
dpc-2259	326	3	dermatol	dermatol	PROPN
dpc-2259	326	4	venereol	venereol	ADJ
dpc-2259	326	5	leprol	leprol	NOUN
dpc-2259	326	6	.	.	PUNCT
dpc-2259	327	1	2019;85(3):248	2019;85(3):248	NUM
dpc-2259	327	2	-	-	SYM
dpc-2259	327	3	257	257	NUM
dpc-2259	327	4	.	.	PUNCT
dpc-2259	328	1	doi	doi	NOUN
dpc-2259	328	2	:	:	PUNCT
dpc-2259	328	3	10.4103	10.4103	NUM
dpc-2259	328	4	/	/	SYM
dpc-2259	328	5	ijdvl.ijdvl_69_18	ijdvl.ijdvl_69_18	NOUN
dpc-2259	328	6	.	.	PUNCT
dpc-2259	329	1	pmid	pmid	NOUN
dpc-2259	329	2	:	:	PUNCT
dpc-2259	329	3	30924446	30924446	NUM
dpc-2259	329	4	.	.	X
dpc-2259	330	1	8	8	X
dpc-2259	330	2	.	.	X
dpc-2259	330	3	zouboulis	zouboulis	PROPN
dpc-2259	330	4	cc	cc	PROPN
dpc-2259	330	5	,	,	PUNCT
dpc-2259	330	6	desai	desai	PROPN
dpc-2259	330	7	n	n	CCONJ
dpc-2259	330	8	,	,	PUNCT
dpc-2259	330	9	emtestam	emtestam	VERB
dpc-2259	330	10	l	l	PROPN
dpc-2259	330	11	,	,	PUNCT
dpc-2259	330	12	et	et	PROPN
dpc-2259	330	13	al	al	PROPN
dpc-2259	330	14	.	.	PUNCT
dpc-2259	331	1	european	european	PROPN
dpc-2259	331	2	s1	s1	PROPN
dpc-2259	331	3	guideline	guideline	NOUN
dpc-2259	331	4	for	for	ADP
dpc-2259	331	5	the	the	DET
dpc-2259	331	6	treatment	treatment	NOUN
dpc-2259	331	7	of	of	ADP
dpc-2259	331	8	hidradenitis	hidradenitis	PROPN
dpc-2259	331	9	suppurativa	suppurativa	PROPN
dpc-2259	331	10	/	/	SYM
dpc-2259	331	11	acne	acne	NOUN
dpc-2259	331	12	inversa	inversa	NOUN
dpc-2259	331	13	.	.	PUNCT
dpc-2259	332	1	j	j	PROPN
dpc-2259	332	2	eur	eur	PROPN
dpc-2259	332	3	acad	acad	PROPN
dpc-2259	332	4	dermatol	dermatol	NOUN
dpc-2259	332	5	venereol	venereol	NOUN
dpc-2259	332	6	.	.	PUNCT
dpc-2259	333	1	2015;29(4):619	2015;29(4):619	NUM
dpc-2259	333	2	-	-	PUNCT
dpc-2259	333	3	644	644	NUM
dpc-2259	333	4	.	.	PUNCT
dpc-2259	334	1	doi	doi	NOUN
dpc-2259	334	2	:	:	PUNCT
dpc-2259	334	3	10.1111/	10.1111/	NUM
dpc-2259	334	4	jdv.12966	jdv.12966	X
dpc-2259	334	5	.	.	PUNCT
dpc-2259	335	1	pmid	pmid	NOUN
dpc-2259	335	2	:	:	PUNCT
dpc-2259	335	3	25640693	25640693	NUM
dpc-2259	335	4	.	.	PUNCT
dpc-2259	336	1	9	9	X
dpc-2259	336	2	.	.	PUNCT
dpc-2259	336	3	lowe	lowe	PROPN
dpc-2259	336	4	mm	mm	PROPN
dpc-2259	336	5	,	,	PUNCT
dpc-2259	336	6	naik	naik	PROPN
dpc-2259	336	7	hb	hb	PROPN
dpc-2259	336	8	,	,	PUNCT
dpc-2259	336	9	clancy	clancy	NOUN
dpc-2259	336	10	s	s	PROPN
dpc-2259	336	11	,	,	PUNCT
dpc-2259	336	12	et	et	PROPN
dpc-2259	336	13	al	al	PROPN
dpc-2259	336	14	.	.	PROPN
dpc-2259	336	15	immunopathogenesis	immunopathogenesis	NOUN
dpc-2259	336	16	of	of	ADP
dpc-2259	336	17	hidradenitis	hidradenitis	PROPN
dpc-2259	336	18	suppurativa	suppurativa	NOUN
dpc-2259	336	19	and	and	CCONJ
dpc-2259	336	20	response	response	NOUN
dpc-2259	336	21	to	to	ADP
dpc-2259	336	22	anti	anti	ADJ
dpc-2259	336	23	-	-	ADJ
dpc-2259	336	24	tnf	tnf	ADJ
dpc-2259	336	25	-	-	PUNCT
dpc-2259	336	26	α	α	NOUN
dpc-2259	336	27	therapy	therapy	NOUN
dpc-2259	336	28	.	.	PUNCT
dpc-2259	337	1	jci	jci	PROPN
dpc-2259	337	2	insight	insight	PROPN
dpc-2259	337	3	.	.	PUNCT
dpc-2259	338	1	2020;5(19):e139932	2020;5(19):e139932	NUM
dpc-2259	338	2	.	.	PUNCT
dpc-2259	339	1	doi	doi	NOUN
dpc-2259	339	2	:	:	PUNCT
dpc-2259	339	3	10.1172	10.1172	NUM
dpc-2259	339	4	/	/	SYM
dpc-2259	339	5	jci.insight.139932	jci.insight.139932	PROPN
dpc-2259	339	6	.	.	PUNCT
dpc-2259	340	1	pmid	pmid	PROPN
dpc-2259	340	2	:	:	PUNCT
dpc-2259	340	3	32841223	32841223	NUM
dpc-2259	340	4	.	.	PUNCT
dpc-2259	341	1	pmcid	pmcid	NOUN
dpc-2259	341	2	:	:	PUNCT
dpc-2259	341	3	pmc7566733	pmc7566733	ADJ
dpc-2259	341	4	.	.	PUNCT
dpc-2259	342	1	10	10	NUM
dpc-2259	342	2	original	original	ADJ
dpc-2259	342	3	article	article	NOUN
dpc-2259	342	4	|	|	ADV
dpc-2259	342	5	dermatol	dermatol	ADJ
dpc-2259	342	6	pract	pract	NOUN
dpc-2259	342	7	concept	concept	NOUN
dpc-2259	342	8	.	.	PUNCT
dpc-2259	343	1	2022;12(4):e2022192	2022;12(4):e2022192	NUM
dpc-2259	343	2	intern	intern	NOUN
dpc-2259	343	3	med	me	VERB
dpc-2259	343	4	.	.	PUNCT
dpc-2259	344	1	2021;181(5):709	2021;181(5):709	NUM
dpc-2259	344	2	-	-	PUNCT
dpc-2259	344	3	711	711	NUM
dpc-2259	344	4	.	.	PUNCT
dpc-2259	344	5	doi	doi	NOUN
dpc-2259	344	6	:	:	PUNCT
dpc-2259	344	7	10.1001	10.1001	NUM
dpc-2259	344	8	/	/	SYM
dpc-2259	344	9	jamainternmed.2020.8360	jamainternmed.2020.8360	PROPN
dpc-2259	344	10	.	.	PUNCT
dpc-2259	345	1	epmid	epmid	ADP
dpc-2259	345	2	:	:	PUNCT
dpc-2259	345	3	33492361	33492361	NUM
dpc-2259	345	4	.	.	PUNCT
dpc-2259	346	1	pmcid	pmcid	NOUN
dpc-2259	346	2	:	:	PUNCT
dpc-2259	346	3	pmc7835916	pmc7835916	ADJ
dpc-2259	346	4	.	.	PUNCT
dpc-2259	347	1	26	26	NUM
dpc-2259	347	2	.	.	PUNCT
dpc-2259	348	1	kwok	kwok	PROPN
dpc-2259	348	2	s	s	PROPN
dpc-2259	348	3	,	,	PUNCT
dpc-2259	348	4	adam	adam	PROPN
dpc-2259	348	5	s	s	PROPN
dpc-2259	348	6	,	,	PUNCT
dpc-2259	348	7	ho	ho	PROPN
dpc-2259	348	8	jh	jh	PROPN
dpc-2259	348	9	,	,	PUNCT
dpc-2259	348	10	et	et	PROPN
dpc-2259	348	11	al	al	PROPN
dpc-2259	348	12	.	.	PUNCT
dpc-2259	348	13	obesity	obesity	NOUN
dpc-2259	348	14	:	:	PUNCT
dpc-2259	348	15	a	a	DET
dpc-2259	348	16	critical	critical	ADJ
dpc-2259	348	17	risk	risk	NOUN
dpc-2259	348	18	factor	factor	NOUN
dpc-2259	348	19	in	in	ADP
dpc-2259	348	20	the	the	DET
dpc-2259	348	21	covid-19	covid-19	PROPN
dpc-2259	348	22	pandemic	pandemic	NOUN
dpc-2259	348	23	.	.	PUNCT
dpc-2259	349	1	clin	clin	PROPN
dpc-2259	349	2	obes	obes	PROPN
dpc-2259	349	3	.	.	PUNCT
dpc-2259	350	1	2020;10(6):e12403	2020;10(6):e12403	X
dpc-2259	350	2	.	.	PUNCT
dpc-2259	351	1	doi	doi	NOUN
dpc-2259	351	2	:	:	PUNCT
dpc-2259	351	3	10.1111	10.1111	NUM
dpc-2259	351	4	/	/	SYM
dpc-2259	351	5	cob.12403	cob.12403	PROPN
dpc-2259	351	6	.	.	PUNCT
dpc-2259	352	1	pmid	pmid	NOUN
dpc-2259	352	2	:	:	PUNCT
dpc-2259	352	3	32857454	32857454	NUM
dpc-2259	352	4	.	.	PUNCT
dpc-2259	353	1	pmcid	pmcid	NOUN
dpc-2259	353	2	:	:	PUNCT
dpc-2259	353	3	pmc7460880	pmc7460880	PROPN
dpc-2259	353	4	.	.	PUNCT
dpc-2259	354	1	doi	doi	NOUN
dpc-2259	354	2	:	:	PUNCT
dpc-2259	354	3	10.1001	10.1001	NUM
dpc-2259	354	4	/	/	SYM
dpc-2259	354	5	jama.2020.1585	jama.2020.1585	PROPN
dpc-2259	354	6	.	.	PUNCT
dpc-2259	355	1	pmid	pmid	NOUN
dpc-2259	355	2	:	:	PUNCT
dpc-2259	355	3	32031570	32031570	NUM
dpc-2259	355	4	.	.	PUNCT
dpc-2259	356	1	pmcid	pmcid	NOUN
dpc-2259	356	2	:	:	PUNCT
dpc-2259	356	3	pmc7042881	pmc7042881	NOUN
dpc-2259	356	4	.	.	PUNCT
dpc-2259	357	1	25	25	NUM
dpc-2259	357	2	.	.	PUNCT
dpc-2259	358	1	lowe	lowe	PROPN
dpc-2259	358	2	ke	ke	PROPN
dpc-2259	358	3	,	,	PUNCT
dpc-2259	358	4	zein	zein	PROPN
dpc-2259	358	5	j	j	PROPN
dpc-2259	358	6	,	,	PUNCT
dpc-2259	358	7	hatipoglu	hatipoglu	PROPN
dpc-2259	358	8	u	u	PROPN
dpc-2259	358	9	,	,	PUNCT
dpc-2259	358	10	attaway	attaway	PROPN
dpc-2259	358	11	a.	a.	PROPN
dpc-2259	358	12	association	association	PROPN
dpc-2259	358	13	of	of	ADP
dpc-2259	358	14	smoking	smoking	NOUN
dpc-2259	358	15	and	and	CCONJ
dpc-2259	358	16	cumulative	cumulative	ADJ
dpc-2259	358	17	pack	pack	NOUN
dpc-2259	358	18	-	-	PUNCT
dpc-2259	358	19	year	year	NOUN
dpc-2259	358	20	exposure	exposure	NOUN
dpc-2259	358	21	with	with	ADP
dpc-2259	358	22	covid-19	covid-19	PROPN
dpc-2259	358	23	outcomes	outcome	NOUN
dpc-2259	358	24	in	in	ADP
dpc-2259	358	25	the	the	DET
dpc-2259	358	26	cleveland	cleveland	PROPN
dpc-2259	358	27	clinic	clinic	PROPN
dpc-2259	358	28	covid-19	covid-19	PROPN
dpc-2259	358	29	registry	registry	PROPN
dpc-2259	358	30	.	.	PUNCT
dpc-2259	359	1	jama	jama	PROPN